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Infection with Campylobacter is considered to be the most common bacterial cause 
of human gastroenteritis worldwide. In light of the dramatic increase of antibiotic 
resistant bacteria, alternative solutions including biological controls such as 
bacteriophage therapy and bacteriophage biosanitization are being considered. 
One way in which campylobacters enter the human food chain is through 
consumption of contaminated raw milk. An updated study of the ability of 
campylobacters to survive in milk, including species other than C. jejuni, was 
carried out. Isolation of bacteriophages from bovine slurry, with potential for 
biocontrol and therapeutic purposes was attempted using conventional methods. 
Campylobacter and Arcobacter hosts were isolated and characterised, including 
genome sequencing, from the same environment. The method used for this 
purpose was proven efficacious for porcine slurry; however, no lytic phage were 
isolated from bovine samples. During the isolation experiments unusual plaques 
were formed on the lawn of the C. hyointestinalis S12 host strain. The causative 
agent of this lytic activity was found to be due to a new predatory bacterium, 
which was characterised with respect host range and genome sequence. 
Phylogenetic analysis placed the new bacterium in the family Oceanospirillaceae 
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1.1 Campylobacteraceae family 
 
1.1.1 Campylobacteraceae family taxonomy 
 
The Campylobacteraceae and Helicobacteraceae families lie within the order 
Camylobacterales within the epsilon subdivision of the phylum Proteobacteria, the 
Campylobacteraceae family contains three closely related genera, Campylobacter, 
Arcobacter, and Sulfurospirillum (On et al., 2017; Lastovica et al., 2014). A 
number of species that at one time were included the genus Campylobacter, have 
been reclassified into other genera and families within the Epsilonproteobacteria, 
before the genus was first described in 1963, what we now know as Campylobacter 
were classified within the genus Vibrio (Moore and Matsuda, 2002; Moore et al., 
2005). The move to a new genus coincided with recognition of their clinical, 
economical, and ecological importance. The family Campylobacteraceae 








Figure 1.1 Phylogenetic relationships based on 16S rRNA genes of type strains 
belonging to the families Campylobacteraceae and Helicobacteraceae which 





presented by neighbour-joining tree using the Kimura 2-parameter distance 
estimation method, with bootstrapping based on 500 replicates 
Spiral shape microbes have been observed in clinical samples from patients with 
diarrhoeal, gastric problems, and abortion cases since the late 1800s (Escherich, 
1886; Solomon, 1896). However, the difficulty in culturing these bacteria was an 
important issue that prevented further progress. Taxonomy methods in the early 
part of the twentieth century were primitive and bacterial classification was limited 
to the microscopic study of cell morphology, growth requirements, biochemical 
and immunological tests. It was established that the genus Vibrio contained 
species with varied growth requirements and hosts. For example, aerobic species 
like V. cholera had been isolated from human hosts. Microaerobic and anaerobic 
species that caused abortions and fertility problems like V. fetus and V. bubulus 
had bovine and ovine hosts (Smith and Taylor, 1919; Florent, 1953; Costas et al., 
1987). Some species had been isolated from human oral specimens such as V. 
sputorum (Prévot, 1940) and finally the intestinal species V. coli and V. jejuni, 
from porcine and bovine hosts (Doyle, 1948; Jones et al., 1931). All these bacteria 
showed profound differences from V. cholera and were reclassified in a new genus 
called Campylobacter, which means curved bacillus (Sebald and Véron 1963). The 
combination of the guanine-cytosine content (G+C content) of the genomic DNA, 
together with fermentation experiments by Hugh and Leifson (1953) that revealed 
that V. fetus and V. bubulus have different metabolic pathways, both confirmed a 
difference to other Vibrio species (Sebald and Veron, 1963). Ten years later, other 
microaerobic and anaerobic species previously classified as Vibrio, were 
reclassified as Campylobacter species by a study based on their different 
biochemical and serological properties and the G+C content of deoxyribonucleic 
acid (DNA) (Véron and Chatelain, 1973). The importance of the Campylobacter 
genus was highlighted after it was discovered that Campylobacter spp. were often 





was only possible once the first selective media had been developed by Skirrow in 
1977 together with incubation at 43°C in a microaerobic atmosphere and following 
this significant step, many new taxa were described, which included: C. mucosalis 
and C. hyointestinalis from pig intestine (Lawson et al., 1975), C. concisus from 
human oral cavity (Tanner et al., 1981), C. nitrofigilis (now reclassified in the 
Arcobacter genus) from plant roots (McClung et al., 1983), C. lari from gulls 
(Benjamin et al., 1983), C. pylori (now reclassified in the Helicobacter genus) from 
human gastric mucosa (Skirrow, 1983), C. cryaerophilus from pig and cattle 
abortions cases (Neill et al., 1985) and C. cinaedi and C. fennelliae (now 
reclassified in the Helicobacter genus) from human intestine (Totten et al., 1985). 
Modifications of selective culture media allowed other new species to be described 
(Karmali et al., 1986). For example C. mustelae (now reclassified in the 
Helicobacter genus) was isolated from ferret gastric mucosa (Fox et al., 1988), C. 
jejuni subsp. doylei from human enteritis and gastritis (Steele and Owen, 1988), 
C. intracellularae from porcine proliferative enteritis (McOrist et al., 1990), C. 
upsaliensis from dog faeces (Sandstedt and Ursing, 1991) and C. butzleri (now 
reclassified in the Arcobacter genus) from human diarrhoea (Kiehlbauch et al., 
1991). More novel Campylobacter species were described as a variety of different 
animal hosts species were investigated (Priest and Austin, 1993; Gupta, 1998; 
Vandamme et al., 1992b). New species were distinguished by chemotaxonomic 
based methods which included: cellular fatty acid and isoprenoid quinone analysis, 
protein profile study and, DNA-DNA hybridization, which was considered as one of 
the most important tools to discriminate a new bacterial species (Wayne et al., 
1987). Notably the DNA sequence of the 16S subunit of bacterial rRNA gene was 
demonstrated to be one of the powerful tools to defining the phylogenetic diversity 
of Campylobacter species (Romaniuk et al., 1987; Paster and Dewhirst, 1988). A 
new genus called Helicobacter (Goodwin et al., 1989a) was proposed for “C. pylori” 
and “C. mustelae” after analysis of their 16S rRNA gene sequence, electron 





cellular fatty acid composition (Goodwin et al., 1989b). A further significant 
change in Campylobacter species classification occurred after the use of rRNA-
DNA hybridisation resulted in the reclassification of the aerotolerant 
campylobacters into a new genus named Arcobacter to give, A. nitrofigilis, A. 
cryaerophilus, and A. butzleri (Vandamme et al., 1992b). Sulfurospirillum, as a 
novel genus was then created, which included species from environmental 
backgrounds only (Schumacher et al., 1992). Bacteroides ureolyticus was 
reclassified to the Campylobacter genus (Vandamme et al., 2005). 
 
1.1.2 Campylobacteraceae Identification 
 
A wide review by Lastovica et al. (2014) described the identification, diagnostic 
methods, genetic studies and epidemiology of the taxa of Campylobacteraceae 
and it was noted that identification of isolates to species or subspecies level, was 
required for epidemiological subtyping studies.  
 
1.1.3 Campylobacter Phenotypical Features 
 
The requirement for a microaerobic atmosphere is an important distinguishing 
feature for most Campylobacter species. A microaerobic gas mixture containing 
approximately from 3 to 8 % O2, 10% CO2, and 85% N2 is required for optimal 
growth (Jorgensen and PFaller, 2015; Agnetti et al., 2019; Khan et al., 2018). 
Some Campylobacter strain such as C. coli OR12 and probably others, show a 
more aerotolerant behaviour under certain circumstances (O’Kane and Connerton, 
2017). The optimal growth temperature for most Campylobacter species is 37 to 
42°C. No growth occurs below 30°C or above 45°C for most Campylobacter 
species. The group known as thermophilic campylobacters including C. jejuni, C. 
coli and C. lari grow at temperatures above 37°C and form an abundant lawn at 





thermotolerant rather than thermophilic, as it does not grow at 42°C (Debruyne 
et al., 2008; Vandamme, 2000).  
Analysis of G+C content of campylobacters indicates that genus members have a 
low ratio of approximately 29 to 47 mol% (On et al., 2017; Lastovica et al., 2014). 
In general, Campylobacter spp. are less robust toward environmental stress 
compared to other food-borne pathogens. Environmentally stressed or old 
Campylobacter cultures cells, may change their morphology to spherical or coccal 
forms (Klančnik et al., 2013; Griffiths, 1993). The cells size varies from 0.2–0.8 
µm wide and 0.5–5.0 µm in length (Vandamme, 2000). Some members of the 
genus such as C. showae and occasionally C. jejuni isolates, may form straight 
rod-shaped cells rather than curved ones (Wassenaar and Newell, 2006). The 
majority of Campylobacter species are motile with a characteristic corkscrew-like 
motion by a single unsheathed polar flagellum at one end, for example C. 
hyointestinalis (Gebhart et al., 1985) or at both ends of the cell for example C. 
jejuni (Vandamme, 2000; Nachamkin et al., 1993). Another species, C. showae 
has multiple unipolar flagella. In contrast C. gracilis and C. hominis are non-motile 
due to their lack of flagella (Vandamme and De Ley, 1991; Lawson et al., 2001). 
Most Campylobacter spp. will die below pH 4.9 and above pH 9.0, while the 
optimum pH is 6.5–7.5 (Silva et al., 2011). Campylobacter colonies are beige grey, 
have a domed shape and are 1-2 mm diameter when grow on blood agar in a 
microaerobic atmosphere (On and Zhang, 2014). Dry conditions are not well 
tolerated (Fernandez et al., 1985). Campylobacters are sensitive to unfavourable 
osmotic conditions and will be inhibited at concentrations of ≥2% sodium chloride 
(Doyle and Roman, 1982b). Until relatively recently it was believed that 
carbohydrates were neither fermented nor oxidised with amino acids or 
tricarboxylic acid cycle intermediates being used to generate energy (Debruyne et 
al., 2008). However, it has now been demonstrated that the genomes of 1.7% of 





incubation of such strains with glucose enhanced stationary-phase survival and 
biofilm formation (Vegge et al., 2016). 
 
1.1.4 Arcobacter Phenotypical Features 
 
The species of the Arcobacter genus can be discriminated from those of the 
Campylobacter genus by two characteristics. Firstly the ability of arcobacters to 
grow aerobically and secondly their ability to grow at 15-30C which is a lower 
temperature range than campylobacters can tolerate (Vandamme et al., 1992a). 
Arcobacter cell morphology, having curved, S-shaped, or spiral rods, closely 
resembles that of the species of the genus Campylobacter. In general arcobacters 
like campylobacters, are motile with a corkscrew-like motion both having a single 
polar unsheathed flagellum at one or both ends of the cell (Vandamme et al., 
1992a; Vandamme, 2000). Frequently, both Arcobacter species and 
Campylobacter species can be isolated from the same primary isolation plate 
(Serraino et al., 2013; Vilar et al., 2010b; Lastovica, 2006) and the discrimination 
of the two genera can be difficult using phenotypic or biochemical methods in 
routine isolation laboratories (Yan et al., 2000; Bhunia, 2018b). Misidentification 
can be avoided by simply incubating the isolates at 25°C and 37°C under aerobic 
conditions Arcobacter are not known to ferment or oxidize carbohydrates, with 
energy obtained from amino acids or tricarboxylic acid cycle intermediates (On et 
al., 2017). On blood agar, Arcobacter appear as smooth domed colonies that are 
off-white or cream in colour and approximately 1 mm in diameter (On et al., 2017; 









1.2 Campylobacter and Arcobacter typing methods 
 
Bacterial strain typing is important because it allows epidemiological tracking of 
strains with antibiotic resistance, pathogens with increased virulence or 
transmissibility. Genetic heterogeneity among Campylobacter and Arcobacter 
species has meant that until recently there was a lack of effective rapid typing 
methods available (Wassenaar and Newell, 2000). Modern genome sequencing 
technology has superseded most of the methods that had previously been useful 
but are now obsolete and examples of some of these methods include: Serotyping 
(Penner et al., 1980; Lior et al., 1982); Amplified fragment length polymorphism 
(AFLP) (Vos et al., 1995; Duim et al., 1999); Restriction fragment length 
polymorphism (RFLP; Meinersmann et al., 1997); Pulsed field gel electrophoresis 
(PFGE; Nielsen et al., 1998); phage typing (Grajewski et al., 1985) and ribotyping 
(Maidak et al., 1997; Kiehlbauch et al., 1994). There are two methods, multi-locus 
sequence typing (MLST) and whole genome sequencing (WGS), that give sensitive, 
reproducible, and standardised isolate typing results are described in more detail 
below (section 1.2.1 and 1.2.2). 
 
1.2.1 Multi-locus sequence typing 
 
The principle of the MLST method is based on sequencing the nucleotide sequence 
of specific regions of seven housekeeping genes, which are amplified by 
Polymerase chain reaction (PCR). The nucleotide polymorphisms generated by 
natural genetic variation in multiple chromosomal locations provide a type of 
“fingerprint” than can be used to group strains. The combination of each these 
alleles give the sequence type that may be identified by reference to a database. 
This method has been used for the typing Campylobacter species such as C. jejuni, 
C. coli, C. lari, C. upsaliensis, and C. helveticus (Miller et al., 2005; Mossong et 
al., 2016; Kiatsomphob et al., 2019). It has also been used for typing Arcobacter 





advantage of using the MLST technique that is highly reproducible, providing a 
standardised typing scheme for Arcobacter and Campylobacter species. (Miller et 
al., 2009; Pérez-Cataluña et al., 2017; Parisi et al., 2019). Internet-based MLST 
databases assist nomenclature and exchange of MLST results between laboratories. 
This database is stored at Oxford University (http://mlst.zoo.ox.ac.uk; Clark et al., 
2005; Merga et al., 2013). 
 
1.2.2 Whole genome sequencing 
 
The whole genome sequence (WGS) technique is one of the most effective 
methods for typing Campylobacter isolates, the use of WSG for Campylobacter 
isolates has also enhanced understanding in many areas of research particularly 
in epidemiology, source attribution, evolution and ecology (Llarena et al., 2017). 
The first whole Campylobacter genome was published in 2000 (Parkhill et al., 
2000). Since then many hundreds of Campylobacter genomes have deposited in 
the NCBI database. Obtaining the WGS of bacteria has become more accessible 
due to a advances in technology allowing this technique to be used for routine 
surveillance and other different studies (Anjum et al., 2016; O’Kane and 
Connerton, 2017; Liang and Connerton, 2018; Köser et al., 2012). Molecular 
epidemiology of Campylobacter is challenging because of the huge phenotypical 
diversity with extensive genomic structure changes in isolates within the same 
species (Ridley et al., 2008, Wilson et al., 2009). An important application of WGS 
is in surveillance and outbreak detection, establishing the pathogen source, 
transmission pathway and risk factors (Mullner et al., 2009). For example, WSG 
was used in an investigation into an outbreak of 69 cases of campylobacteriosis 
caused by consumption of contaminated raw milk, showing that the 
Campylobacter genomic DNA sequences were identical in both patients and milk 
samples (Kenyon et al., 2020). Moreover, several studies have highlighted the 





resistance of Campylobacter isolated from different sources (Collineau et al., 
2019; DiDonato et al., 2020; Elhadidy et al., 2019). Also the WGS can be used to 
study the interactions of Campylobacter with bacteriophage and the effect of 





1.3 Campylobacter pathogenicity 
 
1.3.1 Virulence factors 
 
The exact pathogenesis mechanisms of Campylobacter spp. are still not fully 
understood, due to the unique characteristics of campylobacters compared to 
other pathogens (Al-Banna et al., 2018; Costa and Iraola, 2019; Guerry, 2007; 
Dasti et al., 2010). Various requirements for pathogenicity, known as virulence 
factors, have been identified (Epps et al., 2013), which include flagella for motility, 
adherence and invasion factors and the ability to excrete toxins (Van Vliet and 
Ketley, 2001; Asakura et al., 2007; Dasti et al., 2010). Flagella are also important 
in the colonisation of the small intestine and colon in humans (Poly and Guerry, 
2008; O'Hara et al., 2012). Cellular inflammation in the intestine is caused by the 
invasion stage, which is followed by a reduction in the intestine’s absorptive 
capacity for the nutrients (Van Deun et al., 2007). The ability of Campylobacter to 
colonise and live in the intestinal tract is a source of discussion for many reasons. 
Firstly, bile salts impact on the bacterial cell survival, secondly, gastric acids 
impact the ability to survive through the stomach (Van Deun et al., 2007), and 
finally the host involved for instance colonisation of poultry caeca has little if any 
detrimental effect whilst colonisation of the human intestine causes severe 
enteritis. In poultry, the caeca is the main location for colonisation by 
Campylobacter, with the viable count reaching 106 to 108 cfu/g (Meade et al., 
2009). The first colonisation location in humans is the small intestine and it 
appears that the individual strain virulence and the host immunity both have an 
important part in determining the disease severity (Havelaar et al., 2009; Zibauer 
et al., 2008) and the suggested mechanism for C. jejuni infection was 






Figure 1.2 Proposed mechanisms of C. jejuni of infection (Backert and Hofreuter, 
2013) 
 
To gain a better understanding of pathogenicity, a different study focused on 
genes that participate in producing proteins that are responsible for virulence of 






Motility is essential for any pathogen to move towards the host target attachment 
sites, which then allows the organism to penetrate the mucus lining of the intestine, 
and finally colonise the intestine (Szymanski et al., 1995). Motility and chemotaxis 
are also vital for campylobacters to survive and multiply in the gastrointestinal 
tract by controlling flagellar movement according to the environmental conditions 
around the bacteria (Bolton, 2015) and Campylobacter genes responsible for 







Table 1.1 Campylobacter motility factors  




On encountering the highly viscous conditions in the intestinal mucosa, 
Campylobacter will show an unusual increase in motility, which is thought to be 
important for colonisation of the small intestine (Ketley and Konkel, 2005; Guerry, 
2007). A key role of the flagellum was to enable persistence in the difficult 
conditions encountered in the gastrointestinal tract (Guerry, 2007) the one or two 
polar flagella and the helical cell shape of cells both contributed to motility of 
campylobacters (Ferrero and Lee, 1988). The flagellum of Campylobacter is 
composed of the flagellar basal body and the extracellular filament structural 
components, the flagellar basal body is comprised of a series of discs that link it 
to the cytoplasm through the inner membrane (Burnham and Hendrixson, 2018). 
Different ring structures with a central rod within the periplasm form the 
mechanistic components, the hook protein structure anchors the flagellum 
filament to the outer membrane (Lertsethtakarn et al., 2011). The Campylobacter 
flagellum structure and genes were characterised by Burnham and Hendrixson 
(2018)(Figure 1.3).  
Gene (s) Product 
flaA FlaA, the major flagellin protein 
flaB FlaB, the major flagellin protein 
fliF FliF, hook basal body protein 
fliM and fliY FliM & FliY, flagellar motor proteins 
flgI FlgI, P-ring in the peptidoglycan 
flgH FlgH, L ring in the outer membrane 
flgE and fliK FlgE & FliK, minor hook components 
fliA σ 28 promoter regulates flaA gene expression 
rpoN σ 54 promoter regulates flaB gene expression 












The flagellar basal body is a complex structure with many different components, 
The flagellar M-ring protein (FliF) protein is linked to a multimer of flagellar motor 
switch protein FliF (MS ring) in the inner membrane that attaches the hook 
assembly to the cell membrane, Flagellar biosynthesis protein required for 
formation of the rod structure of the flagellar apparatus, together with FliI and 
FliH, may constitute the export apparatus of flagellin Flagellar biosynthesis protein 
(FlhA and FlhB), Flagellar biosynthetic protein which have role in flagellar 
biosynthesis protine (FliO), Flagellar biosynthetic protein which plays a role in the 
flagellum-specific transport system (FliP), Flagellar biosynthetic protein which 
have role in flagellar biosynthesis (FliQ) and (FliR)proteins are responsible for 
the type III secretion system (T3SS). The flagellar basal-body rod protein (FliG), 
Flagellar motor switch protein (FliM), (FliN) and (FliY) proteins are all parts that 
form the mechanistic core of flagella is the cytoplasmic C ring (C ring) with FliM 
and FliY proteins serving as flagellar motor switch proteins (Carrillo et al., 2004). 
Moreover, putative flagellar motor proton channel (MotA) and Flagellar motor 
protein (MotB) proteins are the motor components, while Flagellar P-ring protein 
(FlgI) makes up the P ring in the peptidoglycan, Flagellar L-ring protein (FlgH) 
protein is embed in the L ring in the outer membrane, and proteins are minor hook 
components (FlgE and FliK). The main flagellin protein FlaA makes up the 
majority of extracellular filament structure while the FlaB is a minor component 
(Nachamkin et al., 1993; Wassenaar et al., 1993; Sommerlad and Hendrixson, 
2007; Lertsethtakarn et al., 2011). The Flagellin A (FlaA) is encoded by the flaA 
gene and transcription is regulated by the σ28 promoter which is highly conserved 
among different Campylobacter species (Guerry, 2007; Ketley and Konkel, 2005; 
Bolton, 2015) and the transcription of the Flagellin B gene (flaB) gene is 
controlled by the σ54 promoter which responsible for encoding the hook basal body 
filament structure (Guerry, 2007; Ketley and Konkel, 2005; Bolton, 2015). The is 
transcriptional step of these genes is regulated by two elements comprising the 





54 associated transcriptional activator (FlgR)(Hendrixson, 2006). The mutation 
studies reported that the flaA gene is essential for the invasion of epithelial cells 
and mutations in this gene make a significant change in flagella filament structure 
leading to a reduction in bacterial motility (Guerry, 2007). However, no significant 
differences were observed in flagella structures after mutations were created in 
the flaB gene (Guerry, 2007). The mutation of the RNA polymerase sigma-54 
factor gene (rpoN) or RNA polymerase sigma factor for flagellar operon gene 
(fliA) genes which are regulated by σ 54 and σ 28 also leads to a reduction in 
colonisation, as does mutation of motility accessory factor gene (maf5) genes, 
which encode mobility accessory element but mutations in sigma-54 associated 
transcriptional activator gene (flgR) genes resulted in extended colonisation times 
(Hendrixson and DiRita, 2004; Wösten et al., 2004; Fernando et al., 2007). Other 
studies have shown the FlaA protein is vital in colonisation of chickens (Wassenaar 
et al., 1993, Jones et al., 2004). This means that, transcription of the flaA gene is 
key to the control of adherence, colonisation of the gastrointestinal tract and 
invasion of the host cells and avoiding the immune system response (Jain et al., 
2008). In addition, most of the flagella genes have been reported to have roles in 
adherence or invasion of intestine 407 cell in human intestine epithelial (Yao et al., 
1994) or in the chick intestine colonisation stage (Hendrixson and DiRita, 2004). 
Another characteristic of the flagella proposed by Poly and Guerry (2008) is the 
capability of secretion of non-flagellar proteins which are vital to virulence of 
Campylobacter. The flagella of Campylobacter are O-linked glycosylated which is 
central for successful flagellin assembly, motility and chick colonisation (Bolton, 
2015). Importantly, a few studies have highlighted that the flagellar can functions 
as a T3SS, transporting Campylobacter invasion antigens (Cia) into the host cell 










Chemotaxis is the ability of bacterial cells to interpret signals from chemical stimuli 
allowing them to move towards or away from specific conditions. Some pathogenic 
bacteria like Campylobacter rely on this mechanism to invade their hosts cells 
(Bolton, 2015; Korolik, 2019). Chemotaxis has been extensively studied in 
Escherichia coli as an example of an enteric pathogen. These studies provide a 
model for analysis of chemotaxis in campylobacters (Yao et al., 1997; Hendrixson 
and DiRita, 2004; Hartley‐Tassell et al., 2010; Kanungpean et al., 2011). The 
chemotaxis mechanism is achieved by the actions of two-component regulator 
system (TCS) which includes a membrane-associated histidine autokinase sensor 
and a cytoplasmic response regulator protein. The fact that TCS assist to 
recognising and responding to stimulus in the environment means they are 
essential in the pathobiology of enteric pathogens (Howitt et al., 2011). There are 
six chemotaxis proteins comprising the TCS, Che A, B, R, W, Y and Z with methyl-
accepting chemotaxis proteins (MCPs) (Hamer et al., 2010) and the 
Campylobacter chemotaxis genes are outlined by Bolton (2015) in (Table 1.2). 
 
 
Table 1.2 Campylobacter chemotaxis factors   
Gene (s) Product 
cheA, cheB, cheR, cheV, cheW 
and cheZ 
Chemotaxis proteins; Che A, B, R, V, W, & Z. 
tlp1, tlp4 and tlp10 Methyl-accepting chemotaxis proteins (MCPs) 
also called transducer-like proteins 
cheY CheY, response regulator controlling flagellar 
rotation 
cetA and cetB Campylobacter energy taxis system proteins 
CetA (Tlp9) and CetB (Aer2) 
luxS AI-2 biosynthesis enzyme 
acfB AfcB, MCP protein required for persistence in 
the cecum 







The role of the CheW protein is to bind the MCPs to the CheA protein that triggers 
the transfer of a phosphoryl group to either CheY or CheB (Bolton, 2015). In many 
Campylobacter strains the CheW protein is replaced by CheV, which is also enables 
phosphorylation of CheY protein, the phosphorylated protein is joined the to the 
FliM component of the flagellar motor which leads to a change in rotation direction 
from counterclockwise to clockwise(Bolton, 2015). This results in a change in 
motility mode, from smooth forward to sideways tumbling motility and a change 
in direction, the CheY protein is then dephosphorylated by CheZ which will 
reverses the effect and returns to the smooth motility (Lertsethtakarn et al., 2011). 
The mechanisms are controlled by CheR, which allocates methyl groups to the 
MCPs enhancing their ability to activate CheA protein (Guccione et al., 2008). 
These steps are reversed by phosphorylated CheB, which removes the methyl 
groups from MCPs decreasing the ability to activate CheA, which resets the system 
to pre-stimulation position (Hamer et al., 2010; Lertsethtakarn et al., 2011; 
Chandrashekhar et al., 2017). Many metabolic substrates including: alpha-
ketoglutarate, cysteine, L-glutamate, L-aspartate, L-asparagine, L- L-serine and 
pyruvate may be considered as chemotaxis activators (Westfall et al., 1986; 
Mohammed et al., 2004; Velayudhan et al., 2004; Guccione et al., 2008). Other 
metabolites have a role in the chemotaxis system such as L-malate, D-lactate and 
succinate, electron donors including formate and electron acceptors including 
fumarate, dimethyl sulfoxide, nitrite, nitrate and hydrogen peroxide (Myers and 
Kelly, 2004; Weingarten et al., 2008). The components of bile components have 
a significant negative impact to C. jejuni chemotaxis (Hugdahl et al., 1988). The 
Campylobacter genome includes several genes encoding important elements 
called methyl accepting chemotaxis proteins also called transducer like proteins 
(Tlps) (Hugdahl et al., 1988). These work as extracellular signals, sensors or 
stimulators in the form of ligands and they transmit signals to the cytoplasmic 
core chemotaxis signal transduction Che proteins network (Lertsethtakarn et al., 





adaptation to different environments and may contribute to their success as 
foodborne pathogens (Bolton, 2015; Chandrashekhar et al., 2017). 
 
1.3.1.2 Adhesion and binding factors 
 
 
Adherence of Campylobacter to epithelium cells in the intestine is an important 
step in the colonisation process ( Krause-Gruszczynska et al., 2007; Chlebicz and 
Śliżewska, 2018). In vitro experiments using human and non-human cell lines, 
have identified a number of adhesion proteins in C. jejuni including, fibronectin-
binding outer membrane protein CadF (Konkel et al., 2001; Konkel et al., 1997). 
The cadF gene, is one of the most highly conserved regions of the chromosome 
and encodes the 37 kDa CadF outer membrane protein (Hofreuter et al., 2006). 
Mutation of the cadF gene was shown to result in a significant reduction in 
Campylobacter internalisation in INT 407 human intestinal epithelial cells (Krause-
Gruszczynska et al., 2007). Interaction with fibronectin, results in activation of the 
GTPases Rac1 and Cdc42 proteins which stimulate internalisation of 
Campylobacter cells (Bolton, 2015). Interestingly, Ziprin et al. (1999) confirmed 
that the absence of cadF proteins renders C. jejuni unable to colonise chickens. 
Other genes associated with C. jejuni adhesion include: capA, pldA, jlpA, the 




In addition to motility, Campylobacter flagella have an important role in invasion 
of host cells acting as a type three secretion system (T3SS) secreting non-flagellar 
proteins (Poly and Guerry, 2008). Various different experimental animal models 
have shown that invasion of C. jejuni into the colonic epithelial cells results in early 
mucosal damage (Poly and Guerry, 2008; Field et al., 1986; Humphrey et al., 
1985; Welkos, 1984). The ability of Campylobacter to invade host cells is strain 





microtubule-independent mechanisms (Bouwman et al., 2013). The adhesion 
factor CadF is also involved in invasion via fibronectin signalling leading to 
internalisation (Dasti et al., 2010). Campylobacter has been shown to enter into 
INT-407 epithelial cells with its tip first, followed by the flagella (Krause‐
Gruszczynska et al., 2007). The contribution of various other factors in the 
invasion process is still unclear, for example lipooligosaccharides sialylation (LOS; 
Louwen et al., 2008), outer core or the capsular polysaccharide (CPS; Karlyshev 
and Wren, 2001), and invasive antigens (Cia) which are produced in the presence 
of bile (Rivera-Amill et al., 2001). The genes that contribute to invasion in 
Campylobacter were detailed by Bolton (2015) (Table 1.3). Several studies have 
highlighted the role of different flagellar export proteins like CiaB, FlaA, FlaB and 
their homolog FlaC that is secreted via the T3SS into host cell. Homologues of a 
type IV secretion system have identified in a plasmid of C. jejuni 81–176. Mutation 
experiments have shown that the absence of the genes encoding these proteins 
could lead to a decrease in invasion (Bacon et al., 2000; Bacon et al., 2002). 
 
Table 1.3 Campylobacter invasion genes 
Gene (s) Product 
flhA, flhB, fliQ, 
fliP, fliO and  
fliR 
FlhA, FlhB, FliO, FliP, FliQ & FliR, components of the flagellar 
T3SS 
flaC FlaC protein secreted into the host cells and essential for 
colonisation and invasion 
ciaB CiaB, 73-kDa protein involved in adhesion 
ciaC CiaC, protein required for full invasion of INT-407 cells 
ciaI CiaI, reported role in intracellular survival 
iamA IamA, invasion associated protein 
htrA HtrA, chaperone involved in the proper folding of adhesions 
virK VirK, may have a role in protection against antimicrobial 
proteins 
fspA FspA, protein with a role in apoptosis 









1.3.1.4 Iron acquisition  
 
 
In the light of dramatic increase in multidrug resistant bacteria and their negative 
impact on human life, the synergistic relationships among microbial communities 
need to be better understand (Jiricny et al., 2010; Griffin et al., 2004). Pathogenic 
bacteria such as Campylobacter require iron III (Fe+3) for survival and growth, 
the accessibility of the beneficial form of iron is restricted for various reasons such 
as it is bound in a complex such as haemoglobin or lactoferrin (Andrews et al., 
2003), there is limited water solubility in certain conditions and pHs, more 
importantly competition from other microbes within the host (Schalk and Guillon, 
2013; Raymond et al., 2015). Moreover, iron deficiency may be a non-specific 
host defence mechanism to eliminate pathogenic bacteria activity (Andrews et al., 
2003). The pathogenic bacteria have evolved efficient Fe+3 uptake mechanisms in 
order to overcome this limited iron abundance, they secrete high-affinity Fe+3 
chelating agents, called siderophores (Hider and Kong, 2010) for example 
enterobactin (Raines et al., 2016). Sharing of siderophores is an example of 
cooperation between cells which supports bacterial virulence (West and Buckling, 
2003). A study of the C. jejuni NCTC 11168 genome revealed a lack of the genes 
encoding enterobactin from the annotated sequence, which suggested that C. 
jejuni 11168 may utilise enterobactin hydrolysis products for the uptake of Fe+3 
from other microflora in their environment (Raines et al., 2016; Palyada et al., 
2004). It has been suggested that Fe+3 uptake across the outer membrane is 
controlled by two receptors CfrA and CfrB (Xu et al., 2010). Other genes important 
in iron uptake are chuA and chuD which encode outer membrane receptors for 
hemin and haemoglobin uptake (Johnson et al., 2016; Palyada et al., 2004). The 
genes cfrA, cfrB encode outer membrane ferric enterobactin (FeEnt) receptors and 
the fur gene which controls ferric uptake regulator all of which are essential for 






1.3.1.5 Toxin production 
 
 
Cytolethal distending toxin (CDT) causes inhibition in the eukaryotic cell cycle at 
the G2 phase before mitosis (Smith and Bayles, 2006). It is the only toxin reported 
and identified in Campylobacter species including C. jejuni, C. coli, C. lari, C. fetus, 
C. upsaliensis and C. hyointestinalis (Asakura et al., 2007; Kamei et al., 2015; 
Samosornsuk et al., 2015; Johnson and Lior, 1988). Over the last two decades 
significant progress has been achieved in terms of analysing the role of CDT in 
virulence (Karlyshev and Wren, 2001; Hickey et al., 2000). The CDT is composed 
of three active proteins: the CdtB which controls the activation step leading to cell 
cycle blockage, and a protein dimer consisting of both CdtA and CdtC subunits, 
which are associated with transfer of CdtB to the inside of the host cell (Pickett 
and Whitehouse, 1999). Following internalisation, the CdtB protein targets the 
nucleus of the cell and triggers a DNase I-like activity that results in DNA double-
strand breaks. As a result, the cell cycle of the eukaryotic cell is inhibited followed 
by cellular distension and finally cell the death (Lara-Tejero and Galán, 2001; 
Smith and Bayles, 2006). The role of CDT in C. jejuni pathogenesis remains an 
active area of research. Not all C. jejuni isolates possess the genes that codes for 
CDT in their genomes, while some strains that encode the genes, do not produce 
CDT (Pickett et al., 1996). This is probably due to natural mutations (AbuOun et 
al., 2005). Mutants of C. jejuni lacking the CDT genes demonstrate effective 
colonisation of NF-kB-deficient mice similar to wild type (Fox et al., 2004). 
 
1.4 Arcobacter pathogenicity  
 
Awareness of arcobacters as important foodborne pathogens has increased 
dramatically due to the rising number of food-related outbreaks of illness (Ramees 
et al., 2017; Mottola et al., 2016; Noor and Maniha, 2019). Arcobacters are 
considered to be emerging, foodborne, zoonotic pathogens, worldwide (Ferreira et 





are not completely understood. The International Commission on Microbiological 
Specifications for Foods (ICMSF) has described Arcobacter as a serious hazard to 
human health (ICOMSFF, 2002). The transmission and pathogenesis mechanisms 
for arcobacters proposed by Ramees et al (2017)(Figure 1.4). Historically, 
Arcobacter was first isolated and described from aborted bovine foetal tissues (Ellis 
et al., 1977), and similarly isolated from porcine foetuses (Ellis et al., 1978). Later 
it was realised that arcobacters can cause bacteraemia, endocarditis, peritonitis, 
gastroenteritis and diarrhoea in humans. They cause diarrhoea, mastitis and 
abortion in animals (Jiang et al., 2010; Figueras et al., 2014; Ferreira et al., 
2016b). The proposed mechanisms of diarrhoea include the production of a 
cytotoxin, affecting expression of tight junction proteins of the epithelial gut cells, 
release of pro-inflammatory cytokines and epithelial barrier dysfunction leading to 
cell death (Figueras et al., 2014). The organism is released from the intestines of 
animals into the environment where it contaminates water and food sources 
thereby entering the human food chain (Ramees et al., 2017). The most frequent 
species of Arcobacter isolated from humans or animals with clinical conditions are 
A. butzleri, A. cryaerophilus, A. skirrowii and A. aremore (Gill, 1983; Kiehlbauch 
et al., 1991; De Oliveira et al., 1997; Wesley, 1997; Wesley et al., 2000; 
Bagalakote et al., 2014; Ramees et al., 2014b). In addition, Arcobacter bacteria 
can found in healthy human stool specimens and animal faeces without any clinical 
signs, which means that their pathology and pathogenicity are contentious (Öngör 
et al., 2004; Shah et al., 2011; Houf and Stephan, 2007; Figueras et al., 2014) 
The confirmation of culturing is still considered as the “gold standard” method for 
distinguishing and diagnosing Arcobacter (Atabay and Corry, 1998; Rahimi, 2014; 







Figure 1.4 The proposed transmission and pathogenesis mechanisms for 
arcobacters. Adapted from Ramees et al. (2017) 
 
1.5 Campylobacter and Arcobacter isolation, 
enrichment and maintenance 
 
1.5.1 Isolation, enrichment, and maintenance of 
Campylobacter 
 
Isolation of thermophilic campylobacters from clinical samples is achieved by using 
selective media supplemented with antibiotics to inhibit the competitive microflora, 
followed by incubation under microaerobic conditions at 42°C (Endtz et al., 1991; 
Jorgensen and PFaller, 2015). For food and environmental samples, which are 
more likely to include low numbers of campylobacters, enrichment methods are 
used, followed by growth on selective media supplemented with antibiotics (Gharst 
et al., 2013). Pre-enrichment may further increase chances of isolating injured 





if mixed populations of strains and species are present only the most numerous 
individual strain may be isolated (Gharst et al., 2013; Silva et al., 2011). The 
Campylobacter species such as C. hyointestinalis and C. concisus have different 
optimum growth temperatures and atmosphere requirements for successful 
culture (Gebhart et al., 1985; Gebhart et al., 1983; Tanner et al., 1981; 
Vandamme et al., 1989). Once single colonies have been obtained, culture media 
such as Columbia agar, Tryptose Blood Agar, and Mueller-Hinton agar can be used 
to sub-culture and maintain the culture for between three to four days (Lastovica 
et al., 2014).  
 
1.5.2 Isolation, Enrichment, and Maintenance of Arcobacter 
 
There is no standard method for the isolation of Arcobacter despite many different 
culture media having been described for use with a variety of different sample 
types (Collado and Figueras, 2011). Probably the most commonly used method 
for isolation of Arcobacter is by inoculation of enrichment broth containing 
cefoperazone, amphotericin B, and teicoplanin (CAT) followed by microaerobic 
incubation at 30°C for two days. (Atabay and Corry, 1997). A study carried by 
Merga et al. (2011) assessed five different methods to isolate Arcobacter from 
various animal faecal samples and revealed that, using enrichment broth prior to 
culture on modified charcoal-cefoperazone-deoxycholate agar (mCCDA) 
supplemented with a combination of antibiotics was the most effective method. 
Many other methods to isolate Arcobacter have been were described (Johnson and 
Murano, 1999; Houf et al. 2001; Van Driessche et al. 2003). Elimination of the 
competitive flora by enrichment may give an advantage to some Arcobacter 
species over other species or other bacteria in the same sample (Atabay et al., 
2006; Houf et al., 2001; Andersen et al., 2007). Inconsistencies outcomes 
between the culture and molecular detection methods for arcobacters have been 





example enrichment periods or different culture media, which may lead to 
unrepresentative results (Ho et al., 2006a; Fera et al., 2004; González et al., 
2006). The ability to grow under both microaerobic and aerobic conditions, has 
also been employed for the isolation of Arcobacter species but more frequently to 
discriminate the Campylobacter genus from the Arcobacter genus (Collado and 
Figueras, 2011; Vandamme et al., 1991). Arcobacter cultures are easy to maintain 
because they have can grow at a range of temperatures between 15 and 30 °C, 
including room temperature, under aerobic conditions. This means that Arcobacter 
may be sub-cultured and left on the laboratory bench to grow without the need 
for an incubator (Lastovica et al., 2014; Vandamme et al., 1992a). Due to the 
fastidious nature of Arcobacter species and their biochemical similarity with 
Campylobacter species, their phenotypic discrimination is complicated. Genetic 
methods such as polymerase chain reaction (PCR)-based methods are employed 
to successfully differentiate isolates (Brightwell et al., 2007; Douidah et al., 2010). 
Multiplex PCR based methods have used to target genus and species-specific 
sequences (Houf et al., 2000; Antolıń et al., 2001; González et al., 2006; Ramees 
et al., 2014b). Conventional PCR has been used as rapid tool for the detection of 
Arcobacter spp. from food and other samples (González et al., 2010; de Boer et 
al., 2013). 
 
1.6 Ecology of Campylobacter and Arcobacter 
 
 
1.6.1 Ecology of campylobacters 
 
Campylobacter species are widely distributed in the environment and have been 
isolated from: soil (Jäderlund et al., 2011), muddy puddles (Blaser et al., 2018), 
beach sand (Yamahara et al., 2012), and environmental water samples (Lévesque 
et al., 2008). The possible routes of transmission of C. jejuni into the human food 







Figure 1.5 Campylobacter jejuni transmission routes into the human food chain 
Adapted from Dasti et al.(2010) 
 
Campylobacters inhabit the intestines of birds, most mammals including humans, 
they are voided in faeces into the environment in large numbers where they 
survive until ingested by a new host (Dasti et al.2010). It has been shown that 
campylobacters can survive in compost made from cattle faeces for up to ten 
months (Inglis et al. (2010). A different Campylobacter species, sources and 
associated disease outlined by  Lastovica et al.(2014)(Table 1.4). These 
thermophilic campylobacters have the ability to invade and colonise the intestinal 
mucosa and caecum of birds that have a normal body temperature of at 42°C 
(Pajaniappan et al., 2008; Line et al., 2010). Campylobacter have been isolated 
from the faeces of cats, dogs (Rahimi et al., 2012; Koene et al., 2009), and also 
from sheep, goats and cattle (Moriarty et al., 2011; Hanlon et al., 2018; Dong et 
al., 2016; An et al., 2018). Also, Non confirmed disease association Campylobacter 





al., 2020), from (Boukerb et al., 2019), from (Gilbert et al., 2018), from (Cáceres 
et al., 2017), from (Van et al., 2016) and from (Piccirillo et al., 2016) (Table 1.5).  
 
In the food chain, seafood, uncooked meat and raw milk are considered to serve 
as reservoirs for some Campylobacter species (Wilson and Moore, 1996; Taylor et 
al., 2013; Wong et al., 2007; Narvaez-Bravo et al., 2017; Davis et al., 2016; Hauri 
et al., 2013; Hill et al., 2012). Consumption of contaminated groundwater has led 
to large waterborne Campylobacteriosis outbreaks in Norway and other countries 




















Adapted from Lastovica et al.(2014) 
 
Campylobacter Isolation sources  Human disease Animal disease 
C. jejuni subsp. jejuni Humans, dogs, cattle, birds, 
poultry, cattle, sheep, milk, 
seafood, water 
Enteritis, septicaemia, abortion, appendicitis, 
colitis, myocarditis, reactive arthritis, Reiter’s 
syndrome, Guillain-Barré syndrome 
Spontaneous abortion (bovine, 
ovine); gastroenteritis (canine, 
feline) 




Pigs, cattle, hamsters Enteritis, septicaemia  
C. ureolyticus Humans, milk, bovine faeces Ulcerative colitis  
C. fetus subsp. fetus Cattle, sheep, dogs, turtles Septicaemia, meningitis, vascular infection, 
abortion 
Spontaneous abortion bovine, 
ovine 
C. concisus Humans, dogs, cats Inflammatory bowel disease, periodontal 
disease, enteritis, septicaemia, Barrett’s 
oesophagus 
Enteritis canine 
C. curvus Humans Gastroenteritis; abscesses  
C. gracilis Dogs, humans Abscesses  
C. fetus subsp. 
venerealis 
Cattle Septicaemia Infectious fertility bovine 
C. insulaenigrae Seals, porpoises Enteritis, septicaemia  
C. jejuni subsp. doylei Humans, dogs Enteritis, septicaemia  
C. lari subsp. lari Cats, dogs, chickens, seals, 
mussels, oysters 
Enteritis, septicaemia  
C. rectus Humans Abscesses  
C. showae Humans, dogs Septicaemia, cholangitis  
C. sputorum bv. 
sputorum 
Humans, cattle, pigs, sheep Abscesses  






Table 1.5 Campylobacter species without any confirmed disease association 
Campylobacter Isolation sources  
C. avium a Chickens, turkeys  
C. canadensis a Whooping and Sandhill 
cranes 
 
C. cuniculorum a Rabbits  
C. helveticus a Dogs, cats  
C. hominis a Humans  
C. hyointestinalis subsp. 
lawsonii a 
Pigs, poultry, birds  
C. lanienae a Humans, cattle  
C. lari subsp. Concheus a Unknown  
C. mucosalis a Pigs, dogs  
C. peloridis a Humans, molluscs  
C. sputorum bv. 
paraureolyticus a 
Cattle, humans  
C. sputorum bv. faecalis 
a 
Cattle  
C. subantarcticus a Penguins, albatrosses  
C. troglodytis a Chimpanzees  
C. volucris a Black-headed gulls  
C. portucalensis b Bulls  
C. armoricus c Surface of water and 
humans 
 
C. blaseri d Common seals  
C. ornithocola e Wild birds  
C. hepaticus f Chickens  
C. geochelonis g Hermann's tortoise  
Adapted from aData from Lastovica et al.(2014), bfrom Silva et al.(2020), cfrom 
Boukerb et al.(2019), dfrom Gilbert et al.(2018), efrom Cáceres et al.(2017), ffrom 
Van et al.(2016) and gfrom Piccirillo et al.(2016).  
 
1.6.2 Ecology of Arcobacter 
 
 
Arcobacters contaminate various types of environmental water which have been 
associated with their transmission to humans and animals (Ho et al., 2006a; 
Snelling et al., 2006). These include groundwater, rivers, lakes, seawater and 
piggery effluent, irrigation water and even drinking water (Talay et al., 2016; 
Chinivasagam et al., 2007; Lee et al., 2012; Fong et al., 2007; Collado et al., 
2010). The most frequently isolated species and most well studied are A. butzleri, 





which can interact with animals and humans (Fernandez et al., 2015, Bogantes et 
al., 2015). Many studies have suggested that animal and human faecal 
contamination may play an important role in Arcobacter contamination of water 
(Van Driessche et al., 2003; Collado et al., 2008). the development of the 
Arcobacter taxonomy scheme proposed by Ramees et al.( 2017)(Figure 1.6). 
 













Table 1.6 Arcobacter species, sources, year of isolation and pathogenicity 
association 
*Known as human and animal pathogens 
 Adapted from Lastovica et al.(2014) 
 
The Arcobacter genus was established in the year 1991, and there are currently 
27 species of Arcobacter. Arcobacter species such as A. halophilus, A. marinus and 
A. defluvii are found in sewage (Pérez-Cataluña et al., 2019, Pérez-Cataluña et al., 
2018). Interestingly, some Arcobacter species can survive in water for 250 days 
at 4°C (Van Driessche and Houf, 2008). The members of Arcobacter species, 
sources of isolation and their pathogen status listed by Lastovica et al.(2014) 
(Table 1.6). Food from animal origin are proposed to be the source of Arcobacter 
entry in to the human food chain (Ho et al., 2006a, Ferreira et al., 2016a, On et 
al., 2002).  
Arcobacters have been isolated from healthy cattle, sheep and pigs (Ho et al., 
2006a, Ho et al., 2006b, De Smet et al., 2011, Patyal et al., 2011, Ferreira et al., 
2016b). More recently, arcobacters have been isolated from raw milk in Italy 
(Traversa et al., 2019, Marta et al., 2020). Poultry have identified as a major 
Arcobacter species Isolation source Isolation year 
A. bivalviorum Mussels, clams 2012 
A. butzleri * Pigs, bulls, horses, cattle, chicken, 
dogs, cats, primates, ostriches, 
ducks, water, sewage 
1991,2000 
A. cibarius Chicken 2005 
A. cloacae Sewage, mussels 2013 
A. cryaerophilus * Pigs, bulls, chicken, sheep, horses, 
dogs, cats, sewage 
1985 
A. defluvii Sewage 2011 
A. ellisii Mussels 2011 
A. halophilus Hypersaline lagoon water 2005 
A. marinus Seawater 2010 
A. molluscorum Mussels, oysters 2011 
A. mytili Mussels 2009 
A. nitrofigilis * Estuarine plant roots 1983 
A. skirrowii Sheep, bulls, pigs, chicken, ducks 1992 
A. suis Pork meat 2013 
A. thereius Pigs, ducks 2009 
A. trophiarum Pigs 2011 





reservoir of arcobacters suggesting they have a central role in the spread of these 
bacteria (Collado and Figueras, 2011, Rahimi, 2014, Dekker et al., 2019). Recently, 
researchers have reported contaminated water and meat as important agents in 
the transmission of this pathogen in to the food chain (González and Ferrús, 2011, 
Snelling et al., 2006, Collado et al., 2010, Rahimi, 2014). Arcobacters have been 
frequently isolated from slaughterhouse samples, even after disinfection; 
therefore, slaughterhouses may be an underestimated epidemiological source of 
these bacteria (Collado et al., 2010, Patyal et al., 2011, Ramees et al., 2014a, 
Ramees et al., 2014b). A wide range of genetic diversity has reported for 
Arcobacter isolates recovered from different parts of the world with associated 
antibiotic resistance (Bagalakote et al., 2014, Mohan et al., 2014, Ferreira et al., 
2016b). Shellfish may present an additional source of Arcobacter where many 
different species have been isolated from clams and mussels such as: A. mytili, A. 
molluscorum, A. bivalviorum, A. venerupis, and A. ellisii ,these findings have 
resulted in increased public health concern about consumption of seafood, which 
may get inadequate heat treatment before consumption (Figueras et al., 2011, 






1.7 Antibiotic resistance 
 
 
1.7.1 Campylobacter antibiotic resistance 
 
Over the decades since Campylobacter was first described, there has been a 
dramatic increase in antibiotic resistance to fluoroquinolones and macrolides. 





cases may require antibiotic therapy (Zhang and Sahin, 2020; Sproston et al., 
2018). Antibiotic resistance in campylobacters has been reported in different 
studies since the 1980’s (Flores et al., 1985; Taylor and Courvalin, 1988; Taylor 
et al., 1987). Studies since then have highlighted a trend of increasing resistance 
among C. jejuni isolates (Gaudreau and Gilbert, 2003). One study in the USA 
observed that the fluoroquinolone resistance among C. jejuni clinical isolates, had 
increased to approximately 40% in 2001 (Nachamkin et al., 2002). Moreover, 
fluoroquinolone resistance among Campylobacter isolates from human or animal 
background, has been detected in many European countries (Pezzotti et al., 2003; 
Papavasileiou et al., 2007; Avrain et al., 2003). Asian and African countries, have 
also observed resistance (Boonmar et al., 2005; Isenbarger et al., 2002; Nhung 
et al., 2016; Bester and Essack, 2008; Samuel et al., 2006). In addition, high 
levels of antibiotic resistance were reported in Australia and New Zealand (Sharma 
et al., 2003; Goodchild et al., 2001; Harrow et al., 2004). Interestingly different 
observations have shown that fluoroquinolone resistance is higher among C. coli 
compared to C. jejuni isolates (Rossi et al., 2015; EFSA, 2015; EFSA, 2014; 
Sproston et al., 2018) but the reasons for this were not clear. However, even 
distribution of fluoroquinolone resistance between the two species has also been 
reported (Gaudreau et al., 2014). The ciprofloxacin (CIP) resistance in C. jejuni 
and C. coli from different sources suggested by Sproston et al.(2018)(Table 1.6). 
It is believed that increasing resistance to fluoroquinolones, tetracycline, and 
erythromycin in C. jejuni and C. coli could be linked to the excessive usage of 
antibiotics in animal production (Silva et al., 2011; Sproston et al., 2018). 
Restrictions and limitations on the use antibiotics in animal production were 
applied in the EU in 2003 and 2006 and in the USA from 2005 (Sproston et al., 
2018; Castanon, 2007; Nelson et al., 2007). Monitoring programs have been 
approved, to ensure the implementation of this legislation (Organization, 2014). 
The resistance to fluoroquinolone mechanism in campylobacters is based on 





inhibition of DNA gyrase A (GyrA), which is responsible for initiation of DNA 
replication and transcription (Wieczorek and Osek, 2013; Smith and Fratamico, 
2010; Luangtongkum et al., 2009). It’s proposed that mutation is achieved by a 
single point mutation in the gyrA gene switching from threonine to isoleucine in 
the Gyrase A subunit at position 86 (Wieczorek and Osek, 2013; Yang et al., 2017). 
Resistance to other antibiotics is often mediated by the Campylobacter multidrug 
efflux pump (CME). CME contains different proteins such as a  periplasmic protein 
CmeA, an inner membrane efflux transporter CmeB and an outer membrane 
protein CmeC (Bolton, 2015). Three types of operon, cme A, B and C, control 
expression of the CME encoding proteins, which is modulated by CmeR, a 
transcriptional repressor, probably by inhibiting the cj0561c gene, which encodes 
a putative periplasmic protein (Lin et al., 2002). Moreover, mutation of the CmeR 



































Table 1.7 Campylobacter jejuni and Campylobacter coli resistance to Ciprofloxacin 
(CIP) 





















UK 2008 Campylobacter 
spp. 
37.5 (803) 
Europe 2014 C. jejuni, C. coli 60.2 (11,585), 
68.9 (1,500) 




USA 2012 C. jejuni 16.3 (22) 
USA 2012-
2013 





















Europe 2015 C. coli 62.1 (704) 




1.7.2 Arcobacter antibiotic resistance 
 
 
Only a few antibiotic susceptibility studies targeting Arcobacter species have been 
carried out. Antimicrobial resistance and potential pathogenicity of Arcobacter 
species are therefore still poorly understood (Levican et al., 2013a; Karadas et al., 
2013). Usually, Arcobacter infections in humans are self-limiting, however when 
antibiotics are recommended, the fluoroquinolones and tetracycline are the most 
frequent treatments prescribed (Son et al., 2007). In a study by Houf et al. (2004) 
isolates of A. butzleri and A. cryaerophilus isolated from poultry were resistant to 





antimicrobials are the most prescribed as antibiotics used to treat human 
Campylobacteraceae infection. In another study, 17 strains of A. butzleri and 13 
strains of A. cryaerophilus, were highly resistant to penicillins, macrolides, 
chloramphenicol, trimethoprim, and vancomycin (Fera et al., 2003). Other studies 
have demonstrated that isolates of A. butzleri, A. cryaerophilus, and A. skirrowii 
were resistant to various antibiotics such as nalidixic acid, metronidazole, 






1.8 Aim of study 
 
One of the objectives of this study was to investigate the survival of 
campylobacters in milk. Another goal was to isolate lytic bacteriophages with 
biocontrol potential from farm environments that could target campylobacters and 
arcobacters and in order to achieve this Campylobacter and Arcobacter hosts had 
to be isolated from farm environments and characterised, which included genome 
sequencing. To achieve these objectives, a novel genus of predatory bacteria was 
















































2.1 Growth, storage media and chemical solutions 
 
All culture media for both growth and storage, were prepared using reverse 
osmosis (RO) water and then sterilised by autoclaving at 121°C and 15 psi for 15 
minutes. The supplements or selective antibiotics were added to agar media when 
tempered to 50°C in a water bath. The molten media were then poured into sterile 
plastic Petri dishes (Sarstedt, Leicester, UK) in a laminar flow cabinet. After they 
were dry, the plates containing media were stored at 4°C for up to four weeks. 
Liquid media were stored at room temperature after autoclaving and cooling, 
unless otherwise stated. 
 
2.1.1 Blood agar (BA) 
 
Blood agar base No. 2 CM0271 (Oxoid, Basingstoke, UK) containing: proteose 
peptone 15.0 g/l, liver digest 2.5 g/l, yeast extract 5.0 g/l, sodium chloride 5.0 
g/l, agar 12.0 g/l, was prepared according to manufacturer’s instructions. After 
the sterilisation, the base medium was cooled down to 45-50°C, then 5 % v/v 
defibrinated horse blood from (HB035; TCS; Buckingham; UK) was added, and 
mixed gently prior to pouring into Petri dishes. To reduce colony swarming the 
percentage of the agar was increased to 2% w/v. Any bubbles were removed by 
briefly passing a Bunsen flame over the molten medium in the Petri dish, to ensure 
clear viewing of the plates and accurate colony counting. 
 
2.1.2 Modified Campylobacter blood-free selective agar 
(mCCDA) 
 
Campylobacter blood-free selective agar CM0739 (Oxoid) containing: nutrient 
broth No.2 25.0 g/l, bacteriological charcoal 4.0 g/l, casein hydrolysate 3.0 g/l, 





g/l, agar 12.0 g/l, was prepared according to manufacturer’s instructions. The 
base medium was supplemented with an extra 4 g of bacteriological agar No. 1 
LP0011 (Oxoid) to give a final percentage agar of 2% (w/v) when prepared for 
colony counting experiments to reduce swarming. For experiments aimed to 
isolate Campylobacter spp. from slurry samples Campylobacter selective 
supplement (SR0155; Oxoid) was added to the culture media. A vial of supplement 
was re-suspended in 2 ml of sterile RO water and aseptically dispensed into 500 
ml of tempered mCCDA, mixed well, then the medium poured into Petri dishes. 
The final concentration of cefoperazone and amphoteracin were 32 mg/l and 10 
mg/l respectively. For experiments that involved the isolation of Arcobacter spp. 
from slurry samples, cefoperazone, amphotericin B, teicoplanin selective 
supplement (CAT) SR0155 (Oxoid) was added to the culture medium. A vial of 
supplement was re-suspended in 4 ml of sterile RO water and aseptically 
dispensing into 500 ml of tempered mCCDA, mixed well, then poured into Petri 
dishes.  The final concentration of cefoperazone, amphotericin B, teicoplanin were 
0.8 mg/l, 0.4 mg/l and 10 mg/l respectively. 
 
2.1.3 New Zealand Casamino Yeast Medium (NZCYM) basal 
agar 
 
NZCYM Broth 240410 (Difco; Oxford, UK) containing: pancreatic digest of casein 
10 g/l, casamino acids 1 g/l, yeast extract 5 g/l, sodium chloride 5 g/l, magnesium 
sulphate, anhydrous 0.98 g/l, was prepared according to manufacturer’s 
instructions and bacteriological agar No. 1 (Oxoid) was added to a final 
concentration of 1.5% w/v, after autoclaving the medium was allowed to cool to 







2.1.4 NZCYM overlay agar 
 
NZCYM overlay agar was prepared as above but to a final bacteriological agar No. 
1 (Oxoid) to a final concentration of 0.6% w/v. The agar was melted in a 
microwave and tempered to 50°C and then aseptically dispensed into 5 ml aliquots 
in sterile glass universal tubes prior to use. 
 
2.1.5 Nutrient broth No. 2  
 
Nutrient Broth No.2 CM0067 (Oxoid) containing: ‘Lab-Lemco’ powder 10 g/l, 
peptone 10 g/l, sodium chloride 5 g/l, was prepared according to manufacturer’s 
instructions by adding 25 g powder to 1 litre of RO water. After autoclaving, the 
medium was stored in at room temperature for a maximum of eight weeks. 
 
2.1.6 Nutrient Agar (NA)  
 
Nutrient Broth No.2 CM0067 (Oxoid) containing: ‘Lab-Lemco’ powder 1 g/l, yeast 
extract 2 g/l, peptone 5 g/l, sodium chloride 5 g/l and agar 15 g/l, was prepared 
according to manufacturer’s instructions by adding 28g powder to 1 litre of RO 
water. After autoclaving this was cooled to 50°C and poured into Petri dishes. 
 
2.1.7 Brain Heart Infusion agar (BHI) 
 
Brain heart infusion agar CM1136 (Oxoid) containing brain infusion solids 12 g/l, 
beef heart infusion solids 5 g/l, proteose peptone 10 g/l, sodium chloride 5 g/l, 
glucose 2 g/l, disodium phosphate 2.5 g/l and agar 10 g/l was prepared according 
to manufacturer’s instructions by adding 47 g powder to 1 litre of RO water. After 





2.1.8 Mueller-Hinton (MH) agar 
 
Mueller-Hinton (MH) agar CM0337 (Oxoid) containing: beef, dehydrated infusion 
from 300 g/l, casein hydrolysate 17.5 g/l, starch 1.5 g/l and agar 17 g/l, was 
prepared according to manufacturer’s instructions by adding 38 g powder to 1 litre 
of RO water. After autoclaving, this was cooled to 50°C and poured into Petri 
dishes. 
 
2.1.9 Maximum Recovery Diluent (MRD) 
 
Maximum Recovery Diluent CM0733 (Oxoid) containing peptone 1.0 g/l, sodium 
chloride 8.5 g/l, was prepared according to manufacturer’s instructions, by 
suspending 9.5 g powder in 1 litre RO water and the mixture autoclaved. 
 
2.1.10 Phosphate Buffer Saline (PBS) 
 
Phosphate buffered saline BR0014 (Oxoid) was prepared from Dulbecco `A’ 
Tablets containing: NaCl 0.8% (w/v), KCl 0.02% (w/v), Na2HPO40.115% (w/v) 
and KH2PO40.02% (w/v). Solutions were prepared by dissolving one phosphate 
buffered saline tablet in 100 ml of RO water. PBS buffer was stored at room 
temperature for a maximum of 8 weeks. 
 
2.1.11 Salt Magnesium (SM) buffer 
 
Salt magnesium buffer was prepared by dissolving NaCl (Thermo Fisher) 5.8 g/l, 
MgSO4.7H2O (Fisher Scientific) 2 g/l, tris (hydroxymethyl) amino methane 
(Sigma-Aldrich, Dorset, UK) 6 g/l and gelatine (Sigma-Aldrich, Dorset, UK) to a 





the buffer was autoclaved and stored at room temperature for a maximum of eight 
weeks. 
2.1.12 Magnesium Sulphate Stock solution 
 
A 1 M MgSO4.7H2O (Fisher Scientific) stock solution was prepared in RO water and 
autoclaved. This was added to bacterial cultures at a working dilution of 10 mM, 
to isolate or propagate bacteriophage, in order to stabilise the phage. 
 
2.1.13 Bacterial storage medium 
 
Bacterial storage medium was prepared by mixed with nutrient broth No.2 (2.1.5) 
with glycerol to a final concentration of 20% v/v. this was followed by autoclaving, 
the bacterial storage medium was then aseptically aliquots in 1 ml in a 1.5 ml 
cryovial tube (Thermo Fisher Scientific) and stored at room temperature for a 
maximum of eight weeks. 
2.2 Bacterial strains 
 
Bacterial strains used in this thesis, listed in (Table 2.1) . 
Table 2.1 Bacterial strains used in this thesis 
Organism Strain Source 
V. cucullus 5Lx Cattle isolate / Laboratory stock 
A. skirrowii A2S6 Cattle isolate / Laboratory stock 
C. jejuni PT14 Human isolate / Laboratory stock 
C. jejuni NCTC 11168 Human isolate / NCTC 
C. jejuni 81-176 Human isolate / Laboratory stock 
C. coli RM2228 Human isolate / Laboratory stock 
C. coli S9 Cattle isolate / Laboratory stock 







2.3 Growth conditions 
 
2.3.1 Microaerobic incubation 
 
Different methods were used to generate microaerobic growth conditions 
according to the circumstances required.  For most of the work described plates 
were incubated in 3.5 litre jars (Oxoid, Basingstoke, UK). A vacuum pump was 
used to reduce pressure was -22 psi and then the gas pressure was restored with 
a gas mix containing 5% v/v hydrogen, 85% v/v nitrogen and 10% v/v carbon 
dioxide (BOC limited, Surrey, UK). This procedure generated an atmosphere 
containing approximately 5.6% v/v oxygen, 3.6% v/v hydrogen, 7.3% v/v carbon 
dioxide and 83% v/v nitrogen. The jar was then placed in an incubator at the 
required temperature. For Venatorbacter cucullus and C. ureolyticus this was 
37°C. For A. skirrowii the jars were incubated at 30°C. This method was also used 
to prepare jars for storage at 4C. Campylobacter jejuni and C. coli isolates were 
cultured in a Modular Atmospheric Controlled System (MACS) cabinet (Don Whitley 
Scientific, Shipley, UK) with a gas mixture of 5% v/v oxygen, 2% v/v hydrogen, 
88% v/v nitrogen, 5% v/v carbon dioxide (BOC Limited) set at 42C.  
 
2.3.2 Aerobic incubation 
 
Different temperatures were used to grow bacterial strains aerobically. For 











2.4.1 Long-term storage 
 
For long-term storage at -80°C, bacterial strains were firstly grown under optimum 
conditions on BA (2.1.1). A sterile cotton swab was then used to collect the pure 
growth from the plates, which was dispersed into 1 ml aliquots of bacteriological 
storage medium (2.1.13) in 1.5 ml cryovial tubes. These were stored at -80°C 
until ready for use. The cryovial was thawed partially and approximately 10 μl of 
the frozen suspension removed to a blood agar plate using a sterile plastic loop. 
This was then incubated depending on the bacterial growth requirements. These 
stocks were revived regularly to check for viability and contamination. 
 
2.4.2 Short-term storage 
 
For short-term storage, a subculture was taken from the -80°C frozen stock to 
plate of BA (2.1.1). This was incubated at optimum conditions for each bacterium, 
which could then be stored at 4°C under ether microaerobic conditions for 
Campylobacter or aerobically for A. skirrowii for a maximum of four weeks.  
 
2.5 Bacterial enumeration 
 
All the bacteria described in this thesis were enumerated by a modification of the 
Miles Misra technique (Miles et al., 1938). Ten-fold serial dilutions from the 
bacterial suspension were prepared into PBS (2.1.10). Triplicate 10 μl aliquots of 
each dilution were dispensed on the surface of a mCCDA (2.1.2) or BA plate (2.1.1) 
containing 2 % agar. The plates were then allowed to dry in proximity of a Bunsen 
burner. Afterwards they were inverted and incubated under optimum conditions 





and 30, were counted and the average of the five spots was determined. The 
colony forming units per ml value (CFU/ml) was then calculated by multiplying the 
average number of colonies by the dilution factor and then by 100. 
 
2.6 Confirmatory tests 
 
Different primary tests were used to confirm the identity of the bacterial isolates 
described in this thesis. 
 
2.6.1 Gram stain 
 
Gram stain reagents were prepared according to manufacturer’s instructions 
before use.  Bacterial colonies to be tested were aseptically removed from a blood 
agar plate (2.1.1) and then emulsified into 10 μl of PBS (2.1.12) on a glass 
microscope slide (BDH Lab supplies, Leicestershire, UK) using a 10 μl inoculation 
loop. The bacterial suspension was air-dried followed by fixing with heat from a 
Bunsen burner. The slide was immersed in crystal violet solution (Prolab 
diagnostics, Bromborough, UK) for one minute and the excess solution was rinsed 
off with RO water. The slide was then placed in Lugol’s iodine (Prolab) for thirty 
seconds and excess solution was rinsed off with RO water. Then, the slide was 
immersed in 70% ethanol v/v (ThermoFisher) for one minute in order to 
decolourise the stained bacterial cells, followed by rinsing off excess ethanol with 
RO water. Finally, the slide was immersed in carbol fuschin counterstaining 
solution (Prolab) for thirty seconds and then excess solution was rinsed off with 
RO water. The slide was air-dried and examined under oil immersion using a light 






2.6.2 Oxidase test 
 
Oxidase detection strips (MB02666; Oxoid) were used in this test. Each strip is 
impregnated with NNN’N’ tetramethyl-p-phenylene-diamine dihydrochloride to 
detect the bacterial cytochrome oxidase enzyme activity. A single colony was 
removed by loop to oxidase detection strips, after 5 to 10 seconds the presence 
of the deep blue colour indicated a positive result and either light blue or no colour 
indicated a negative result.  
 
2.6.3 Absence or present of aerobic growth 
 
With all bacterial isolates, this test was carried out by taking a loopful of pure 
culture and using it to inoculate duplicate BA (2.1.1) plates. These were then 
incubated under aerobic and microaerobic conditions at the required temperature 
for example 30, 37, or 42°C. The growth was checked daily for up to 7 days. 
 
2.7 Sample collection 
 
Cattle slurry samples were collected from University of Nottingham - Dairy Centre 
located at Kingston on Soar, Nottingham LE12 5RY coordinates (52.839240, -
1.249674). The slurry samples were collected in 50 ml sampling pots with aseptic 
technique and put into a sterile polythene bag then into a sampling box. The 
samples were then transferred immediately to the laboratory and kept at 4C to 







2.8 Bacteria isolation from cattle slurry 
 
A mix of 1 g cattle slurry sample and a 9 ml of maximum recovery diluent was 
prepared (2.1.9). This was considered as 10-1 dilution and serial ten-fold dilutions 
were made from this suspension. Campylobacter spp. were isolated by plating 100 
µl from the 10-3 and 10-4 dilutions, in triplicate, on mCCDA supplemented with 
Campylobacter selective supplement (2.1.2). To isolate Arcobacter spp. 100 µl of 
the same dilutions were spread on mCCDA in triplicate but this time the media 
was supplemented with CAT (2.1.2). Plates were then incubated under 
microaerobic conditions (2.3.1) for 48 h at 42°C for Campylobacter spp. isolation 
work and at 30°C for Arcobacter spp. isolation. For both purposes, single colonies 
which had a typical Campylobacter or Arcobacter morphology on mCCDA media 
were sub-cultured on BA (2.1.1) and incubated under similar conditions before 
Gram stains of selected colonies were carried out to confirm typical Campylobacter 
and Arcobacter cell morphologies. Sub-culture was repeated for another four times 
to purify the single colony. Pure isolates were stored for the long term in bacterial 
storage media (2.1.13) at -80 °C in sterile 1.5 ml cryogenic tubes. 
 
2.9 Confirming bacterial identity by molecular 
techniques  
 
2.9.1 Genomic DNA extraction 
 
All bacterial genomic DNA were isolated using the GenElute Bacterial Genomic DNA 
Kit (Sigma-Aldrich) following the manufacturer’s instructions. In brief, cells from 
individual purified isolates were harvested from a quarter of an abundant lawn 
grown on BA plates (2.1.1) into 1.5 ml of PBS (2.1.10). The suspensions were 
then centrifuged at 12,000 x g for 2 minutes at room temperature using a Heraeus 





Solution T (BB6678: composition confidential) and 20 μl of RNase A solution 
(R6148: composition confidential) were added followed by incubation at room 
temperature for 2 minutes. A 20 μl aliquot of 20 mg/ml Proteinase K (Sigma-
Aldrich) stock solution was then added and the mixtures was incubated for 30 
minutes at 55°C. Then, 200 μl of Lysis Solution C (B8803: composition 
confidential) was added to each sample and thoroughly vortexed for 15 seconds 
to achieve a homogenised mixture followed by a further incubation at 55°C for 10 
minutes. Columns were prepared by adding 500 μl of Column Preparation Solution 
(C2112: composition confidential) then centrifuged in a Heraeus Pico 17 bench-
top at 12,000 x g for 1 minute. The eluates were then discarded. An aliquot of 200 
μl of absolute ethanol (Fisher Scientific) was added to each lysate samples and 
mixed well by vortexing for 5-10 seconds. This was then loaded onto the prepared 
column and centrifuged at 6,500 x g for 1 minute using a Heraeus Pico 17 bench-
top centrifuge. The eluate and collection tube were both discarded, while all 
columns were placed into new 2 ml collection tubes. Next, 500μl of Wash Solution 
1 (W0263: composition confidential) was added to the columns and all the tubes 
were again centrifuged for 1 minute at 6,500 x g. The collection tubes were 
discarded and replaced and 500 μl of Wash Solution 1 was added to the column 
for a second wash. The columns were then centrifuged at maximum speed of a 
Heraeus Pico 17 bench-top centrifuge for 3 minutes to dry the column. The 
collection tube was discarded and replaced. The DNA was eluted by carefully 
adding 200 μl of Elution Solution (B6803: 10 mM Tris-HCl, 0.5 mM EDTA, pH 9.0) 
directly to the centre of each column. Finally, tubes were then centrifuged at 6,500 
x g for 1 minute in a Heraeus Pico 17 bench-top centrifuge in order to collect the 
eluted DNA. The genomic DNA samples were then stored at 4°C for short-term 










The primers used to amplify the V3-V4 region of the bacterial 16S rRNA are listed 
in (Table 2.2). 
Table 2.2 The primers used to amplify the V3-V4 region of bacterial 16S 
rRNA genes 
 
2.9.2.2 PCR amplification of the 16S rRNA gene 
 
The PCR reaction was conducted using DreamTaq Green 2x PCR Master Mix 
(applied Biosystems, 850 Lincoln Centre Drive, Foster City, California,USA) 
(ThermoFisher) in a BIOER XP thermal cycler machine. A Master Mix containing 2 
U of DreamTaq DNA polymerase, 2x DreamTaq Green buffer, 0.4 mM of dNTP each 
and 4 mM of magnesium chloride along with two dyes (blue/yellow) to monitor 
electrophoresis progress was prepared. The reaction was prepared by adding 12.5 
μl of PCR master mix with 30- 50 ng of template DNA, 10 pmol of forward and 
reverse primer in a final volume of 25 μl, RNAase free water was used during 
preparation of the PCR mix. The reaction was carried out using the following 
parameters: initial denaturation at 95°C for five minutes; the PCR cycle, starting 
from amplification including denaturation at 94°C for 30 seconds, annealing at 
55°C for 30 seconds and extension at 72°C for 2 minutes. This cycle was repeated 
35 times. A final extension period at 72°C for ten minutes completed the reaction. 
Amplified PCR products were verified by agarose gel electrophoresis (2.9.3.1), and 
then stored at either 4°C for short term or -20°C for long term storage. 
Primer 
Name 









61.2 ~450-bp (Hugerth et al., 
2014) 





2.9.2.3 Cleaning PCR products 
 
A Wizard SV Gel and PCR clean up system from Promega (2800 Woods Hollow 
Road · Madison, WI 53711-5399 USA) was used to remove debris, extcess 
nucleotides and primers. An equal volume of membrane binding solution was 
added to the PCR product. This mixture was transferred into the SV minicolumn. 
Prior to the centrifuge, the column was incubated at room temperature for one 
minute and then centrifuged in a Biofuge Pico bench top centrifuge at 13,000 x g 
for one minute. The flow- through solvent was discarded and 700 μl of Membrane 
Wash Solution was added onto the SV minicolumn. Again, the column was 
centrifuged in a Biofuge Pico bench top centrifuge (Hettich Lab Technology, North 
America, USA) at 13,000 x g for one minute and the flow through was discarded. 
A second 500 μl of membrane Wash Solution was added to the column and the 
column was centrifuged in a Biofuge Pico bench top centrifuge at 13,000 x g for 
five minutes. The flow-through of Wash Solution was removed and the column 
was centrifuged in a Biofuge Pico bench top centrifuge at 13,000 x g, with open 
lids to evaporate ethanol residual which can interfere with the samples. The SV 
minicolumn was then transferred into a new 1.5 ml fresh Eppendorf tube and 50 
μl of nuclease free water was applied to the column. The column was incubated at 
room temperature for one minute to elute the DNA sample. This was followed by 
centrifuging in a Biofuge Pico bench top centrifuge (Hettich Lab Technology, North 
America, USA) at 13,000 x g for one minute. The eluate contained the pure PCR 
product. The DNA concentration was measured using a Nano-drop 
spectrophotometer. Purified PCR products were stored at either 4°C for short term 







2.9.3 Gel electrophoresis 
 
2.9.3.1 Agarose gel electrophoresis 
 
DNAs extracted from bacterial isolates were routinely analysed by agarose gel 
electrophoresis (0.8% agarose) unless otherwise stated. Briefly, the agarose gel 
was prepared by adding 0.8% w/v agarose (Invitrogen) to 50 ml of 1x TAE buffer 
(40 mM tris-acetate adjusted with glacial acetic acid to pH 8, 1 mM disodium 
ethylene diamine tetra acetic acid) in a 250 ml sterile conical flask. The mixture 
was melted in a microwave and allowed to cool to approximately 50°C. Ethidium 
bromide (Fisher Scientific, Bishop Meadow Road, Loughborough, Leicestershire, 
LE11 5RG) was added at a final concentration of 0.4 μg/ml and mixed by gently 
swirling the flask. The mixture was then poured into a gel casting tray with an 
appropriately sized comb. The gel was allowed to set at room temperature for 
approximately 35 minutes. Carefully, the end rubbers and comb were removed 
from the casting tray. The casting tray was then placed in a gel electrophoresis 
tank containing TAE buffer, and DNA samples mixed with 1 x blue/ orange loading 
dye (Promega) were loaded into the wells. A 100 bp DNA ladder (Promega,2800 
Woods Hollow Rd., Madison, Wisconsin, USA) was also loaded to estimate the size 
of DNA samples. A negative control was also loaded in to one of the gel wells to 
check for contamination. The gel was run at 75 V for approximately 50 minutes 
until the bromophenol blue dye reached more than 1/2 length of the gel. Finally, 









2.9.3.2 Purification of amplified 16S rRNA gene sequences from agarose 
gels 
 
PCR amplification products were separated by agarose gel electrophoresis and 
visualised using a long-wavelength UV transilluminator. The fragments were 
excised from the gel using a sterile scalpel and transferred into a pre-weighed 
Eppendorf tube. The weight of the excised gel slice was determined using a digital 
balance and the amplified DNA extracted from gel slice using wizard SV Gel and 
PCR clean up system (section 2.9.2.3). After estimating the gel weight, membrane 
binding solution was added at the ratio of 10 μl of solution per 10 mg of agarose 
gel. This was then incubated at 60°C until the gel was completely dissolved. Next, 
melted gel mixture was transferred SV minicolumn. The DNA samples were then 
purified as described in (2.9.2.3) and stored at 4°C for a short term or -20°C for 
long term storage. 
 
2.10 DNA sequencing and analysis  
 
 
2.10.1 Dye-terminator DNA sequencing 
 
Purified PCR products were sequenced using dye-terminator chemistry with 
custom primers (Eurofins Value Read Service, Germany). PCR amplified 16s rRNA 
gene sequences were compared with other 16s rRNA gene sequences using the 
BLAST-N algorithm to search the 16 rRNA database (Camacho et al., 2009). 
 
2.10.2 Genome sequencing of bacterial isolates 
 
Genomic DNA from A. skirrowii A2S6, C. coli S9 and C. hyointestinalis S12 were 





the Illumina MiSeq platform (The University of Nottingham, Sutton Bonington 
Campus, UK). Sequence libraries were prepared following the Illumina NexteraTM 
tagmentation protocol (Illumina, Cambridge, UK). The libraries were sequenced 
using the v3 Illumina cassette. The data consisted of 3-4 million 100-250 bp 
paired-end sequence reads. Initial processing of the raw data and de novo 
assembly was performed using CLC Genomic Workbench v. 11.0.1 (Qiagen, 
Aahus, Denmark) by Prof. I. Connerton. 
 
2.10.3 Annotation of A. skirrowii A2S6, C. coli S9 and C. 
hyointestinalis S12 isolates  
 
The complete genome of A. skirrowii A2S6, C. coli S9 and C. hyointestinalis S12 
were annotated automatically using the program Prokka version 1.07 (Seemann, 
2014) running on a virtual unix machine (unbuntu). Frame shifts or any errors in 
the sequence assembly were confirmed using a combination of translated Basic 
Local Alignment Search Tool (BLAST; (Camacho et al., 2009), to observe protein 
translations for each nucleotide sequence and Artemis (Rutherford et al., 2000), 
to examine the six reading frames and determine which bases were responsible 
for the frame shifts. Once all potential frameshifts were confirmed the complete 
genome of A. skirrowii A2S6, C. coli S9 and C. hyointestinalis S12 were deposited 
in GenBank under the accession number CP034309.1, CP040239.1and 
CP040464.1 respectively. Genome comparisons were made between the genome 
sequences of A. skirrowii A2S6, C. coli S9 and C. hyointestinalis S12 and the 








2.11 Transmission electron microscopy 
 
The transmission electron microscopy (TEM) was performed for some of the 
bacterial isolates discussed in this thesis. The TEM technique used included two 
staining steps. The first step was sample fixing, which aimed to render the bacteria 
non-viable and stabilise the bacterial cell wall. This involved adding a loopful of 
bacterial culture to 600 μl of fixative solution in 1.5 ml Eppendorf tube, which has 
been prepared in advance through mixing 2.5 ml 0.2 M cacodylate buffer (pH 7.4), 
1.9 ml distilled water into 600 μl 25% v/v EM glutaraldehyde. The suspension was 
then incubated at room temperature for 1 hour. The tube was then centrifuged 
using a Biofuge Pico bench top centrifuge at room temperature at 10,000 x g for 
1 minute. Using a sterile 1 ml tip, the supernatant was removed to a disposable 
tube under fume hood section. An aliquot of 1 ml of 0.1 M cacodylate buffer was 
added without disturbing the pellet to wash the pellet then incubated for 10 
minutes at room temperature and then centrifuged at room temperature at 10,000 
x g for one minute. The supernatant was discarded, and the pellet was then 
resuspended into 700 μl of 0.1 M cacodylate buffer twice. The sample was then 
stored at 4°C until required. The second step was staining. An aliquot of 13 μl of 
fixed bacterial suspension was transferred onto the formvar carbon film on copper 
200 mesh grid (Emgrid Australia Pty Ltd PO Box 118, The Patch Vic 3792, 
Australia) and incubated at room temperature for 5 minutes. The suspension was 
removed by using filter paper and 13 μl of 2% w/v uranyl acetate was added onto 
the grids for 30 seconds. After staining, uranyl acetate was removed by using filter 
paper Whatman No.1 (Camlab Ltd, Unit 24, Norman Way Industrial Estate, Over 
Cambridge, CB24 5WE, United Kingdom). The sample was then washed twice to 
improve the image quality by adding 13 μl of distilled water to the grid, then 







2.12 Statistical analysis 
 
 
For statistical analysis, the one-way analysis of variance (ANOVA) is used to 
determine whether there are any statistically significant differences between the 
means of two or more independent (unrelated) groups.  The (ANOVA) was 









Survival of Campylobacter spp. and 





























Milk is a nutritious liquid secreted by female mammals for the sustenance of their 
young, it consists of an emulsion of fat in an aqueous solution of protein, lactose 
and inorganic salts (Bianchini et al., 2014). Milk from cows’ forms a major part of 
the human diet in many countries, however, is an excellent medium for bacterial 
growth and can therefore be a source of pathogens (Robinson et al., 2014). Heat 
treatment known as pasteurisation has done much to make milk a safe product 
but occasional failure of the process (Fernandes et al., 2015), or the desire of 
people to consume raw milk can lead to large outbreaks of diarrhoeal and other 
illnesses for example those caused by Campylobacter spp. Campylobacter spp. 
detected in milk or in milk filters include: C. jejuni, C. hyointestinalis ssp. 
hyointestinalis, C. concisus, C. fetus ssp. fetus, C. coli and C. lari (Bianchini et al., 
2014; Del Collo et al., 2017). Most cases of Campylobacterosis associated with 
milk consumption are caused by C. jejuni (Robinson et al., 2014). ISO 10272 
provides general guidance for the preparation of test samples for milk and milk 
products (https://www.iso.org/obp/ui/#iso:std:iso:10272:-1:ed-2:v1:en), formulated in 
response to the recognition that milk is a source of Campylobacter. The advent of 
molecular techniques has meant that the more unusual species, that cannot be 
detected by routine culture, have been identified in cattle stool samples and in 
milk, one of these species is C. ureolyticus that is a known gastrointestinal 
pathogen, and for which a source had not previously been identified (Koziel et al., 
2012). Little research has been carried out on the survival of Campylobacter in 
milk since the 1980s and none reported on the more recently described species 
such as C. ureolyticus. In addition to the role of milk in the diet, it can also be 
used as protective medium for preserving bacteria and bacteriophage when freeze 
drying. The ability of Campylobacter bacteriophage survival in milk still not fully 
understood, then the work in this chapter will clarify bacteriophage survival in milk. 





applications, ensuring stability and protecting phage particles from acid and 
digestive enzymes. It is unknown whether immunoglobulins, proteins lipids or 
other components of milk might inactivate the phage or inhibit their ability to bind 
their target bacteria. To answer these questions, basic survival tests on 





















3.2 Material and Methods  
 
3.2.1 Campylobacter recovery experiments  
 
3.2.1.1 Preparation of Campylobacter jejuni PT14 suspension 
 
Campylobacter jejuni PT14 was grown (section 2.3.1) as confluent lawns on BA 
plates (section 2.1.1) and incubated at 42°C under microaerobic conditions. Three 
individual samples were prepared by suspending one half of the lawn into 10 mM 
MgSO4 (w/v) from 1 M stock (section 2.1.12) to give a suspension of 
approximately 108 CFU/ml. The optical density at 600 nm was taken to standardise 
the suspensions and the actual viable count was determined by serial dilution in 
MRD (section 2.1.9) by the Miles and Misera method (section 2.5). The diluted 
samples were applied as triplicate 10 µl aliquots onto mCCDA agar (section 2.1.2), 
allowed to dry and incubated under microaerobic conditions. 
 
3.2.1.2 Preparation and inoculation of UHT whole milk with 
Campylobacter   
 
The pH of 3 individuals 500 ml UHT whole milk cartons with valid expiry dates, 
were adjusted to be between 6.53 ± 0.2 to 7.45 ± 0.04, by adding 500 µl of 10 M 
NaOH solution, to each. UHT milk was chosen for these experiments to avoid 
variability of indigenous flora. The Campylobacter suspension (section 3.1.1), was 
used to inoculate 25 ml volumes of the pH adjusted milk. Tenfold serial dilutions 
were performed in the pH adjusted milk, with the highest dilution containing 
approximately 1 cell/ml. A negative control with no Campylobacter added was also 
prepared. The dilutions containing approximately, 0, 103, 102, 101 and 1 CFU/ml 
were used for the experiment. One ml of milk from each of the samples was 







3.2.1.3 Enumeration of Campylobacter in different fractions of UHT milk 
 
The remaining 24 ml of the milk samples from (section 3.2.2) were centrifuged at 
20,000 x g for 40 min at 4°C in Oakridge tubes. The fat layer from each tube was 
removed and collected into marked sterile glass universal tubes (weighed) using 
a sterile spatula. This was resuspended in 5 ml PBS (section 2.1.10). One ml from 
the remaining supernatant was collected to marked sterile glass universal tubes. 
The rest of the supernatant was discarded. The pellets were re-suspended in 5 ml 
MRD (section 2.1.9) and transferred to marked sterile glass universal tubes with 
a further 5 ml of MRD being used to collect any remaining pellet. All layer partitions 
were stored microaerobically at 4°C, until used in the experiment. The viable count 
of Campylobacter from each of the milk partitions were determined using the Miles 
and Misra technique (section 2.5). For each dilution of Campylobacter there were 
three biological replicates and three technical replicates. 
 
3.2.2 Campylobacter survival in UHT milk  
 
Survival of Campylobacter inoculated in milk and MRD samples were studied under 
different parameters. During the experiments, samples were stored under 
different conditions. First, microaerobic conditions at 4°C. Second, aerobic 
conditions at 4°C. Finally, aerobic conditions at room temperature. All time point 
samples were collected and the viable counts tested at 8 hours, accept for the 
aerobic treatment condition at room temperature, where samples were collected 
and processed at 30 minute intervals for the first and second time point samples 








3.2.2.1 Preparation of Campylobacter jejuni PT14 suspension 
 
Three different suspensions of C. jejuni PT 14 were prepared as biological 
replicates as described previously in 3.2.1. 
 
3.2.2.2 UHT whole milk and MRD samples preparations:  
 
Three 10 ml milk samples contained approximately 106 CFU/ml present three 
biological replicates were prepared from 500 ml Tesco UHT Whole Milk. The pH 
and the room temperature were recorded. Three parallel MRD replicates were 
prepared from the same suspension. The negative control treatment was also 
prepared for both milk and MRD (section 2.1.9). A 20 µl sample for each time 
point was removed (0, 8, 16, 24, and 48 hours) for micraerobic conditions. 
Samples stored aerobically were collected at 0, 30, 60, 120, 180 and 360 min, 
and the viable counts determined (section 2.2.2). The inoculated Petri dishes were 
incubated under microaerobic and aerobic conditions at 42°C, for 48 h. Three 
biological replicates and three technical replicates were obtained using 96-well 
microtitre plates with the Miles and Misa technique (section 2.5) used for 
enumeration.  
 
3.2.3 The heat resistance of campylobacters during 
pasteurisation 
 
3.2.3.1 Preparation the Campylobacter jejuni (PT14) suspension 
 







3.2.3.2 UHT whole milk sample preparation and pasteurisation 
 
Three 10 ml milk samples contained approximately 108 CFU/ml to represent three 
biological replicates were prepared from 500 ml Tesco UHT Whole Milk. The pH 
and the room temperature were recorded. Three MRD replicates were prepared 
and the same suspension was used each time. The negative control treatment was 
also prepared for both milk and MRD (section 2.1.9). Then, 1.3 ml from the milk 
and MRD replicates were removed to 1.5 ml marked sterile glass vials. Before the 
heat treatment 200 µl of milk and MRD were moved from replicates as 0 time point 
samples and used to obtain the viable count as described above. The 
pasteurisation was complete when the temperature reached 72°C for 25 seconds 
and was stable. After that the samples were cooled down to the 4°C. The initial 
temperature (4°C), heating time to 72°C and cooling time from 72°C to 4°C were 
recorded. After pasteurisation, samples were taken from milk and MRD samples, 
to enumerate Campylobacter. The inoculated Petri dishes were incubated under 
microaerobic and aerobic conditions at 42°C, for 48 h. Three biological replicates 
and three technical replicates were obtained using 96 microplates with the Miles 
and Misa technique (section 2.5) used for enumeration. 
 
3.2.4 Campylobacter bacteriophage CP30A recovery 
experiments 
 
3.2.4.1 Bacteriophage propagation 
 
Propagation of bacteriophage was carried out using the full plate lysis method. 
Prior to the propagation, an overnight growth of C. jejuni PT14 as a host was 
swabbed from a BA (section 2.1.1) plate into sterile 10 mM magnesium sulphate 
solution was prepared from 1 M stock solution (section 2.1.12) to contain 





was mixed with 100 μl of CP30A bacteriophage at approximately 7 log10 PFU/ml 
and incubated at room temperature for 10 minutes for the phage to absorb to the 
bacteria. The top layer agar (section 2.1.4) was melted in a microwave, dispensed 
in 5 ml aliquots in sterile universal bottles and tempered to 50°C in a water bath. 
The Campylobacter and bacteriophage mixed suspension was then transferred into 
5 ml of melted NZCYM overlay agar and thoroughly mixed. This was poured onto 
the surface of a NZCYM agar plate (section 2.1.3) and allowed to set. The plates 
were then incubated at 42°C under microaerobic conditions, overnight. The 
propagated bacteriophage was harvested with 5 ml of SM buffer (section 2.1.11), 
dispensed onto the surface of the plate, and incubated at 4°C on a gyratory shaker 
with 60 cycles per minute, overnight. After incubation, SM buffer containing 
bacteriophage was recovered, and bacterial cells and cell debris were removed by 
filtering the sample through a 0.2 μm filter. Finally, the filtered bacteriophage 
sample was stored at 4°C in sterile plastic universals. 
 
3.2.4.2 Efficiency of CP30A plaquing (EOP) 
 
Bacteriophages were enumerated by determining their efficiency of plaquing 
against their host strain. Lawns of host Campylobacter strains were prepared 
(section 3.2.4.1). but without addition of bacteriophage. Instead the 
bacteriophage suspension was ten-fold serially diluted with SM buffer down to a 
dilution factor of 10-8, and 10 μl of each dilution was dispensed onto the bacterial 
lawn, in triplicate and allowed to dry next to a Bunsen burner. The plates were 
incubated at 42°C under microaerobic conditions overnight and the number of 
plaques were counted for dilutions that gave rise to between 3 and 30 plaques. 
Finally, the average plaque number was used to calculate the efficiency of plaquing 
using the following equation. 





3.2.5 UHT whole milk samples preparations 
 
Suspensions of 10-fold diluted bacteriophage CP30A between 108, 107, 106 PFU/ml 
were used to inoculate 25 ml of UHT whole milk in 40 ml Oakridge tubes. To 
validate the results, three biological replicates for each bacteriophage 
concentration were prepared. A negative control was also prepared with 25 ml of 
UHT whole milk with no phage. The samples were then centrifuged at 10000 x g 
for 10 min and the supernatant used for bacteriophage enumeration. The 
efficiency of CP30A plaquing assay was used to enumerate (section 3.4.2.2). 
3.2.6 Campylobacter ureolyticus 
 
3.2.6.1 C. ureolyticus growth 
 
Campylobacter ureolyticus NCTC 10941 was grown in the same way as C. jejuni 
PT14 (section 3.3.1.1) but incubated at 37°C instead of 42°C. 
 
3.2.6.2 C. ureolyticus motility 
 
Motility tests were performed on fresh C. ureolyticus and C. jejuni PT14 to confirm 
that C. ureolyticus was not motile (O’Donovan et al. 2014). Cultures of each were 
grown on BA at 37°C under microaerobic conditions. A semi-solid motility agar 
plate made from Mueller-Hinton broth (section 2.1.8) contained 0.4 % agar No. 1 
(Oxoid) was inoculated with the culture using a sterilised pipette tip to stab the 
centre of the plate. Three replicates for C. ureolyticus NCTC 10941 and C. jejuni 
PT14 were prepared, and one plate with no cells as negative control. The plates 
were incubated at 37°C under microaerobic conditions for 72 hours and then the 
diameter of the motility halo was measured. This confirmed that C. ureolyticus 






3.3 Results  
 
3.3.1 Campylobacter survival in UHT milk 
 
3.3.1.1 Campylobacter recovery experiments  
 
This experiment was performed to validate the methods that were used to isolate 
Campylobacter from milk samples. Statistically significant differences (p < 0.05) 
were assessed using a one-way single factor (ANOVA) (section 2.12). The average 
Campylobacter counts (log10 CFU/ml) recovered immediately after addition of 
Campylobacter cells (Table 3.1). Campylobacter ureolyticus NCTC 10941, C. jejuni 
NCTC 11168 and C. coli RM2228 showed no significant changes in viable counts 
(p=0.1, 0.3 and 0.3, respectively), between the number of viable Campylobacter 
cells added, compared to the number of the cells that were recovered. In contrast, 
C. jejuni PT14 and C. jejuni 81-176 showed significant differences (p=0.0004 and 
0.003, respectively), between viable counts before and after addition to milk.  
Table 3.1 Recovery of Campylobacter strains after addition to UHT milk 
*The standard deviation   
Campylobacter Average log10 CFU/ml 
number added to milk  
Average log10 CFU/ml  
number recovered from 
milk  
C. jejuni PT 14 2.64(0.03)* 2.43(0.00)* 
C. jejuni NCTC 81-176 2.97(0.05)* 2.67(0.06)* 
C. jejuni NCTC 11168 2.66(0.12)* 2.56(0.10)* 
C. coli RM2228 2.72(0.20)* 2.53(0.15)* 








     
Figure 3.1 The percentage recovery of Campylobacter inoculated into milk 
Despite the significant loss of viable Campylobacter cells following addition to milk 
and recovery for C. jejuni PT14 and C. jejuni 81-176, greater than 50% recovery 
was considered acceptable for the purpose of these experiments.  
 
 
3.3.1.2 Survival of Campylobacter in UHT milk under microaerobic 
conditions at 4°C  
 
For the first experiment, triplicate 10 ml of UHT milk samples, together with 
triplicate MRD controls, were inoculated with Campylobacter cells and incubated 
under microaerobic conditions, at 4°C. The survival of Campylobacter under these 
conditions (Figure 3.2) A for inoculated UHT milk and (Figure 3.2) B for inoculated 









Figure 3.2 Campylobacter survival in milk under microaerobic conditions at 4°C 
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Experimental results (Figure 3.2) A Showed that the different Campylobacter 
strains and species varied in their ability to survive in milk under microaerophilic 
conditions at 4°C. Statistically significant differences (P < 0.05) were assessed 
using a one way single factor (ANOVA) (section 2.12). The C. coli RM2228 and C. 
ureolyticus 10941 strains, showed the greatest decline in average log10 viable 
counts from 4.81 and 5.32 at 0 h to 3.45 and 4.64 at 48h respectively following 
incubation in milk (P = 0.0009 and 0.0003 respectively). In contrast, two C. jejuni 
strains (81-176 and 11168) showed no significant difference in viability between 
0 and 48 h (P= 0.06 and P= 0.47). The third C. jejuni strain (PT14), showed a 
statistically significant (P=0.007) reduction in viability, in UHT milk, over 48 h. 
Comparison of inoculated milk to MRD inoculated controls under the same 
conditions, showed a similar pattern of survival over the 48 h of incubation with 
the exception of C. coli RM2228, which declined by approximately 2 log10 CFU/ml 
over the first 24 h in MRD and viability was significantly different between 0 and 
48 h (P=0.0001). For C. ureolyticus 10941, the viable count between 0 and 48 h 
did not show any significant difference (P=0.82). Two of the C. jejuni strains (PT14 
and 81-176) showed a significant difference between 0 and 48 h in MRD (P=0.01 
and 0.007 respectively) whilst the third C. jejuni (11168) showed no difference in 
viability (P= 0.24). 
Statistical analysis of the UHT milk and MRD Campylobacter counts in the 48 h 
samples from each strain showed that there was significant difference for C. jejuni 
PT14, C. jejuni 81-176 and C. jejuni 11168 (P=0.07, 0.24 and 0.16). In contrast, 
C. coli RM2228 showed a significant reduction (P=0.01), in MRD, compared to milk 
after incubation for 48 h under microaerobic conditions at 4 °C. Conversely the C. 
ureolyticus 10941 strain exhibited a significant decrease (P=0.0003) in viable 






3.3.1.3 Survival of Campylobacter in UHT milk under aerobic conditions 
at 4°C  
 
The second experiment was similar to the first except that the samples were 





Figure 3.3 Campylobacter survival in milk and MRD under aerobic conditions at 






































































































Two of the C. jejuni strains (PT14 and 11168) showed significant difference in 
viability between 0 and 48 h (P= 0.22 and 0.043 respectively). The third C. jejuni 
strain (81-176) and the C. ureolyticus strain showed only moderate differences 
following incubation in milk from an average log10 count of 5.6 and 5.24 at 0 h to 
5.17 and 4.9 at 48 h respectively. However, a statistically significant reduction 
(P=0.003) was observed when C. ureolyticus was inoculated in UHT milk and 
incubated aerobically for 48 h at 4°C. In contrast, C. coli RM2228, exhibited a 
much greater reduction in viability of > 1 log10 CFU/ml, between 16 and 48 h (P= 
0.001). Comparison of the UHT milk aerobic survival with MRD control aerobic 
survival, revealed that all the strains declined more in MRD than in UHT milk, with 
C. jejuni PT14 and C. ureolyticus showing the greatest difference. All were 
significantly different between UHT milk and MRD after 48 h incubation (C. jejuni 
PT14 P= 0.0001, C. jejuni 11168 P= 0.001, C. coli RM2228 P= 0.002, C. jejuni 















3.3.1.4 Survival of Campylobacter in UHT milk under microaerobic 
conditions at 23 ± 0.5°C 
 
The third experiment was similar to the second using aerobic conditions, but the 
incubation temperature was raised to 23 ± 0.5°C. The results are presented in 





Figure 3.4 Campylobacter survival in milk and MRD under aerobic conditions at 














































































































In UHT milk, only C. coli RM2228 showed a rapid reduction in viable count of cells 
after 360 min of incubation, under aerobic conditions at 23 ± 0.5°C. A similar 
pattern was observed for the inoculated MRD samples with C. coli RM2228 
declining the most and the other strains being relatively stable over the incubation 
period. 
Finally, the comparison between incubation in UHT milk and incubation in MRD 
showed no significant difference (P=0.93 and 0.051 respectively) for both C. jejuni 
PT14 and 11168 from an of 6.0 and 5.64 at 0 minutes. There was also no 
significant difference in the average log10 count before and after the 360 minutes 
incubation period at 23C (5.97 and 5.74 respectively). In contrast, C. coli RM2228 
showed a more rapid decline in UHT milk than MRD (P=0.037). Conversely viable 
counts of C. jejuni 81-176, and C. ureolyticus 10941 were significantly higher 
(P=0.007 and 0.001 respectively) in UHT milk than MRD. 
3.3.2 The heat resistance of campylobacters during 
pasteurisation 
 
Heat treatment of 1 ml of C. jejuni PT14 suspensions in milk containing 106 CFU/ml 
at 72°C, in triplicate for 25 seconds followed by cooling to 4°C resulted in complete 
loss of viability. 
3.3.3 Survival of Campylobacter CP30A bacteriophage in 
milk 
 
Campylobacter CP30A bacteriophage recovery experiments were designed to 
assess the validity of experimental methods used to isolate Campylobacter 
bacteriophage from milk and test its suitability as a medium for administering 
bacteriophage in phage therapy. Table 3.2 shows the different CP30A titres used 
in the experiments and the average titre of the bacteriophage recovered after the 





dilutions containing approximately 106, 107 and 108 PFU/ml. The results clearly 
show that there was no significant difference between number of phage added and 
the number recovered (P= 0.65, 0.44 and 0.74 respectively).  

















106 5.97 5.89 
 
81.11 0.24 
107 7.02 6.86 
 
68.27 0.05 




Figure 3.5 Recovery of bacteriophage CP 30A after inoculation in milk at different 
titres 
 
These data indicate that Campylobacter bacteriophage can be efficiently recovered 










A review of the literature revealed that the majority of studies reporting the 
survival of Campylobacter in milk were published in 1980’s (Doyle and Roman, 
1982a). Since that time, there have been major developments in culture 
techniques and the discovery of many new species of Campylobacter, for example 
C. ureolyticus. As bovine milk has been suggested as a source of C. ureolyticus 
associated with human disease (O'donovan et al., 2014), it is clearly important to 
investigate the survival characteristics of this species and compare it to other 
Campylobacter species. Early studies of survival of C. jejuni strains in milk did not 
address different atmospheric conditions or temperatures, and used raw milk 
containing indigenous microflora. The experiments described in this study are the 
first to assess the survival of different Campylobacter strains and species including 
C. ureolyticus, in UHT milk, comparing aerobic and microaerobic conditions at 
refrigeration and room temperatures. The strains tested in this study all proved to 
be able to survive for considerable lengths of time, both aerobically and 
anaerobically, at refrigeration temperatures. Different study was proposed the 
sterilisation failure or contamination post-sterilisation, would prove a considerable 
reason for Campylobacter outbreak associated with consumption of milk. In this 
study, even at room temperature the Campylobacter strains were able to survive 
in considerable numbers, for more than 5 h, under aerobic conditions. It was 
interesting to note that in many cases, the strains tested survived better in UHT 
milk than in MRD, which contains peptone in an isotonic solution, and is considered 
an ideal medium for protecting microorganisms from stress (Straka and Stokes, 
1957). It was also interesting to note that C. coli RM2228 declined in viability in 
UHT milk more quickly than the other strains. This strain was originally isolated 
from an avian host, whereas the other strains were isolated from human hosts. 
Further studies of the survival of many different strains would need to be 





To sum up, in this study the survival of Campylobacter under different conditions 
in UHT milk, compared to MRD, as a standard buffer, had not previously been 
studied. These experiments can help in understanding the mechanisms of 
outbreaks of Campylobacter related to consumption of raw milk and in the food 
chain in general. 
The results in this study have demonstrated the ability of Campylobacters to 
persist and survive under what are perceived to be unfavourable conditions for 
this bacterium. Campylobacter ureolyticus in milk could not only survive but 
showed evidence of increasing numbers of viable cells. Further studies to isolate 
campylobacters from milk or cattle carcases could allow further understanding of 
how these foodborne pathogens enter the human food chain and the possible 
development of rapid detection methods. More refined experiments, together with 
survival curve modelling, will be needed to better understand how the 
campylobacters differ when incubated in milk and experimental buffers, and how 
this is affected by oxygen tension and temperature.  
These results show that bacteriophage survive can in milk under aerobic conditions. 
This basic knowledge is important in extending work on the isolation and 
preservation of bacteriophage and in determining the most appropriate media to 

















Genomic characterisation of Arcobacter spp. 





















Arcobacter and Campylobacter spp. are zoonotic pathogens present in cattle 
intestines, that may contaminate raw drinking milk (RDM) and dairy products 
(Hansson et al., 2019; Mungai et al., 2015). Since it was most likely that candidate 
bacteriophages would be isolated using Arcobacter and Campylobacter spp. hosts 
from the same environment, examples of these bacteria were isolated from bovine 
slurry (Giacometti et al., 2015). The genomic characterisation of these bacterial 
isolates is described in this chapter.  
There are relatively few studies that report the prevalence and characterisation of 
isolates of Arcobacter and Campylobacter spp. from cattle compared to the 
number of studies reporting their prevalence in poultry. Despite this, a large 
number of outbreaks of human illnesses are caused by these zoonotic pathogens 
(Guévremont et al., 2014; Serraino et al., 2013; Yesilmen et al., 2014; Del Collo 
et al., 2017). 
A description of the genus Arcobacter is given in Chapter 1 (section 1.1.4). 
Arcobacter spp. have been detected in faecal samples from healthy cattle and 
other ruminants with no clinical symptoms observed (Shah et al., 2011). 
Arcobacter varies in prevalence with one study in Belgium showing a range of 5.9 
to 11% in dairy cattle, but it was more prevalent in calves and young animals 
(18.9 and 27.3% respectively). In a different study in Galicia (northwest of Spain) 
which included 89 dairy farms, Arcobacter spp. was isolated from 68.5% of the 
farms and 41.7% of faecal samples (Vilar et al., 2010a).  
At least 27 different species have been described within the genus Arcobacter, 
Moreover, some species have been reassigned to different genera (Pérez-Cataluña 
et al 2018). Of the species that remain, A. butzleri, A. cryaerophilus and A. 
skirrowii have been most associated with human disease. The same species have 
been isolated from bovine samples with A. butzleri being most frequently isolated, 





2010; Fisher et al., 2014; Collado and Figueras, 2011; Collado et al., 2008). The 
absence of standard methods to isolate Arcobacter may have had a significant 
impact on the range of different species that have been detected (Van Driessche 
et al., 2005; Collado and Figueras, 2011). Arcobacter spp. was first isolated from 
bovine foetuses by Ellis et al. (1977), this was followed by isolation of what was 
named as “Campylobacter cryaerophila” by (Neill et al., 1985) which then renamed 
and reclassified as A. cryaerophilus after Arcobacter genus was proposed by 
(Vandamme et al., 1991). Not long after that A. skirrowii was isolated in 1992 
from preputial fluids of bulls (Vandamme et al., 1992b).  
Modern genome sequencing techniques have led to great improvements in our 
understanding of epidemiology and infection. Several sequences of A. butzleri and 
A. cryaerophilus are available but only one closed genome sequence of Arcobacter 
skirrowii (LMG 6621) is currently available. This isolate from lamb faeces isolated 
in the United Kingdom showed the bacterial chromosome length was 1,969,846 
bp with a G+C content of 27.7% (Miller and Yee). Three genomic islands were 
identified encoding different functions and a type III Clustered Regularly 
Interspaced Short Palindromic Repeat (CRISPR)-Cas system. There were no 
plasmids identified in the LMG 6621T genome (Miller and Yee, 2018). 
Most cases of campylobacteriosis are attributed to C. jejuni but there were 
246,158 confirmed cases of human campylobacteriosis due to C. coli reported in 
the EU in 2017 equating to 24% of the total number reported cases (EFSA, 2018). 
Considering outbreaks in the same study, 66% of cases that were caused by 
contaminated milk and dairy products were attributed to Campylobacter spp. other 
than C. jejuni (EFSA, 2018). Campylobacter coli have been identified in 3 to 10 % 
of human Campylobacter cases in different various countries (Sheppard et al., 
2009; Cody et al., 2012; Nohra et al., 2016).  
A description of the genus Campylobacter and how species of the genus are 





studies have shown that dairy cattle are a reservoir for Campylobacter so further 
research is required to reduce the impact of bovine Campylobacter spp.in human 
disease (Guévremont et al., 2014). Cattle can be colonised by C. jejuni and/or C. 
coli (Arsenault et al., 2012). Studies have also identified other species of 
Campylobacter such as C. hyointestinalis colonising cattle (Oporto and Hurtado, 
2011; Guévremont et al., 2008). A study in United States of America showed that 
from a total of 181 Campylobacter isolates from cattle faeces, 71 were C. jejuni, 
132 were C. coli, and 10 were other Campylobacter spp. (Sanad et al., 2011). In 
Japan, C. coli were detected in 3.6% (9/250) of beef cattle and from 16.0% (4/25) 
of beef farms (Haruna et al., 2013). In a French study, 12.8% of isolates were 
identified as C. jejuni and 3.7% identified as C. coli (Chatre et al., 2010). Most 
campylobacteriosis studies worldwide have focused on the role of C. jejuni. There 
is however still an important gap in understanding of the impact of C. coli and 
other campylobacters in the zoonoses cycle (Nohra et al., 2016; Elhadidy et al., 
2019). 
The prevalence of campylobacters other than C. jejuni and C. coli such as C. 
hyointestinalis may be underestimated for several different reasons including: the 
isolation technique, inappropriate antibiotics in selective media or unsuitable 
recovery conditions such as insufficient incubation period or unsuitable 
temperature and gas mixture (Lastovica and Allos, 2008). The C. hyointestinalis 
species is divided to two subspecies: C. hyointestinalis subsp. hyointestinalis and 
C. hyointestinalis subsp. Lawsonii (BLOCH et al., 1995). Campylobacter 
hyointestinalis was first isolated from swine with proliferative ileitis and other 
enteric diseases (Gebhart et al., 1983).  
As previously (section 1.2.2), the sequencing of whole genomes has significantly 
advanced our understanding of bacterial zoonosis particularly with regard to C. 
jejuni for which many genomes available. The first reported C. coli genome 





to a range of antibiotics (Fouts et al., 2005a). The chromosome length was 
1,684,122 with a G+C content of 31.37 % and contained a single plasmid 
approximately 178 kb in size. The first fully assembled genome sequence of the 
gentamicin resistant C. coli CVM N29710 from chicken had a chromosome length 
was 1,673,221 bp and a G+C content of 31.4 % and a plasmid with multiple 
antibiotic resistance genes (Chen et al., 2013). The first complete genome 
assembled of a clinical isolate C. coli strain (15-537360) had a chromosomal length 
of 1,658,751 bp with a G+C content of 31.5 % and also included a conjugative 
plasmid with a type IV secretion system, but no antibiotic resistance genes were 
identified (Pearson et al., 2013). 
The first complete genome sequence for both C. hyointestinalis subsp. 
hyointestinalis strain LMG 9260 and C. hyointestinalis subsp. lawsonii strain LMG 
15993 were published in 2016 (Miller et al., 2016). The bacterial chromosome for 
C. hyointestinalis subsp. hyointestinalis LMG 9260, a human isolate, was 
1,753,385 bp in length with a G+C content of 34%. The chromosome for C. 
hyointestinalis subsp. lawsonii strain LMG 15993 (from swine) was 1,753,277 bp 
in length and had a G+C content of 33.5%. In the C. hyointestinalis subsp. lawsonii 
genome, variable genes in integrated elements such as clustered regularly 
interspaced short palindromic repeats (CRISPR) arrays and Mu-like phage were 
identified. Insertion sequences (IS) were identified in both strains. (Miller et al., 
2016).  
The aim of this study then to characterise and analysing the genome sequence of 
selected isolates of Arcobacter and Campylobacter to use as candidate 
bacteriophage hosts. These were A. skirrowii A2S6, C. coli S9, and C. 
hyointestinalis S12. It was also to compare these isolates with known sequences 
from isolates from different sources to identify any source-specific genes 






4.2 Materials and Methods 
 
4.2.1 Whole genome sequencing, assembly and annotation 
of cattle isolates  
 
Whole genomic DNA for all strains in this study were isolated as described in 2.9.1. 
DNA sequencing were performed using the Illumina MiSeq platform at the 
University of Nottingham (Sutton Bonington Campus; UK) as described in 2.10.1. 
The data for A. skirrowii A2S6, C. coli S9 and C. hyointestinalis subsp. 
hyointestinalis S12 was processed and annotated as described in 2.10.2 and 
2.10.3 The complete annotated sequence of A. skirrowii A2S6, C. coli S9 and C. 
hyointestinalis subsp. hyointestinalis S12 were deposited in GenBank under the 






4.3 Results  
 
4.3.1 A. skirrowii A2S6 chromosomal features 
 
4.3.1.1 Structure and genes of A. skirrowii A2S6 
 
The assembled circular chromosome of A. skirrowii A2S6 was determined to be 
1,877,752 bp in length with 1,953 genes and an average G+C content of 27.8%. 
The sequence contained 4 copies of the ribosomal RNA operon and 44 tRNA genes. 
The chromosome of A. skirrowii A2S6 was found to have one duplicate region of 
1,090 bp spanning from nucleotide positions 7, 463, 61 to 7, 474, 51. Figure 4.1 
shows the genome map of the A. skirrowii A2S6 chromosome and indicates the 
positions of the duplicated sequence. Arcobacter skirrowii A2S6 is currently the 
second Arcobacter from the species of skirrowii that has been completely 








Figure 4.1 Circular representation of A. skirrowii A2S6 chromosome 
(Light blue represents coding DNA sequences) (Red shows rRNA and Dark blue 
represents tRNA sequences) (Black arcs show the regions of duplicate sequences) 






The A. skirrowii A2S6 genome contains 3 homopolymeric G:C tracts, which are 
defined as containing more than 7 consecutive G or C residues and are presented 
in Table 4.1 . Hompolymeric tracts have been observed to vary in Campylobacter 
spp. to alter the reading frames of genes to effectively turn them on and off.  
 














G(8) intergenic N/A  
1133858-
1133865 
C(8) intergenic N/A  
1746691-
1746697 







4.3.1.2 Nucleotide sequence statistics of A. skirrowii A2S6 
The distribution of nucleotides (Figure 4.2)is typical of an AT-rich Arcobacte genome 
 
Figure 4.2 Nucleotide distribution histogram for the A. skirrowii A2S6 
chromosome 
 
The frequency of codon usage reflects the tRNA pools available in the genome. 
The nucleotide frequency in codon positions (Table 4.2). Adenine residues show 
similar distribution at each position. Thymine residues are most frequent at the 
third position. Cytosine residues were the least commonly occurring nucleotide 
overall, and in the first and third positions. Guanosine residues were the least 
common in the third position. The codon AAA, which encodes the amino acid lysine 
was the most abundant codon occurring 50,456 times and the codon CGG, which 






Table 4.2 Frequency of nucleotide codon positioning for the A. skirrowii 
A2S6 chromosome 
 
Codon position A C G T 
1.position 0.38 0.11 0.30 0.21 
2.position 0.37 0.17 0.13 0.33 
3.position 0.42 0.05 0.09 0.44 
 
4.3.1.3 Comparison with the nearest A. skirrowii sequence neighbour 
 
The program LAGAN shuffle available from mVISTA  
(http://genome.lbl.gov/vista/mvista/submit.shtml) was used to compare and 
identify the similarity between  A. skirrowii A2S6 and the nearest neighbour from 
the same species available in the NCBI database. The complete genome sequence 
for A. skirrowii A2S6 cattle strain was A. skirrowii CCUG 10374, which was selected 
for comparison using mVISTA. (Figure 4.3 )the alignment of the genomes where 
it is evident that large regions of low sequence identity with A. skirrowii A2S6 are 
present. The mVISTA browser function allowed analysis of the genome data for 
genes present and absent that distinguish A. skirrowii A2S6 and A. skirrowii CCUG 
10374. There were a total of 243 genes represented in A. skirrowii A2S6 but absent 








Figure 4.3 Chromosomal alignment of A. skirrowii A2S6 and A. skirrowii CCUG 
10374 
 
Plot showing the percentage identity and locations of missing genes across the A. 
skirrowii A2S6 chromosome aligned with and A. skirrowii CCUG 10374. Purple 
represents conserved regions; pink represents conserved non-coding sequences 
(CNS) and white represents missing or relocated genes. Generated by mVISTA 
with the LAGAN function. There were 342 genes absent from the A. skirrowii A2S6 
genome but present in A. skirrowii CCUG 10374. Of these 89 were hypothetical 






4.3.1.4 Plasmids  
No plasmids were identified in the A. skirrowii A2S6 genome. 
4.3.1.5 Taxonomic characterisation of A. skirrowii A2S6 by whole 
genome BLAST 
 
The nearest neighbour to A. skirrowii A2S6 with whole genome sequenced, as 
determined by NCBI Genome neighbour report was found to be A. skirrowii CCUG 
10374. The symmetric identity and gapped identity with A. skirrowii A2S6 were 
83.36 % and 98.67% respectively which present the second member of skirrowii 
species have been uploaded to NCBI website under a session number 
NZ_CP034309. Arcobacter skirrowii A2S6 strains fall within one of four genomic 
groups, which is represented by A. skirrowii strain L403. (Figure 4.4) the 








Figure 4.4 Phylogenetic comparison of A. skirrowii A2S6 with other A. skirrowii 
strains 
 
Arcobacter skirrowii A2S6 is in the red colour. Comparisons are based on genomic 
BLAST searches and the dendrogram was calculated using the Genome feature of 






4.3.1.6 CRISPR sequences of A. skirrowii A2S6 
 
Clustered regularly interspaced short palindromic repeats (CRISPR) loci are arrays 
of short repeats named direct repeats (DR), followed by noticeable short 
sequences known called spacers. The CRISPR sequences, present in many bacteria 
and archaea, in parallel with cas genes, are proposed to provide host resistance 
against infection with lytic phage and foreign plasmids in (Marraffini, 2013). 
Arcobacter skirrowii A2S6 has two pairs of CRISPR arrays in the chromosome. 
(Figure 4.5) the positions of the CRISPR arrays and cas genes in A. skirrowii A2S6. 
The first CRISPR array is from position 746361 to 747451. The second CRISPR 
array is truncated from position 1870865 to 1870973. This CRISPR array did not 
have any cas genes in the vicinity. 
 
Figure 4.5 the positions of the CRISPR arrays and cas genes in A. skirrowii A2S6 






Table 4.3 shows the sequences of direct repeats and spacers as calculated by 
the CRISPRs web server: (https://crisprcas.i2bc.paris-
saclay.fr/MainDb/StrainList/CP034309.1). The length of direct repeats and 
spacers appear to vary between the two pairs of arrays (Abby et al., 2014). 
Table 4.3 Direct repeat and spacer sequences within the CRISPR 1 array 






























































































Table 4.4 Direct repeat and spacer sequences within the CRISPR 2 array 





Nucleotide BLAST results from CRISPR direct repeats consensus sequence in A. 
skirrowii A2S6 in (Appendix 3) shows that the DR consensus sequence of the first 
CRISPR is present in two different Arcobacter spp. genomes: the A. thereius LMG 
24486 chromosome and the A. pacificus LMG 26638 chromosome with 100% for 
both cover and identity and the same e- value of 8 X 109. 
 
4.3.1.7 Prophage insertions of Arcobacter skirrowii A2S6 
 
The A. skirrowii A2S6 chromosome contained three different prophage insertions. 
These prophage insertions were classified as incomplete (score < 70; by 
http://phaster.ca/).  The first region position was between 676,005-683,290 bp 
and was 7.2 kb in length which orientated in both directions. The second region 
was between 721,479-730,691 bp and was 9.2 kb in length. It was located in the 
forward directions. The third prophage insertion region was 9.9 kb and extended 
from1,017,007 to 1,026,955 bp, orientated in the reverse strand, the three.  
CRISPR 2 




















Figure 4.7 shows the three regions of prophage insertions in A. skirrowii A2S6 







Nucleotide BLAST analysis of the three prophage regions showed that A. skirrowii 
CCUG 10374 was the only Arcobacter genome that had similar sequences to the 
first and third prophage sequences whilst the second sequence showed no 
similarity. Examining the Shuffle-LAGAN analysis using mVISTA shown in Figure 
4.3 showed that the expected prophages were represented as regions of no 
sequence identity.  
 
4.3.1.8 Virulence Factors of A. skirrowii A2S6 
 
To date, the potential pathogenicity mechanisms of the genus Arcobacter are not 
fully understood with a limited number of studies available (section 1.4). Proposed 
pathogenicity gene markers from the A. butzleri RM4018 genome (Ferreira et al., 
2016b, Miller et al., 2007) identified due to their role in pathogenicity in other 
microorganisms, which include: cadF, cj1349, ciaB, mviN, pldA, tlyA ,hecA, hecB, 
irgA. The locus tags of homologues of these proposed virulence markers were 






Table 4.5 Homologues of proposed virulence gene markers found in A. 
skirrowii A2S6  
Genes 
name 
Function A. skirrowii 
A2S6 locus 
tag 
*% Identity to 
A. butzleri 
RM4018 
cadF Adherence/ internalisation 
to host cells  
EI285_RS07655 28% 
ciaB Invasion protein  EI285_RS02790 83% 
cjl349 Adherence to fibronectin EI285_RS00810 69% 
irgA iron-regulated outer 
membrane protein  
EI285_RS08660 36% 
hecA Encodes for a filamentous 
haemagglutinin 
No match  
hecB Encoding for a haemolysin 
activation protein 
No match  
mviN  Peptidoglycan synthesis  EI285_RS02745 82% 
pldA phospholipase A  EI285_RS05575 58% 
tlyA Haemolysin/ adherence  EI285_RS04050 73% 
*BLASTP comparison of protein sequences 
 
4.3.1.9 Antibiotic resistance genes of A. skirrowii A2S6 
 
The Resistance Gene Identifier (https://card.mcmaster.ca/analyze/rgi) was used 
to predict the resistome of A. skirrowii A2S6 from protein, genome, or nucleotide 
data based on homology and SNP models by CARD, with stingent criteria: perfect 
and strict hit only. The results identified the adeF gene in A. skirrowii A2S6 giving 
fluoroquinolone and tetracycline resistance by an efflux mechanism. The identity 






4.3.2 C. coli S9 chromosomal features 
 
4.3.2.1 Structure and genes of C. coli S9 
 
The assembled circular chromosome of C. coli S9 was 1,713,481 bp in length with 
1,806 genes and an average G+C content of 31.37%. The sequence contained 
three copies of the ribosomal RNA operon and 44 tRNA genes. Figure 4.8 shows 
the genome map of the C. coli S9 chromosome. The genome contains 18 
homopolymeric G:C tracts, which are defined as containing more than 7 








Figure 4.8 Circular representation of C. coli S9 chromosome (Light blue 
represents coding DNA sequences) (Red indicates rRNA and dark blue represents 











c G/C tract 
(no.) 
Locus_ tag Putative function 
65378-65388 C (11) FD987_0024
0 
Iron binding protein 
486878-486886 G (9) Intergenic  
648010-648020 G (10) FD987_0334
5 
DUF2920 family protein 

























































DUF2920 family protein 
1375610-
1375619 













4.3.2.2 Nucleotide sequence statistics C. coli S9 
 
The distribution of nucleotides, shown in Figure 4.9 is typical of an AT-rich 
Campylobacter genome. The nucleotide frequency in codon positions (Table 4.. 
 






Codon usage indicates adenine residues have no significant difference in 
distribution at any position. Cytosine residues were the least frequent nucleotide, 
particularly in the third positions. Guanosine residues were the most frequent 
nucleotide in first position and least frequent in the third position. Thymine 
residues showed a different distribution from the other nucleotides and was most 
frequent at the third position. 
The codon AAA, which encodes the amino acid lysine was the most frequent 
codon repeated 40,572 times and the codon CGG, which encodes arginine, had 
the lowest abundance with 57 instances.  
 
Table 4.7 Frequency of nucleotide codon positioning for the C. coli S9 
chromosome 
 
4.3.2.3 Comparison with nearest C. coli sequence neighbour 
 
The LAGAN shuffle comparison program using mVISTA was used to identify the 
similarity between the C. coli S9 and its nearest neighbour C. coli BFR-CA-9557. 
Figure 4.10 shows the alignment of Campylobacter coli BFR-CA-9557 genome, 
where it is evident that large regions of low sequence identity with C. coli S9 are 
present. The mVISTA browser function allowed the analysis of the genome data 
to identify genes which present or absent in C. coli BFR-CA-9557compared to C. 
coli S9 (Appendix 1). This showed that a total of 69 genes were present in C. coli 
S9 and absent in C. coli BFR-CA-9557. This set included encoded 21 hypothetical 
proteins (Appendix 4). 
Codon position A C G T 
1. position 0.36 0.13 0.30 0.21 
2. position 0.36 0.17 0.14 0.33 






Figure 4.10 Chromosomal alignment of C. coli S9 and C. coli BFR-CA-9557. Plot 
showing the percentage identity and locations of missing genes across the C. coli 
S9 chromosome aligned with and C. coli BFR-CA-9557. Purple represents 
conserved regions; pink represents conserved non-coding sequences (CNS) and 
white represents missing or relocated genes. Generated by mVISTA with the 
LAGAN function. The genes absent from C. coli S9 but present in C. coli BFR-CA-







4.3.2.4 Plasmids of C. coli S9 
 
 
4.3.2.4.1 Identification of plasmids 
 
 
Three plasmids were identified associated with the genomic DNA of C. coli S9. 
These were named pCcS9_1 pCcS9_2 and pCcS9_3.  
 
4.3.2.4.2 Plasmid pCcS9_1, and Plasmid pCcS9_2  
 
 
The sequence for plasmid pCcS9_1 has been uploaded to the NCBI website with 
the accession number CP040240.1. It has a G+C content of 31.83% and is 3321 
bp in length. The pCcS9_1 plasmid contains 19 open reading frames. The plasmid 
pCcS9_2, NCBI accession no CP040241.1, is 3351 bp in length and has a G+C 
content of 31.24% with 17 open reading frames. Nucleotide BLAST, (with align 
two sequences option) showed a high degree of similarity between these two 
















4.3.2.4.3 Comparison of Plasmid pCcS9_1 with Plasmid pCcS9_2 and 
other nearest plasmid DNA sequences from C. coli 
 
BLASTN analysis for both plasmids, identified 10 nearest neighbours with high DNA 
sequence identity. (Figure 4.12) distance tree analysis shows Plasmid pCcS9_1 
Comparison and Plasmid pCcS9_2 and the relation to other similar plasmids. These 
plasmids are typical of the cryptic plasmids found in C. coli and C. jejuni and which 
have been used to construct shuttle vectors for gene manipulation such as 







Figure 4.12 Evolutionary relationships taxa of Plasmid pCcS9_1 and Plasmid 
pCcS9_2 with nearest neighbour’s plasmids belong to C. coli 
The evolutionary history was inferred using the UPGMA method (Sneath and Sokal, 
1973). The optimal tree with the sum of branch length = 19.71906880 is shown. 
The evolutionary distances were computed using the Maximum Composite 
Likelihood method (Tamura et al., 2004) and are in the units of the number of 





positions included were 1st+2nd+3rd+Noncoding. All ambiguous positions were 
removed for each sequence pair (pairwise deletion option). There were a total of 
3707 positions in the final dataset. Evolutionary analyses were conducted in MEGA 
X (Kumar et al., 2018), this tree was generated using (Molecular Evolutionary 
Genetics Analysis) MEGA X software https://www.megasoftware.net/  
 
4.3.2.4.6 Plasmid pCcS9_3 Structure and genes 
 
Plasmid pCcS9_3, NCBI accession no. CP040242.1, has a G+C content of 29.09%, 
103 open reading frames and is 25776 bp in length. Figure 4.13 shows the plasmid 
pCcS9_3, including 31genes. 
 
4.3.2.4.7 Plasmid pCcS9_3 Comparison with nearest plasmid DNA 
sequence neighbours from C. coli 
 
BLASTN analysis of Plasmid pCcS9_3, was carried out with 10 nearest neighbours 
with high DNA sequence identity from C. coli. The distance tree and the relation 












Figure 4.13 Evolutionary relationships taxa of Plasmid pCcS9_3 with nearest 10 
neighbour’s plasmids belong to C. coli 
The evolutionary history was inferred using the UPGMA method (Sneath and Sokal, 
1973). The optimal tree with the sum of branch length = 50.43766930 is shown. 
The tree is drawn to scale, with branch lengths in the same units as those of the 
evolutionary distances used to infer the phylogenetic tree. The evolutionary 
distances were computed using the Maximum Composite Likelihood method 
(Tamura et al., 2004) and are in the units of the number of base substitutions per 
site. This analysis involved 11 nucleotide sequences. Codon positions included 
were 1st+2nd+3rd+Noncoding. All ambiguous positions were removed for each 
sequence pair (pairwise deletion option). There were a total of 30303 positions in 






4.3.2.5 CRISPR sequences of C. coli S9 
 
No CRISPR arrays were detected in the C. coli S9 genome using the CRISPRs web 
server: (https://crisprcas.i2bc.paris-saclay.fr/MainDb/StrainList/CP040239). 
 
4.3.2.6 Taxonomic characterisation of C. coli S9 by whole genome BLAST 
 
The nearest neighbour to C. coli S9, as determined by NCBI Genome neighbour 
report was C. coli BFR-CA-9557. The symmetric identity and gapped identity with 
C. coli S9 were 94% and 98.97% respectively. The C. coli S9 strain fell within a 
genomic group representing non-poultry C. coli strains. (Figure 4.14) the 








Figure 4.14 Phylogenetic comparison of C. coli S9 with other C. coli strains 
Campylobacter coli S9 is in the blue circle. Comparisons are based on genomic 
BLAST searches and the dendrogram was calculated using the Genome feature of 
the NCBI website. 
4.3.2.7 Prophage insertions 
 
One prophage insertion was detected in the C. coli S9 chromosome, orientated in 
both directions. This prophage insertion was classified as “Intact” (score > 90) 
using the web-based program http://phaster.ca/. The region is positioned 
between 84181 and 131496 bp and was 47.3 kb in length (Figure 4.15). The 
prophage sequence could be identified as a region of no sequence identity in Figure 








Figure 4.15 (A Prophage insertions in C. coli S9) (B Position in C. coli S9 
chromosome) 
 
4.3.2.8 Virulence factors of Campylobacter coli S9  
 
The current knowledge regarding the pathogenicity of Campylobacter infection is 
described in Chapter 1.3. Genes thought to be involved are detailed in (Tables 1.1 
to 1.3) The locus tags of each of these genes identified in C. coli S9 and a 
comparison of the protein sequence identity with nearest neighbour C. coli BFR-








Table 4.8 Virulence factors present in Campylobacter coli S9 
Virulence 
factor 
Gene Locus Tag C. coli S9 Identity to C. coli 
BFR-CA-9557 %* 
Adhesion/ cadF  FD987_07545 99.7 
Invasion flaC  FD987_03765 99.9 
flhB  FD987_04345 100 
fliR  FD987_05995 97 
fliQ  FD987_08565 100 
ciaB  FD987_04835 99.5 
ciaC  FD987_06370 100 
flhA  FD987_04650 99.9 
fliP FD987_04205 99.6 
Chemotaxis cheA FD987_01785 99 
cheV FD987_01790 99.7 
cheW FD987_01780 100 
cheY FD987_05705 99.2 
Motility flgE  FD987_00230 99.8 
flaB FD987_03765 99.6 
flaA FD987_06890 94.4 
fliM FD987_00640 100 
fliF FD987_01960 100 
flgI FD987_07470 100 
rpoN FD987_03565 100 
fliK FD987_04350 99.3 
fliA FD987_00645 100 
fliY FD987_00635 99.6 
flgH FD987_03605 99.1 
Other cdtB  FD987_01820 99.63 
*BLASTP comparison of protein sequences 
 
4.3.2.9 Antibiotic Resistance Genes of C. coli S9  
 
Antibiotic resistance in Campylobacter is discussed in (section 1.7.1). The 
Resistance Gene Identifier was used to predict the resistome of C. coli S9 from 





The results showed that C. coli S9 had the OXA-61 gene which is one of the AMR 
gene family encoding OXA beta-lactamase. This resistance gene functions by an 
antibiotic inactivation mechanism giving resistance to the antibiotic classes 
cephalosporins and penams. The identity of the matching region was 99.22% and 
the length of reference sequence was 100% 
In addition, the genome of the C. coli S9 included multidrug and bile resistance 
response genes (Table 4.9) which are generally present in all Campylobacter.  
Table 4.9 Multidrug and bile resistance genes in C. coli S9 
Gene Product Function locus_tag 





cmeC outer membrane 
subunit CmeC 
 
efflux pump  FD987_02200 
cmeR transcriptional 
regulator CmeR 
transcriptional repressor FD987_02215 
 
The gene cmeB encodes the multidrug efflux RND transporter permease subunit 
CmeB, which works as part of CME efflux pumps. This consists of the inner 
membrane efflux transporter (CmeB), and cmeC encoding an outer membrane 
CME efflux pump. The cmeR gene encodes CmeR, the CME efflux pump 







Figure 4.17 AMR gene family for C. coli S9 
 
This figure was generated using the CARD: RGI online application and Perfect, 









4.3.3 C. hyointestinalis subsp. hyointestinalis S12 
chromosomal features 
 
4.3.3.1 Structure and genes 
 
The assembled circular chromosome of C. hyointestinalis S12 is 1,752,184 bp in 
length with 1,811 genes and an average G+C content of 34.28. The sequence 
contains 3 copies of the ribosomal RNA operon and 43 tRNA genes. Two duplicated 
regions were identified, the first was 1,599 bp in length and the second was 2,927 
bp. The first started from nucleotide position 1,171,550 to 1,173,149 and second 
started at nucleotide position 1, 90,767 to 1,193,694. (Figure 4.the genome map 
of the C. hyointestinalis S12 chromosome and indicates the positions of the 
duplicated sequences. The median chromosomal length of C. hyointestinalis 
strains listed in NCBI is 1.779 Mb, while the C. hyointestinalis S12 is the largest 
C. hyointestinalis chromosome complete sequences and the first with a single 
















Figure 4.18 Circular representation of C. hyointestinalis S12 chromosome 
Light blue represents coding DNA sequences (Black arcs show the regions of 
duplicate sequences) (Red shows rRNA and Dark blue represents tRNA sequences) 
(The inner circle is a % G+C plot) The C. hyointestinalis S12 genome was found 
to contain 56 homopolymeric G:C tracts, defined as containing more than 7 










Table 4.10 Homopolymeric repeats present in the C. hyointestinalis S12 
genome 
Position G/C tract 
(no.) 
Putative function Locus 
8720-8728 G(9) intergenic  
19852-19861 G(8) intergenic  
21920-21929 G(9) glycosyltransferase famliy  FFA43-00095 
27380-27388 G(8) aceetyltransferase FFA43-00120 
34080-34088 G(9) methionyl-tRNA formyltransferase FFA43-00155 
40544-40552 G(9) PIG-L famliy deacetylase FFA43-00195 
41900-41908 C(8) intergenic  
43048-43056 C(9) N-acetyl sugar amidotransferase FFA43-00210 
45535-45543 G(9) acylneuraminate 
cytidylyltransferase  
FFA43-00220 
47227-47234 G(8) h pothetic l protein FFA43-00225 
49447-49454 G(8) intergenic  
54036-54043 G(8) hypothetical protein FFA43-00260 
55283-55292 G(10) hypothetical protein FFA43-00265 
56510-56559 G(9) hypothetical protein FFA43-00275 
65645-65653 G(9) glycosyltransferase famliy 2 
protine 
FFA43-00320 
105816-105825 G(10) formyl tra sferase FFA43-00600 
154265-154267 C(12) intergenic N A  
161128-161136 G(9) intergenic  
173050-173058 G(9) intergenic  
250852-250861 G(10) intergenic  
284391-284399 C(9) TonB-dependent receptor FFA43-01565 
427898-427906 G(9) intergenic  
474542-474550 G(9) intergenic  
515758-515767 C(10) intergenic  
522901-522909 G(9) intergenic  
524705-524713 G(9) intergenic  
631301-631308 C(9) intergenic  
633286-633294 C(9) intergenic  
647121-647131 G(10) GGDEF domain-containing protein FFA43-03470 
722941-722949 C(9) intergenic  
723138-723146 G(9) intergenic   
775780-775789 C(9) hypothetical protein FFA43-04110 
786380-786389 G(10) intergenic  
830766-830773 C(8) MBOAT family protein FFA43-04370 
853098-853106 G(9) DUF2334 domain-containing 
protein 
FFA43-04485 
884539-884547 C(9) interg ic  
1156144-1156151 C(8) intergenic  
1163285-1163294 G(10) intergenic  
1206299-1206306 C(8) intergenic  
1208128-1208136 C(9) intergenic  
1244496-1244504 G(9) intergenic  
1318551-1318559 G(9) AAC(3) famliy N-acetyltransferase FFA43-06775 
1349008-1349016 G(9) intergenic  
1365757-1365764 C(8) intergenic  
1480180-1480188 C(9) 3-oxoacyl-ACP synthase FFA43-07555 
1485507-1485515 C(9) DUF4910 domain-containing 
protein 
FFA43-07580 
1560558-1560566 G(9) hypothetical protein FFA43-07975 
1560747-1560756 G(10) intergenic  
1562529-1562537 G(9) class 1 SAM-dependent 
methytransferase 
FFA43-07990 
1596066-1596074 C(9) methytransferas  domain- FFA43-08165 
1635490-1635498 G(9) intergenic  
1660776-1660784 C(9) intergenic  
1674792-1674800 C(9) EAL domain-containing protein FFA43-08570 
1689550-1689558 C(9) methyl-accepting chemotaxis 
protein 
FFA43-08635 






4.3.3.2 Nucleotide sequence statistics 
 
The distribution of nucleotides (Figure 4.19) was typical of an AT-rich 
Campylobacter genome. The median G+C content of C. hyointestinalis genomes 
listed on the NCBI website is 34% the nucleotide frequency in codon positions 
(Table 4.11).  
 
Figure 4.19 Nucleotide distribution histogram for the C. hyointestinalis S12 
chromosome 
 
Adenine residues were the most highly represented and distributed equally at each 
position whilst thymine residues were most frequent at the third than the second 
position. Guanosine residues were the least common in the third position and 
significantly more frequent in the first position. Cytosine residues were the least 
commonly occurring nucleotide overall, with no significate difference in frequency 
detected amongst each of the positions. The codon AAA, which encodes the amino 
acid lysine was the most abundant codon occurring 38,889 times and CGG, which 






Table 4.11 Frequency of nucleotide codon positioning for the C. 
hyointestinalis S12 chromosome 
Codon 
position 
A C G T 
1. position 0.37 0.13 0.31 0.18 
2. position 0.35 0.17 0.15 0.33 
3. position 0.36 0.15 0.13 0.37 
 
4.3.3.3 Comparison with nearest C. hyointestinalis DNA sequence 
neighbours 
 
The LAGAN shuffle comparison was used to identify the similarity between the C. 
hyointestinalis S12 and the nearest neighbour from the same species and 
subspecies. There was only one C. hyointestinalis subsp. hyointestinalis complete 
assembled genome sequences available in the NCBI database at the time of 
analysis. This was C. hyointestinalis subsp. hyointestinalis LMG 9260. Figure 4.16 
shows the alignment of the two genomes, where it is evident that there were large 
regions of low sequence identity present. The mVISTA browser function identified 
of genes which were present and absent in C. hyointestinalis LMG 9260 compared 








Figure 4.16 Chromosomal alignment of C. hyointestinalis S12 and C. 
hyointestinalis LMG 9260. Plot showing the percentage identity and locations of 
missing genes across the C. hyointestinalis S12 chromosome aligned with and C. 
hyointestinalis LMG 9260. Purple represents conserved regions; pink represents 
conserved non-coding sequences (CNS) and white represents missing or relocated 







Table 4.12 Nucleotide sequence similarity of C. hyointestinalis S12 





C. hyointestinalis subsp. hyointestinalis LMG 9260 89.13 98.39 
C. hyointestinalis MGYG-HGUT-02307 89.11 98.38 
C. hyointestinalis subsp. lawsonii CCUG 27631 76.36 94.73 
*Identities were calculated by whole genomic BLAST 
 
A total of 182 genes were identified to present in C. hyointestinalis S12 and 
absent in C. hyointestinalis LMG 9260 with 52 being hypothetical proteins 
(Appendix 6). The absent genes from C. hyointestinalis S12 but present in C. 






4.3.3.4 Plasmid pCh1 (S12) 
 
4.3.3.4.1 Structure and genes 
 
Analysis of the whole genome sequence of the C. hyointestinalis S12 cattle strain 
revealed the presence of one plasmid. This was the first recorded plasmid 
sequence belonging to C. hyointestinalis in the NCBI data base (accession number 
CP040465.1). The plasmid (Figure 4.21) was 6,796 bp in length and had a G+C 





Figure 4.21 shows the structure of plasmid pCh1, which contained 37 open 






4.3.3.5 CRISPRs of C. hyointestinalis S12 
 
Campylobacter hyointestinalis S12 also has three CRISPR arrays in the 
chromosome (Figure 4.22). Table 4. shows the sequences of direct repeats and 
spacers as calculated by the CRISPRs web server: (https://crisprcas.i2bc.paris-
saclay.fr/MainDb/StrainList/CP034309.1). The length of direct repeats and 
spacers appear to vary between the two pairs of arrays (Abby et al., 2014) . 
 
 
Figure 4.22 the positions of the CRISPR arrays and cas genes in details on 
Campylobacter hyointestinalis S12 genome. Red represents CRISPR arrays and 







Table 4.13 Direct repeat and spacer sequences in the C. hyointestinalis 
S12 genome 
 

















































































































































































































































































































































































































Noticeably, the results revealed that chromosome has two cas gene clusters, the 
first classed as a CAS-TypeIIC_1 which started from position 341,841 to 346,085. 
This includes the genes: Cas9_0_II_1, (341,841-344,318), Cas1_0_II_2 (344,872 
- 345,765) and Cas2_0_I-II-III_3 (345,765 - 346,085),  all of them in the forward 
orientation. The second cas gene cluster may be classed as a CAS-TypeIB_2, which 
starts from position 1,147,311 to 1,152,909. This includes 6 genes: Cas1_0_I-II-
III-V_1 (1,147,311-1,148,303), Cas2_0_I-II-III_2 (1,148,313-1,148,591), 
Cas4_0_I-II_3 (1,148,626 1,149,123), Cas3_0_I_4 (1,149,154-1,151,334), 





all of them in reverse orientation. Appendix 8 details the nucleotide BLAST results 
from the CRISPR direct repeats consensus sequence of C.hyointestinalis S12. This 
shows that the DR consensus sequence of the CRISPRs arrays are present in the 
genomes two other Campylobacter species. The C. fetus subsp. testudinum 772, 
C. fetus subsp. testudinum Sp3 and C. fetus subsp. testudinum pet-3 
chromosomes have 100% for both coverage and identity and same e-value with 
C. hyointestinalis S12 DR consensus sequence from the first CRISPR array. While, 
only Campylobacter hyointestinalis MGYG-HGUT-02307 have 100% coverage and 
identity with 2e-06 for the second and the third CRISPRs arrays DR consensus 
sequences. Nucleotide BLAST results from CRISPR Number 1 spacers of C. 
hyointestinalis S12 are listed in Appendix 9. Nucleotide BLAST results from CRISPR 
Number 2 spacers of C. hyointestinalis S12 are listed in Appendix 10. Nucleotide 
BLAST results from CRISPR Number 3 spacers of C. hyointestinalis S12 are listed 
in Appendix 11. In addition, Nucleotide BLAST X results from the CAS-Type IB 
genes sequences of C. hyointestinalis S12 are recorded in Appendix 12. 
 
4.3.3.6 Prophage insertions 
 
A single prophage insertion was present in C. hyointestinalis S12 (Fig 4.23 A and 
B), orientated in both directions that correlated with a region of sequence non-
identity with C. hyointestinalis LMG 9260 (Figure 4.16). The prophage had an 
approximate position of 229499-264445 kb and was 34.9 kb in length. This 










Figure 4.23 A) Prophage insertion in C. hyointestinalis S12 in both strands of the 








4.3.3.5 Taxonomic characterisation of C. hyointestinalis S12 by whole 
genome BLAST 
 
The nearest neighbour to C. hyointestinalis S12, according to the NCBI Genome 
neighbour report was C. hyointestinalis LMG 9260, which exhibits a symmetric 
identity and gapped identity with C. hyointestinalis S12 of 89.13 % and 98.39% 
respectively. The C. hyointestinalis S12 genome represents one of four complete 
C. hyointestinalis genomes available at the NCBI database at the time of analysis. 
All four of these chromosomes were approximately 1,750,000 bp in size. (Figure 
4.17) the dendrogram, based on genomic BLAST, of C. hyointestinalis S12 
phylogeny. 
 
Figure 4.17 Phylogenetic comparison of C. hyointestinalis S12 with C. 
hyointestinalis LMG 9260 Campylobacter hyointestinalis S12 is red coloured 
comparisons are based on genomic BLAST searches and the dendrogram was 





4.3.3.6 Virulence Factors  
 
As a member of the genus Campylobacter most of the genes which potentially 
encode virulence factors are common to both C. hyointestinalis and C. coli. BLAST 
analysis of the genome sequence of C. hyointestinalis S12 using revealed similar 























Table 4.14 Virulence factors identified in C. hyointestinalis S12 
Virulence 
factor  
Gene Locus Tag C. 
hyointestinalis S12 
Identity to C. 
hyointestinalis LMG 
9260 %* 
Adhesion/  cadF  FFA43_07125 98.8 
Invasion  flaC  Not found  
flhB  FFA43_03045 98.8 
fliR  FFA43_01805 100 
fliQ  FFA43_00990 100 
ciaB  FFA43_06450 97.7 
ciaC  Not found  
flhA  FFA43_01515 98.5 
fliP FFA43_05180 99.6 
Chemotaxis  cheA FFA43_07410 98.45 
cheV FFA43_07415 98.8 
cheW FFA43_07405 99.4 
cheY FFA43_06745 99.2 
Motility  flgE  FFA43_08695 99.4 
flaB FFA43_08150 87.3 
flaA FFA43_05910 98 
fliM FFA43_07775 100 
fliF FFA43_01525 100 
flgI FFA43_02165 100 
rpoN FFA43_05905 99 
fliK FFA43_00055 100 
fliA FFA43_07770 100 
fliY FFA43_07780 99.6 
flgH FFA43_03855 98.7 











4.3.3.7 Antibiotic Resistance Genes  
 
The Resistance Gene Identifier was used to predict the resistome of C. 
hyointestinalis S12 from protein, genome, or nucleotide data based on homology 
and SNP models by CARD, using the stingent criteria: perfect and strict hit only 
option used to detect the antibiotic resistance genes. The results showed that C. 
hyointestinalis S12 has the gyrA allele, which is one of the AMR gene family 
encoding for fluoroquinolone resistance. This resistance gene functions by an 
antibiotic target alteration mechanism. The identity of the matching region was 





















This work provides new genomic information on Campylobacter and species from 
cattle, which have been somewhat neglected. This was essential for their intended 
use as hosts for phage isolation. All the isolates (A. skirrowii A2S6, C. coli S9 and 
C. hyointestinalis S12) results demonstrate that, all three strains had a genomic 
structure typical of their relatives with sequenced genomes. The presence of 
homopolymeric repeats is common in Campylobacter (Clark et al., 2016, Miller et 
al., 2010), but the number identified in C. hyointestinalis appears particularly high. 
There is little information published related to Arcobacter species. Interestingly, 
the taxonomic analysis revealed that each of the three strains grouped with 
isolates from a similar source. The two Campylobacter strains had plasmids which 
has been highlighted in many other campylobacters (Boukerb et al., 2020, Chen 
et al., 2013, Marasini et al., 2018). The A. skirrowii A2S6 genome did not include 
any plasmids, however plasmids have been reported in different species of 
Arcobacter (On et al., 2019). This study identified a completely new plasmid in C. 
hyointestinalis named pCh1, which had not been reported before in any C. 
hyointestinalis that have been sequenced (Miller et al., 2016). All three sequenced 
strains had prophage sequences. Prophages in Campylobacter are common (Liu 
et al., 2016, Marasini and Fakhr, 2016), and also have been reported in many 
Arcobacter species (Miller et al., 2007, Millar and Raghavan, 2017, Rovetto et al., 
2017). The campylobacters had the expected virulence factors (Bolton, 2015, Mm 
Hassan, 2019). The virulence of Arcobacter is completely unknown and there is 
little evidence of virulence factors corresponding to those of campylobacters in 
their genomic sequence. In humans, Arcobacter have been associated with 
gastrointestinal disease. Arcobacters are also thought to contribute to abortion in 
cattle as they can be isolated from aborted cattle foetuses. They can be isolated 
from pets with no disease symptoms, but they are considered as opportunistic 





seem to be generally harmless organisms living in cattle and chickens which 
occasionally cause disease in humans that is largely self-limiting. Whilst the A. 
skirrowii A2S6 strain had only one AMR associated gene it was important because 
fluroquinalones are used to treat human clinical cases (see 1.7.2). Further work 
should undertake to further explore the role of arcobacters in the increase in 
antibiotic resistance. 
From the total results in this chapter (Chapter 4) which provides a strong base for 
the bacteriophage isolation experiments (Chapter 5) and considerably adds to our 
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5.1 Introduction  
 
Bacteriophage, or phage, are viruses that target bacteria. Phages can be present in 
any environmental system containing their bacterial hosts having an important role 
in biological processes related to their environments (Kakasis and Panitsa, 2019). 
Phage are known to be highly host specific, which can be to a species or even one 
strain. Bacteriophage are believed to be the most abundant and diverse organisms in 
nature (Keen, 2015). 
The majority of phages (more than 95%) that are isolated and classified belong to 
the order Caudovirales. These include the families Siphoviridae, Myoviridae and 
Podoviridae, which all have double stranded DNA, isometric heads and tails (Kabwe 
et al., 2020, Al-Zubidi et al., 2019, Sharp, 2001).  
The bacteriophage life cycle can divided into virulent or temperate types. Virulent or 
lytic phages, are phage that replicate through the lytic cycle. The phages attach to 
the bacterial host and then inject their genomic material which redirects the host’s 
molecular machinery to synthesize virus particles before the final destruction of the 
host cell to release new virions (Sausset et al., 2020). Lysis of the cell wall by virulent 
phages is controlled by two types of protein, the holins and the lysins, both of which 
play pivotal roles in the final stages of the lytic cycle (Cisek et al., 2017). Temperate 
or lysogenic phages, have the capability to integrate their genome into the host DNA 
and stay dormant as prophage. Here they are replicated with the host genome but 
under specific circumstances, such as host stress, can shift into the lytic cycle to 
replicate new virions and exit the cell (Sausset et al., 2020). The importance of the 
lysogenic cycle on the host cells is that the lysogen can encode genes that confer 
phenotypic advantages to the host bacteria, including antibiotic resistance, virulence 





Bacteriophages that attack Campylobacter have been reported over the last sixty 
years, although changes in Campylobacter taxonomy  have sometimes made the host 
phage relationships unclear (Connerton et al., 2011). However, the first lytic phages 
that can infect what are reclassified as C. coli and C. fetus were isolated from cattle 
and pigs between 1964 -1968 (Fletcher and Bertschinger, 1964, Firehammer and 
Border, 1968, Fletcher, 1965). The first temperate bacteriophages and their host were 
isolated from aborted sheep foetuses by Bryner et al. (1982). The majority of 
Campylobacter bacteriophage isolated possess double-stranded DNA, with 
icosahedral heads and tails, belonging to the Myoviridae family (Connerton et al., 
2008). Lysogenic or temperate bacteriophage of Campylobacter are variably observed 
as prophages in genome sequence data. For C. jejuni these include a Mu-like 
bacteriophage (Fouts et al., 2005b), which was notably absent in the first genomic 
sequence of the type strain C. jejuni NCTC 11168 (Parkhill et al., 2000). Moreover, 
Mu-like prophage have been demonstrated to mediate genomic rearrangements in C. 
jejuni DNA that can lead to phage resistance and the generation of infectious 
bacteriophage CampMu (Scott et al., 2007). 
Virulent Campylobacter bacteriophages can reduce the intestinal carriage of 
Campylobacter by broiler chickens (Atterbury et al., 2005). Using phage as an 
intervention in controlled trials (Loc Carrillo et al., 2005; Wagenaar et al., 2005; El-
Shibiny et al., 2009) and in broiler house applications (Kittler et al., 2013) has 
demonstrated reductions in the intestinal load of Campylobacter by approximately 2 
log10 CFU/g (Carvalho et al., 2010; Connerton et al., 2011; Hammerl et al., 2014; 
Richards et al., 2019). This represents a potential reduction in the risk of infection 
from contaminated poultry meat (Crotta et al., 2017). No Arcobacter phage have not 





the control Campylobacter in dairy production and to attempt to isolate Arcobacter 






5.2 Material and Methods 
 
5.2.1 Collection of cattle slurry samples 
 
Cattle slurry samples were collected from Centre of Dairy Research and Innovation 
located Sutton Bonington, Nottingham, LE12 5RY, coordinates (52.839240, -
1.249674) on two occasions (9/9/2018 and 12/04/2019). Slurry samples were 
collected from different farm locations including: Site 1 “Silage pit”; Site 2 “Crud 
Stackable deep litter bedding mature”; Site 3 “Dairy cow and shed effluent”; site 4 
“Heifers shed effluent” and Site 5 “Growing heifer (11 to 15 meters) and cow effluent”. 
The sampling locations are shown in Figure 5.1. The sample from Site 5 was collected 
by means of a 100 ml plastic pot attached to 20 m plastic rope, which allowed 
collection from a 5-6 m depth. These silage, effluent and other slurry samples were 
collected in 50 ml sampling pots, placed in a sterile polythene bag, and then placed 
in a cooled sample box. The samples were then transferred immediately to the 







Figure 5.1 Birds Eye view of University of Nottingham - Centre of Dairy Research and 
Innovation A) Site locations 1-5, B) Maximised view of sample 5 location 
 
5.2.2 Host lawn preparation  
 
Fresh subcultures of C. jejuni PT14, C. hyointestinalis S12 and A. skirrowii A2S6 
described and characterised in Chapter 4, were made on BA (2.1.1) plates and 
incubated under microaerobic conditions at 42°C for 24 h (C. jejuni PT14), 
microaerobic conditions at 37°C for 48 h (C. hyointestinalis S12) or microaerobic 
conditions at 30°C for 48 h (A. skirrowii A2S6). Bacterial growth from each strain was 
harvested in a 10 ml solution of 10 mM MgSO4 and 1 mM CaCl2 using sterile swab. 
The cell density was then adjusted to approximately 108 CFU /ml, which approximated 
to growth from half of the plate having an OD600 of approximately 0.350 for C. jejuni 





harvested in the same amount of solution. An aliquot of 500 µl of each suspension 
was added to 5 ml of molten NZCYM overlay agar (section 2.1.4) at 50°C mixed and 
quickly added to the surface of pre-warmed NZCYM basal agar (section 2.1.3). Plates 
were then left to set. 
 
5.2.3 Detection and isolation of bacteriophages, non- 
enrichment method 
 
To each slurry sample, 1 g was mixed with 9 ml of SM buffer (section 2.1.11). The 
mixtures were then incubated at 4°C for 24 h with slow rotation to elute the phage 
into the buffer. A 1 ml aliquot of the first dilution was removed and centrifuged at 
3,000 x g for 3 minutes, the supernatant from which was then subjected to second 
centrifugation step for 5 minutes at 13,000 x g. The second supernatant was then 
passed through a 0.45 µm-pore-size membrane filter (Minisart; Sartorius, Gottingen, 
Germany) and a 0.22 µm-pore-size membrane filter (Minisart; Sartorius, Gottingen, 
Germany) to remove any remaining bacterial cells. After that, 10 µl aliquots of 10 fold 
serial dilutions were dispensed onto a lawns of the host strain lawns (section 5.2.2) 
in triplicate with positive control (lawn only) and negative control (media only). All 
the plates were then incubated under microaerobic conditions for 48 h, C. jejuni PT14 
plates incubated at 42°C, while the C. hyointestinalis S12 were incubated at 37°C and 
A. skirrowii A2S6 plates were incubated at 30°C. Any visible plaques of lysis were 
monitored after the incubation period. Any spots that showed lytic reactions were 







5.2.4 Plaque purification  
 
Primary plaques were sequentially propagated to ensure single clones were obtained. 
Single, well isolated plaques were picked with a pipette tip and suspended in 500 μl 
SM buffer (section 2.1.11). The suspensions were then passed through a 0.45 µm-
pore-size membrane filter (Minisart; Sartorius, Gottingen, Germany) and a 0.22 µm-
pore-size membrane filter (Minisart; Sartorius, Gottingen, Germany). After which 
serial dilutions of the supernatant were performed, and 10 μl of each dilution in 
triplicates were dispensed on NZCYM overlay plates (section 2.1.4) containing the 
bacterial host isolates in the top layer. Plates were then incubated according to the 
host requirements as mentioned above. The process was repeated selecting well 
isolated plaques from the dilution series. Finally, after five rounds of purification, a 
single purified plaque of suspected bacteriophages was suspended in 100 μl SM buffer 
(section 2.1.11) and stored at 4°C. 
5.2.5 Bacteriophage propagation and storage  
 
For the propagation of bacteriophages host cells were prepared as described in 
(section 5.2.2) To 400 μl of the cell suspension, a 100 μl aliquot of a bacteriophage 
stock containing 8 log10 PFU/ml was then added and mixed. This mixture was 
incubated for 20 - 30 minutes under microaerobic conditions at the appropriate 
temperature for the host. Next, 5 ml NZCYM overlay agar aliquots (section 2.1.4) in 
sterile universal bottles were melted in the microwave, and kept in a water bath at 
55°C. The incubated host cell and bacteriophage suspensions were then transferred 
to the overlay agar tube and mixed prior to pouring onto plates of NZCYM basal agar 
(section 2.1.3) and allowed to set. The plates were then incubated under microaerobic 
conditions for 48 hours at the appropriate temperature for the host. Successful lysis 





infected host control plates by a reduction in turbidity. The propagated bacteriophages 
were then harvested, by addition of 5 ml of SM buffer (section 2.1.11) onto the 
surface of the plates. The plates were then incubated overnight at 4°C with shaking 
on a shaker platform with 60 cycles/minute. Following incubation, SM buffer 
containing bacteriophage was collected and filtered by passing through a 0.22 µm-
pore-size membrane filter (Minisart; Sartorius, Gottingen, Germany) to remove cell 
debris and residual agar. The filtered bacteriophage stocks were stored at 4°C in 
sterile plastic universals or Eppendorf tubes. Enumeration of bacteriophage obtained 
was determined by serial dilution and titration on host cell lawns prepared as 
described in (section 5.2.2). 
 
5.2.6 Bacteriophage transmission electron microscopy 
 
Transmission electron microscopy (TEM) was performed to examine bacteriophage 
morphologies. High titre bacteriophage suspensions (section 5.2.5) free of host 
material, increasing the chance to produce high quality images were prepared. The 
bacteriophages were fixed using a similar method to that used for bacterial 
transmission electron microscopy section (section 2.11). An aliquot of 13 μl of fixed 
phage suspension was transferred onto the formvar carbon film on copper 200 mesh 
grid and incubated at room temperature for five minutes. The suspension was 
removed by using filter paper and 13 μl of 2% w/v uranyl acetate was added onto the 
grids for 30 seconds. After staining, uranyl acetate was removed by using filter paper. 
The sample was then washed twice to improve the image quality by adding 13 μl of 
distilled water to the grid, then removing using filter paper. The grid was then ready 






5.2.6 Bacteriophages genomic DNA extraction  
 
Different two methods have been applied to extract the phage genomic DNA in this 
study. 
 
5.2.6.1 Phage DNA preparation using Wizard® DNA Clean-Up System 
 
The isolation of phage DNA suitable for sequencing was achieved using the Promega 
Wizard® DNA Clean-Up System A7280. High titre bacteriophage suspension was 
prepared using 20 full plate lysates (section 5.2.5) to produce approximately 100 ml 
of 9 log10 PFU/ml. The phage suspension was filtered through a 0.22 µm-pore-size 
membrane filter (Minisart; Sartorius, Gottingen, Germany), and the filtered phage 
suspension centrifuged at 37,500 x g for 2 h at 4C in 35 ml Oakridge tubes. The 
pellets were re-suspended in 0.5 ml of 5 mM MgSO4 per tube (prepared from 1 M 
stock section 2.1.12). Aliquots of 1 µl 10 mg/ml DNase and 1 µl 10 mg/ml RNase 
were added and the suspension incubated at 37°C for 30 minutes. Following the 
incubation, 10 µl of 0.5 M EDTA and 5 µl of 10 mg/ml Proteinase K were added. 
Wizard® DNA Clean-Up Resin was dissolved by warming to 37°C for 10 minutes and 
then cooling to 25–30°C. One Wizard® Minicolumn was prepared for each sample by 
attaching the barrel of a 5 ml syringe to the Luer-Lok® extension of each Minicolumn. 
One ml of Wizard® DNA Clean-Up Resin was added to each sample and mixed by 
inverting several times and transferred into the syringe barrel. The sample forced 
through the column using the plunger. The column then was washed by pipetting 2 
ml of 80% isopropanol into the syringe and gently pushed through the Minicolumn. 
The Minicolumn was placed into to a 1.5 ml Eppendorf tube then centrifuged for 2 
minutes at 10,000 x g then transferred to a fresh Eppendorf tube. An aliquot of 50 µl 





incubated for 1 minute at room temperature. To elute the bound DNA fragments, the 
Minicolumn was then centrifuged for 20 seconds at maximum speed and stored for at 
4°C. 
 
5.2.6.2 Phenol extraction for purification phage genomic DNA  
 
High titre bacteriophage suspension was prepared as described in (section 5.2.6.1). 
Following centrifugation at 37,500 x g and resuspension of pellets, an aliquot of 400 
µl phage suspension was transferred to a 1.5 ml Eppendorf tube. Lysis solution 
containing 25 µl 10% SDS, 50 µl 1 M Tris-HCl pH 8.0, 25 µl 0.5 M EDTA, pH 8.0 and 
200 µg Proteinase K was added to the tube. The tube was then gently mixed by 
inverting the tube back and forth. The suspension was incubated for 20 minutes at 
56-65°C. Next, organic extraction of the protein from the aqueous phase was 
achieved by adding a mix of a 500 µl phenol:chloroform:isoamyl alcohol (25:24:1) to 
the tube. Without using the vortex, the tube was then mixed well for 2 minutes. The 
tube was centrifuged in a microfuge at maximum speed for 2 minutes. The top 
aqueous layer was transferred to a clean 1.5 ml Eppendorf tube. Residual phenol was 
removed by extraction two times with 100% chloroform. After removing the phenol, 
50 µl of 3M NaOAc (pH 5.2) was added and mixed. Directly, a 1 ml volume of ice-cold 
100% EtOH was added to the tube and mixed by repeatedly inverting the tube. The 
DNA was then moved to a fresh a 1.5 ml Eppendorf tube containing 70% EtOH at 
room temperature using a plastic loop, then centrifuged and the pellet dried by 
incubating at 55°C with lid open the dissolved in 200 µl TE buffer (10 mM Tris, 1 mM 







5.2.7 Bacteriophage DNA sequencing  
 
The DNA sequence of phage genomes were determined using the Illumina MiSeq next 
generation sequencing technology from libraries prepared using the NexteraTM 
tagmentation protocol and run on an Illumina v3 cassette to produce between 0.7 
and 0.9 million sequence reads of 80 to 250 bps per genomic DNA preparation. These 
reads were used for de novo assembly of the phage genomes using the CLC Genomic 
Workbench Software package version 9.1 (Qiagen). The phage DNA sequence was 







5.3 Results  
 
5.3.1 Plaque formation and recognition 
 
Visual examination of phage isolation plates following sample application produced 
some unexpected results. Samples applied to C. jejuni PT14 host lawns produced no 
plaques. However, severe damage to the lawns was observed on the surfaces of all 
the treatment plates incubated at 42°C compared to control plates of C. jejuni PT14.  
No plaques were detected on Arcobacter plates for any samples incubated under 
microaerobic conditions at 30°C for 48 h, with monitoring every 12h. However, 
unusual circular zones were observed inside the 10 µl spot areas in all treatment 
plates compared to the positive control.  These observations were hampered because 
A. skirrowii A2S6 did not form a uniform lawn on NZCYM. (Figure 5.2) The primary 
unusual circular pitting in A. skirrowii A2S6 lawn when inoculated with 10 µl of cattle 
slurry supernatant sample. The areas of pitting were reduced upon serial dilution 







Figure 5.2 Circular zones resulted from slurry supernatant in A. skirrowii A2S6 lawn 
grown on NZCYM 
 
The application of slurry filtrate samples to C. hyointestinalis S12 lawns also exhibited 
unusual plaque-like features when incubated under microaerobic conditions at 37°C 
for 48 h, with monitoring every 12 h. These unusual plaques could only be seen if the 
light source was tilted at an acute angle of approximately 45° when the plates were 
examined. These plaques on the C. hyointestinalis S12 lawn only appeared inside the 
sample application area and declined decimally through the dilution series implying 
they were particulate. (Figure 5.3) A and B shows these primary plaques on lawns of 
C. hyointestinalis S12. The sample from which these plaques were obtained was taken 
from Site 5 (section 5.2.1). The effect was reproduced among all replicates from this 
site giving a total of 15 replicates from three separate experiments. Plaque 
purification was carried out as described in (section 5.2.4) and propagation as 








Figure 5.3 Serial dilutions of the filtered slurry supernatant applied as 10 l droplets 
to C. hyointestinalis S12 lawn, resulted in an unusual, difficult to visualise plaques 









Figure 5.4 Two examples of haemolysis-like activity of the bacterial isolate when 






5.3.2 Evidence that a bacterium was responsible for plaque 
formation 
 
The propagated lytic material from the plaques in (section 5.3.1) was examined by 
TEM (section 5.2.6). The images shown in (Figure 5.5) A and B confirmed that the 
source of the lytic activity was bacterial rather than due to phage lysis. This was 
surprising as initial samples for TEM were prepared with the expectation of discovering 
bacteriophage and had been filtered two times through a 0.22 µm-pore-size 
membrane filter to remove all potentially pathogenic bacteria from the preparation 
but had not been formalin fixed to inactivate living bacteria. However, during the TEM 
session the clear observation of bacterial cells (Figure 5.5 A) resulted in ending the 
TEM session for safety reasons. Further TEM sessions with formalin fixed samples 










Figure 5.5 (A shows a part of a bacterial cell wall and flagella that were un-stained 
and un-fixed, as the sample had been treated as phage TEM sample) Bar represents 
200 nm and (B TEM image of novel bacteria ASxL5, after stained with 2% w/v uranyl 





Following this observation the purified, propagated stock from the plaques was 
stained using Gram’s method which revealed the presence of a very small slender 
poorly staining, Gram-negative, curved rod-shaped bacteria (Figure 5.6). Subsequent 
it was discovered that the ASxL5 bacterium could be cultured on rich media such as 
BA or BHI (section 2.1.1 and 2.17) independent of it’s host, although growth was 
poor. Colonies produced were very small, round, and transparent. Following storage 
of inoculated BA for seven days at 4°C an unusual haemolysis-like activity was 
observed (Figure 5.4 ). Further experiments were carried out on this novel bacterium 
and are described in Chapter 6. 
 
 







5.3.3 Bacteriophage associated with predation by novel 
bacterium  
 
Experiments were carried out using TEM (section 5.2.6) to attempt to understand the 
predation process by the novel bacterium ASxL5. This resulted in a further interesting 
observation shown in (Figure 5.7) which revealed phage particles associated with C. 
hyointestinalis S12 post-attack by the predatory bacteria. Images of C. hyointestinalis 
S12 alone did not show the phage particles. The appearance of the phage particles 
seemed to be associated with the stress of predation suggesting the particles 
represent excised lysogenic bacteriophages. (Figure 5.7) A and B show purified 
particles harvested post-attack of C. hyointestinalis S12, which have a long, 
contractile tail of 134 nm and icosahedral heads with diameters of 71 nm. This 
morphology indicates that these phages belong to the Myoviridae family of tailed 
phages. (Figure 5.7) B and C show phage particles that are broken or misassembled 
post-predatory attack of the host C. hyointestinalis, which may be a consequence of 







Figure 5.7 Transmission electron micrographs of lysogenic bacteriophages isolated 
from C. hyointestinalis S12 after attack by ASxL5 predatory bacterium (A and B show 
intact phage particles) (C and D show typical broken or misassembled phage particles) 
 
5.3.4 Identification of an excised prophage 
 
The whole genome sequencing of the DNA isolated from phage preparations of post-
predatory attack of C. hyointestinalis S12 was undertaken using Illumina MiSeq next 
generation sequencing technology. The resulting reads were then assembled using 





33,817 bp with sequence heterogeneity at each end. The consensus sequence had 
nucleotide identity with a putative prophage sequence in the genome of C. 
hyointestinalis S12, which unequivocally defines the source of the phage as an excised 
prophage. The phage sequence was annotated using Phaster and HHpred, and the 
corresponding map (Error! Reference source not found.). 
The sequence heterogeneity at the left and right ends of the phage sequence is similar 
to that observed for transposable phage Mu from E. coli, whereby non-Mu host DNAs 
adjacent to the site of integration are packaged with the Mu genome on the basis of 
the head-full mechanism during the lytic phase. The number of bases flanking the 
phage genome is between 60 to 150 kb for the left-hand end and 0.5 to 3 kb for the 
right-hand end (Symonds et al., 1987). Due to the sequence heterogeneity the 
assembly program could not extend the contig but upon examining individual 
sequence reads extending from the left and right-hand ends of the phage genome 
enabled the positions in the C. hyointestinalis S12 genome from where they were 
excised to be determined, (Table 5.1 The locations of flanking sequences from 
the excised Mu-like phages from C. hyointestinalis S12. The locations of 
flanking sequences outside the prophage region implies that the sequences have been 
transposed, and that the element is a functional transposable phage that responds to 
stress. 
Annotation of the phage sequence revealed predicted functions consistent with a 
functional phage, (Error! Reference source not found.). Most notable were r
ecognisable functions associated with the ability of phage Mu to transpose, a DDE-
type integrase and the DNA transposition protein B. Structural similarities predicted 
by HHpred also highlighted specific orthologues of phage Mu: the Mu middle operon 






Table 5.1 The locations of flanking sequences from the excised Mu-like 







CGTAAAAC/TGTGA 64,022 Glycosyltransferase (transposition) 
AATAAAAC/TTAAT 227,963 Intergenic (native position) 
TACGATTT/TGTGA 227,610 Hypothetical (transposition) 
GGGTATTT/TGTGA 258,741 Intergenic (transposition) 
TTCACTTC/TGTGA 828,021 Hydroxymethylbilane (transposition) 




CTGAGACT/TGTGA 1,391,337 Flavodoxin (transposition) 
TTGAGTAT/TGTGA 1,727,388 Hypothetical (transposition) 
CTATATTT/TGTGA 227,897 Intergenic (internal inversion) 
ACCTTTCT/TGTGA 231,320 Integrase (internal inversion) 
The DNA sequences in bold are host flanking sequences. Nucleotide locations relate 





The direction of translation is indicated by the arrows and the location within the nucleotide sequence indicated by the 
 numbers below. Unidentified open reading frames are marked as URFs. 
 
 










Plaques observed on bacterial lawns often represent lytic activity which is 
frequently caused by lytic bacteriophage and occasionally can linked to predatory 
bacteria. In this study, it was observed that supernatants from cattle slurry 
samples produced cloudy plaques on lawns of C. hyointestinalis S12 isolated from 
the same environment. Faecal matter and manure samples of some farm animals 
like chicken and pigs were good sources of Campylobacter bacteriophages 
(Brathwaite et al., 2013; El-Shibiny et al., 2005) so the expectation of this study 
was that cattle slurry would likewise be a source of useful bacteriophage from 
various Campylobacter species likely to be present. The isolation methods were 
successfully tested on faecal material from pigs but the same methods as applied 
to cattle slurry, did not produce the abundant phage populations anticipated. 
There are no previous studies, that use cattle faecal or slurry samples as sources 
of Campylobacter specific phages. The unusual lytic activity that prevented 
adequate lawn formation could be one reason behind this. The unusual plaques 
generated by the predatory bacteria may play a role as the predator may play to 
trigger the excision of lysogenic phage. All these results represent a unique 
phenomenon, which has only been observed during the work in this study. It is 
assumed that microbiological diversity and environmental conditions can 
represent potent effectors of changes in bacterial populations in closed ecological 












Unusual lytic activity was found to be caused by a predatory bacterium ASxL5. 
This were confirmed by Gram stain and by TEM imaging. Bacteriophages observed 
following predation by ASxL5 were lysogenic phage released from the C. 
hyointestinalis S12. The C. hyointestinalis S12 genome includes a prophage 
insertion (section 4.3.3.6) was integrated in genome. However, the sequence data 



























Characterisation of novel predatory bacteria 








A predatory bacterium is one that demonstrates the ability to pursue and kill other 
living bacteria to obtain biosynthetic materials and energy (Pérez et al., 2016). 
This is distinct from the universal recycling of the nutrients from dead 
microorganisms and from parasitic interactions where bacteria form close 
associations with their hosts without killing them. Predatory bacteria have evolved 
diverse life cycles to exploit abundant food sources in the niches where they are 
found, for example in marine habitats (Linares-Otoya et al., 2017). They are a 
taxonomically diverse group connected only by their unique bactericidal life cycle 
(Pérez et al., 2016). Examples of predatory bacteria are found in several different 
phyla including: Proteobacteria, Bacteroidetes, Chloroflexi, Actinobacteria and 
Firmicutes (Pasternak et al., 2013). However, the most well-studied predatory 
bacteria are, Bdellovibrio and Bdellovibrio-and-like organisms (BALOs) Sockett 
(2009). Predatory bacteria are promising sources of new bioactive compounds and 
antibiotics (Korp et al., 2016). 
Predatory bacteria are suggested to enhance microbial diversity, have the 
potential to prevent dysbiosis and have a positive effect on ecosystem health, 
productivity and stability (Johnke et al., 2020). Despite these positive attributes, 
there are few studies of new predatory bacteria because of difficulties in culturing 
the bacteria, and the need for careful observation of cellular interactions in order 
to understand their complex lifecycles. This information is not readily available 
from in silico analysis. 
In an era of increased antimicrobial resistance novel strategies such as the use of 
bacteriophage, that target bacterial pathogens, are being investigated (Vila et al., 
2019). The ASxL5 bacterium was isolated from cattle slurry collected from the 
University of Nottingham Dairy Centre, Nottinghamshire, in 2019 using techniques 





isolate organisms that had potential as biocontrol agents. Campylobacter 
hyointestinalis, a zoonotic pathogen that is increasingly associated with enteric 
disease in humans (Wilkinson et al., 2018), was prevalent in all cattle slurry 







6.2 Materials and Methods 
 
6.2.1 Isolation of host bacteria 
 
Bacterial isolates to use as potential hosts were isolated and identified as described 
in (section 2.7, 2.8) from all cattle slurry samples. 
6.2.1 Isolation of ASx5L 
 
The ASxL5 bacterium was isolated from cattle slurry using C. hyointestinalis S12 
as host using techniques described in Chapter 5.2.  
 
6.2.3 Phenotypic characterisation of ASx5L 
 
Once it was established that a bacterium was responsible for the lytic plaques 
rather than a bacteriophage, attempts were made to cultivate the organism 
independently from the host and characterize it further. Weak growth that 
improved on subculture was obtained BHI (section 2.1.7) and BA (section 2.2.1) 
with aerobic incubation at 37°C. Antibiotic sensitivity was tested was carried out 
on BHI agar incubated aerobically at 37°C using discs with the following antibiotics 
(Oxoid): amoxycillin and clavulanic acid 30 µg; cefotaxime 30 µg; streptomycin 
10 µg; ciprofloxacin 5µg; ceftazidime 30 µg nalidixic acid 30 µg; imipenem 10 µg; 
azithromycin 15 µg; chloramphenicol 30 µg; cefoxitin 30 µg; tetracycline 30 µg; 
nitrofurantoin 300 µg; aztreonam 30 µg; ampicillin 10 µg; cefpodoxime 10 µg; 
trimethoprim-sulfamethoxazole 25 µg. Salt tolerance was established by 
cultivation aerobically at 37°C on BHI agar plates to which additional NaCl was 









ASxL5 was cultured aerobically by spreading uniformly on BA for 24 h at 37°C and 
harvested into 1 ml of 3 % (v/v) glutaraldehyde in 0.1 M cacodylate buffer, fixed 
for 1 h at room temperature then centrifuged at 10,000 g for 3 min. The pellet 
was then re-suspended gently into 600 μl of 0.1 M cacodylate buffer. The fixed 
ASxL5 suspension was transferred onto Formvar/ carbon film on copper 200 mesh 
grids. The bacteria stained with 0.5% (w/v) uranyl acetate for 1 min and examined 
by TEM using a TEI Tecnai G2 12 Biotwin microscope. The predator prey interaction 
was also examined by TEM as described above combining equal numbers of prey 
and predator in NZCYM broth (BD DifcoTM, Fisher Scientific UK Ltd, Loughborough) 
and incubating for 48 h at 37°C, under microaerobic conditions for Campylobacter 
or aerobic conditions for E. coli. Prey and predatory bacteria were examined 
independently to establish any changes in cell morphology arising as a 
consequence of predation.  
 
6.2.5 Host range determination 
 
Overnight cultures of ASxL5 were grown by spreading growth on BHI or BA plates 
using a sterile swab. The ASxL5 cells were collected and suspended in MRD 
(CM0733, Oxoid) and then placed at 4°C for 7 d, to starve the cells. NCTC 
reference or laboratory stock bacteria cultures were inoculated into BHI broth or 
NBroth No 2 (section 2.5.1), incubated overnight, centrifuged at 13,000 g and re-
suspended in MRD to an OD600 of 0.4. The cultures were: Bacillus subtilis NCTC 
3610, Citrobacter freundii NCTC 9750, Enterobacter aerogenes NCTC 10006, 
Enterococcus faecalis NCTC 775, Escherichia coli NCTC 86, Klebsiella oxytoca 
11466, Leuconostoc mesenteroides NCTC 10817, Listeria monocytogenes NCTC 
4885, Paenibacillus macerans NCTC 6355, Providencia stuartsii NCTC 10318, 





enterica Montevideo NCTC 5747, Serratia liquefaciens NCTC 10861, 
Staphylococcus aureus NCTC 8532, Streptococcus pneumoniae NCTC 7465, 
Yersinia enterocolitica NCTC 10460. Campylobacter hosts were incubated 
microaerobically at 37C on BA plates and then suspended in NZCYM broth. 
Campylobacter hosts tested were: C. coli 12667 NCTC, C. jejuni 12662, C. jejuni 
PT14, C. jejuni NCTC 11168, C. helveticus NCTC 12472, C. lari NCTC 11458, C. 
upsaliensis NCTC 11541, C. hyointestinalis NCTC 11608. Cells were collected in 
MRD, centrifuged at 13,000 g and re-suspended in MRD to an OD600 of 0.4. An 
aliquot of 0.5 ml of the suspensions was added to 5 ml aliquots of molten NZCYM 
top agar (section 2.1.4) and poured on to 1.2 % NZCYM baseplates (section 2.1.3). 
Once set and dried, serial dilutions of ASxL5 were dispensed as 20 µl droplets in 
triplicate onto each lawn plate. The incubation temperature and atmosphere were 
dependent on the test bacteria’s requirements. 
 
6.2.6 16s rRNA and Whole Genome Sequence Determination 
 
The DNA was prepared from bacterial isolates using GenElute™ Bacterial Genomic 
DNA Kit (section 2.9.1). The PCR amplification of 16S rRNA gene and sequence 
determination of the product was carried out using standard methods (section 
2.9.2). The DNA for whole genome sequencing was extracted using the PureLink™ 
Genomic DNA Kit (Fisher Scientific, Loughborough, UK). The genome sequence of 
ASxL5 was determined using a combination of Illumina MiSeq consisting of 250 bp 
paired-end reads using libraries prepared from the Nextera tagmentation kit, and 
long reads of 2 to 20 kb from the PacBio (Pacific Biosciences) platform performed 
at the Nu-Omics DNA Sequencing Research Facility, Northumbria University. The 
genome was assembled using CLC Genomics Workbench 12.0.3 (Qiagen, Aarhus, 
Denmark). ASxL5 cultures were deposited at National Collection of Type cultures 





related organisms used for comparisons were: Thalassolituus oleivorans MIL-1 
(Golyshin et al. 2013; accession HF680312, complete); Bacterioplanes sanyensis 
NV9 (accession CP022530, complete); Oceanobacter kriegii DSM 6294 (accession 
NZ_AUGV00000000, incomplete); Marinomonas communis DSM 5604 (accession 
ASM436330v1, incomplete) and Thalassolituus sp. C2-1 (accession 
NZ_VNIL01000001, incomplete). The Ortho average nucleotide identity 
(OrthoANI) and amino acid identity (AAI) were determined using software 
available online (Lee et al., 2016, Rodriguez-R and Konstantinidis, 2014). The 
digital estimates for DNA–DNA hybridization values using formula 2 from these 
five genomes from related organisms were computed by using the online software 
tool gbdp2_blastplus available at http://ggdc.dsmz.de/ (Meier-Kolthoff et al., 
2013). Functional annotation of the ASxL5 genome using orthology assignment 
was carried out by using the BlastKOALA KEGG online tool for functional 
characterisation of genome sequences (Kanehisa and Goto, 2000) and COGs were 

















6.3.1 ASxL5 is a predatory Bacterium with Unusual Cell 
Morphology 
 
The ASxL5 bacterium was isolated from bovine slurry because it formed plaques 
on C. hyointestinalis host similar to those produced by bacteriophage. It was an 
unexpected finding because part of the phage isolation procedure involved 
filtration through a 0.2 µm filter designed to remove bacterial cells. Microscopic 
examination of the material extracted from the plaques revealed small Gram-
negative curved rod-shaped bacteria. Axenic culture was achieved independent of 
prey cells on rich solid media such as BHI and BA, with weak growth that improved 
on subculture using heavy inocula. Colonies were small reaching 2 mm in diameter 
after 72 h and were beige, translucent, circular, convex and shiny. It was not 
possible to carry out most standard biochemical tests as ASxL5 could not be 
reliably cultured in liquid medium suggesting a complex life cycle with possible 
dependence on biofilm formation. ASxL5 was aerobic, oxidase and catalase 
positive and able to tolerate 5% NaCl. It was resistant to streptomycin 10 µg, but 
sensitive to all other antibiotics tested. The characteristics of ASxL5 are 
summarized in Table 6.1. The ASxL5 bacterial cells were examined by (TEM 





Table 6.1 Phenotypic characteristics of ASx5L 








Catalase  + 
Oxidase  + 
pH range: 3-9 (tested) 4-9 
Salt tolerance: 0.5-10 % (tested) 0.5 to 5% 
Cell dimensions: 
Grown on BA 48 h   
length 1.63 µm (±0.42)  
width  0.37 µm (±0.08) 
 
Incubated with C. jejuni 48 h  
length 2.09 µm (±0.69)  
width 0.30 µm (±0.06) 
 
Incubated with E. coli 48 h  
length 4.99 µm (±2.45)  





























Figure 6.1 TEM of ASx5L showing: (A ASx5L showing long polar flagellum) (B 
typical ASx5L cell) (C coccal ASx5L cell following prolonged incubation without 
nutrients) (D group of ASx5L cells showing unusual apical structure indicated with 
arrow)(E group of ASx5L cells incubated with Campylobacter prey showing 
increased cell length compared with those grown without prey (panel D) also 
showing apical structures) (F large filamentous aflagellate, ASx5L cells, following 
incubation with E. coli prey)(G single ASx5L cell following incubation with E. coli 






Host independent grown on BA, the ASxL5 cells were small curved bacteria with 
an average length of 1.63 m (0.4) and width of 0.37 m (0.08), with a single 
long (up to 5 m) polar flagellum. Approximately 1.6 % of cells appeared to have 
a width of less than 0.2 m which would allow passage through a filtration device. 
An unusual structural extension resembling a cowl (latin cucullus), was observed 
at the apex of some cells (arrow Figure 6.1 D, E and G). This appeared to be 
composed of excess outer membrane, possibly due to a rapid reduction in size of 
the periplasmic envelope, with the outer membrane remaining intact, giving a 
“baggy” appearance. Prolonged incubation of ASxL5 without nutrients (in PBS), at 
4 C, resulted in most, but not all, of the cells exhibiting coccal morphology (Figure 
6.1 C). When ASxL5 was grown for 48 h with C. jejuni as prey, the mean cell sizes 
were significantly longer and narrower, than cells grown without host, (2.1 m by 
0.3 m; p = 0.0003 and p = 4 x 10-15, by ANOVA respectively; Table 6.1 and 
Figure 6.1E). In contrast when ASxL5 was grown for 48 h with E. coli as prey, the 
mean cell sizes were longer and wider than when grown without prey (5.0 m by 
0.63 m; p = 0.00016 and p = 2 x 10-15, by ANOVA respectively, Table 6.1). Cell 
length was variable, often showing filamentation (Figure 6.1F). ASxL5 cells 
showed a complete absence of flagella when incubated for 48 h with either C. 
jejuni or E. coli as prey. The name Venatorbacter cucullus gen. nov. sp. Nov was 
proposed for the ASxL5 bacterium (full description following section 6.4). 
 
6.3.2 The 16s rRNA and Genome Sequence of ASxL5 Reveal 
a Relationship with Marine Bacteria 
 
Determination of the 16S rRNA gene sequences enabled database searches to 
establish the sequence resembled those in the class Gammaproteobacteria and 
were most closely aligned with marine bacteria in the family Oceanospirillaceae 



















































Figure 6.2 Phylogenetic tree using 16S rRNA sequences highlighting the position 
of Venatorbacter cucullus gen. nov. sp. nov. strain A (red) relative to relative to 
uncultured and marine bacteria genera within the family Oceanospirillaceae. 
Genbank accession numbers are presented in parentheses. Sequences were 
aligned using CLC Genomics Workbench with default parameters and phylogenetic 
relationship inferred using the Unweighted Pair Group Method using Arithmetic 





The 16S rRNA sequences were notably diverged from predatory bacteria belonging 
to the family Bdellovibrionaceae (Deltaproteobacteria). The Venatorbacter cucullus 
ASxL5 bacterium had 3 copies of the 16S rRNA genes with two being identical to 
each other and the third differing by 3 bases. Two further predatory bacterial 
isolates from the same location with similar morphology and phenotypic 
characteristics (V. cucullus ASx5S and V. cucullus ASx5O) were not identical, but 
clustered with V. cucullus ASxL5 and uncultured bacterial database sequences, 
separate from other genera in the Oceanospirillaceae (Figure 6.2). The whole 
genome sequence of V. cucullus ASxL5 was determined and appears in the NCBI 
database under the accession number CP046056. The genome size of V. cucullus 
ASxL5 was 2 831 152 bp with a G+C ratio of 56.1%. The genome sequence 
contained 2 653 CDSs (total), of which 2 567 were predicted to encode proteins, 
and of these 1596 could be assigned a putative function (60.2%). The genome 
contained 67 RNA genes comprising of 9 rRNAs (3 each 5S, 16S and 23S) together 
with 57 tRNAs. The genetic characteristics of ASxL5 were compared to the 
available genomes of the closest relatives identified from the 16s rRNA gene 
sequences (Table 6.2). Ortho Average nucleotide identity (OrthoANI) Lee et al. 
(2016) comparing ASxL5 with related taxa gave values ranged between 64.48 and 
79.39. This analysis is better suited to more closely related isolates from the same 
genus (Qin et al., 2014)but is included for completeness. Instead AAI is frequently 
recommended for comparing different genera because resolution is progressively 
lost at the nucleotide level for more distantly related populations (Rodriguez-R and 
Konstantinidis, 2014). Comparative AAI values ranged between 45.67 and 74.84. 
The closest related available genome sequence (incomplete), determined by AAI 
was that of Thalassolituus sp. C2-1 (accession NZ_VNIL01000001). This strain 
was isolated from a deep-sea sediment of the Mariana Trench, but no phenotypic 
information regarding this strain is available for comparison at present. This 
organism has a much larger genome at 4.36 Mb compared to 2.82 Mb for ASxL5. 





available genomes from related genera are also presented in (Table 6.2). 
Estimated digital DNA–DNA hybridization values between 19.8 and 28.9%, and 
differences in G+C contents of between 2.7 and 11.2 %, respectively. These data 
together with the other genomic characterizations indicate that ASxL5 is clearly 
distinct from its relatives in the Oceanospirillaceae for which genomic data are 
available. 
The genome sequences of ASx5S and ASx5O were determined and respectively 
appear in the NCBI database under the Genbank accession numbers CP045550 
and CP046055. Although the sequences exhibited marked similarity as may be 
expected from bacteria of the same putative species, the genome sequences 
revealed a notable difference in that ASx5S contained an inversion of 
approximately 0.9 Mb compared to the other predatory bacterial isolates. (Figure 
6.3) a graphical representation of the whole genome alignments of the isolates. 
Table 6.2 Genomic comparison of ASx5L with closely related genera for which 
















ASxL5  100 100 56.1 100 2.82 - 








70.47 66.11 53.4 94.64 4.29 19.9 
Oceanobacter kriegii DSM 
6294 
 











Figure 6.3 Whole genome sequence alignments of the predatory bacteria of the 
Oceanospirillaceae, the genome sequences are indicated by their Genbank 
accession numbers and were aligned using CLC Genomics Workbench 20.0.3 
 
Examination of the component genes present in ASxL5 genome using the KEGG 
database (Kanehisa and Goto, 2000) reveals metabolic pathways typical of an 
aerobic Gammaproteobacterium. ASxL5 contains a total of 75 genes assigned to 
bacterial motility proteins including those involved in chemotaxis, flagella 
assembly and type IV pilus systems. Within the last category are 9 out 10 genes 
are responsible for twitching motility in a range of other organisms. The genome 
of ASxL5 contained the complete ectoine biosynthesis pathway involved in the 
protective response to osmotic stress (Czech et al., 2018), as might be expected 
for a halophilic organism. The genome also contains the complete pathways for 
many cofactors and vitamins including the riboflavin synthesis pathway. 
Hydrocarbon utilization pathways were incomplete. A comparison of the 
distribution of genes in COG categories for ASxL5 with the two most related 
genomes available, T. olerverans and T. sp. is presented in (Figure 6.4). The most 
notable difference between ASxL5 and the other two genomes is the greater 





the whole the smaller genome of ASxL5 contained proportionally less genes from 













Figure 6.4 Functional class distribution of predicted genes according to the clusters 
of orthologous groups of proteins of ASx5L compared to T. oleivorans MIL-1 (TO) 
and Thalassolituus sp. C2-1 (TS) J, translation, ribosomal structure and 
biogenesis; K, transcription; L, replication, recombination and repair; D, cell cycle 
control, cell division, chromosome partitioning; V, defence mechanisms; T, signal 
transduction mechanisms; M, cell wall/membrane/envelope biogenesis; N, cell 
motility; O, posttranslational modification, protein turnover, chaperones; U, 
Intracellular trafficking, secretion, and vesicular transport; C, energy production 
and conversion; G, carbohydrate transport and metabolism; E, amino acid 
transport and metabolism; F, nucleotide transport and metabolism; H, coenzyme 
transport and metabolism; I, lipid transport and metabolism; P, inorganic ion 
transport and metabolism; Q, secondary metabolites biosynthesis, transport and 






6.3.3 ASxL5 Preys on Campylobacter species and Other 
Gram-Negative Hosts 
 
The predatory activity of the ASxL5 bacterium was investigated to determine host 
range. The bacterium was able to form plaques on Campylobacter species 
including: C. hyointesinalis 11608, C. jejuni PT14, C. jejuni 12662, C. jejuni NCTC 
11168; C. coli NCTC 12667; C. helveticus NCTC 12472; C. lari NCTC 11458 and 
C. upsaliensis NCTC 11541. Testing of a wider selection of Gram-negative and 
Gram-positive bacteria revealed that ASxL5 could also form plaques on Escherichia 
coli NCTC 86, Citrobacter freundii NCTC 9750 and Klebsiella oxytoca 11466. The 
microscopic interaction with E. coli NCTC 86 is shown in (Fig 6.5 A-D) whilst the 
interaction with C. jejuni PT14 and C. hyointestinalis S12 are shown in (Fig 6.5 E-
H). The attack mechanism appeared to be different between the preys types 
tested, with one or more E. coli cells becoming attached to each ASxL5 cell, 
positioned laterally along the extended cell before adsorption. In contrast ASxL5 
appeared to attach to campylobacters via a single contact point, often with the 




























Figure 6.5 TEM of ASx5L interacting with prey showing (A-D with E. coli prey; E-
H with C. jejuni prey) (A typical cell ASx5L attached to single E. coli (EC) cell) (B 
filamentous ASx5L attached to single EC cell) (C filamentous ASx5L cells attached 
to multiple EC cells) (D smaller ASx5L cell attached to single E. coli (EC) cell) (E 
single ASx5L cell attached to C. jejuni (CJ) cell) (F ASx5L attacking a C. 
hyointestinalis (CH) cell) (G two ASx5L cells attacking a CJ cell) (H close view of 
attachment point of ASx5L, close to apex of CJ cell (bar 0.2 m)) Bar represents 







Predatory bacteria have evolved to exploit abundant prey sources; it is becoming 
apparent that they are widespread in many different environments (Pérez et al., 
2016) . In this study the ASxL5 bacteria was isolated from slurry using phage 
isolation methods because of the organism’s small cell size and the genomic 
relatedness of ASxL5 to members of the marine bacterial family Oceanospirillaceae 
was surprising, even though the organism was halotolerant being able to grow on 
5% salt containing medium. Water quality analysis of the slurry revealed the 
sodium chloride level to be less than 0.1%. The slurry is therefore far from a 
marine environment - geographically and chemically. The presence of at least two 
related, but non-identical isolates from the same source, provided evidence that 
these predators were thriving in this non-marine environment. Moreover, 
microbiome analysis revealed identical 16S rRNA sequences to be in the top 50 
most abundant operational taxonomy units (OTUs) in the slurry collected in this 
study and several uncultured bacteria were identified in the Genbank database 
that had similar 16s rRNA sequences to the ASxL5 bacterium. Three of these 
(GQ921362,  GQ921357 and GQ921396; Figure 6.6) were all isolated from 
fracture water, from a depth of 1.3 km depth in a South African gold mine in 2009, 
while a further two (DQ256320 and DQ337006) were obtained from subsurface 
water (in South Africa) in 2005 (16S rRNA sequences Blasted into Gene bank data 
base; 
https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSea
rch&LINK_LOC=blasthome ). The most closely related 16S rRNA sequence relative 
to ASxL5 is a partial 16S rRNA sequence that was obtained from enrichment 
culture of sandy sediment, obtained from a beach in Northern France in 2006 
(accession number AM292408) Alain et al. (2012). A further closely related 16s 
rRNA sequence from an uncultured bacterium, HQ183822.1, was obtained from a 





Clearly, the ASxL5 bacteria is not highly represented in taxonomic databases but 
it is likely that these sequences from uncultured bacteria represent similar 
organisms to ASxL5, which are distributed worldwide, often in challenging 
environments. The closest relatives to ASxL5 from whole genome phylogenetic 
analysis were: Thalassolituus sp. C2-1, Thalassolituus marinus, T. oleivorans. and 
Oceanobacter kriegii. All these cultures were isolated from marine environments 
and utilise hydrocarbons (Bowditch et al., 1984, Yakimov et al., 2004, Choi and 
Cho, 2013) and from the literature, T. marinus, T. olevorans and O. krieggi are 
motile, halotolerant, oxidase positive curved rods but have few other phenotypic 
characteristics were common with ASxL5. However, the phenotypic characteristics 
of Thalassolituus sp. C2-1.are unknown.  
In this study examination of the coding content of the ASxL5 genome provided 
functional insights into the phenotypic characteristics. The presence of genes that 
encode type IV pili (Tfp) are of particular interest as these facilitate cell movement 
referred to as social gliding or twitching without flagella over surfaces. The Tfp 
have other functions including predation, pathogenesis, biofilm formation, natural 
DNA uptake, auto‐aggregation of cells and development (Wall and Kaiser, 1999). 
The presence in the ASxL5 genome of numerous copies (18 in total) of genes 
encoding diguanylate cyclase (enzyme that catalyses the conversion of 2 
guanosine triphosphate to 2 diphosphate and cyclic di-GMP) and the presence of 
the corresponding diguanylate cyclase phosphodiesterase (catalyses the 
degradation of cyclic di-GMP to guanosine monophosphate; 6 copies present) was 
of interest because cyclic-di-GMP is an important second messenger involved in 
many processes including: biofilm development and detachment, motility, 
attachment and virulence (Wall and Kaiser, 1999, Dow et al., 2006). In 
Bdellovibrio bacteriovorus it has been shown to control the switch between free-





Most research into predatory bacteria has centred on Bdellovibrio, Bdellovibrio-
like organisms and Myxocococcus species. These and other known examples of 
predatory bacteria form a taxonomically diverse group. Despite this diversity, a 
group of signature protein families that reflect the phenotype of 11 known 
predatory bacteria has been identified (Pasternak et al., 2013, Pasternak et al., 
2015). The two genes in this study that are frequently associated with predatory 
bacterial genomes were those encoding O-antigen ligase (waaL) and tryptophan 
2,3-dioxygenase (kynA). The former was present in the ASxL5 genome sequence, 
but the latter was not. The transcriptional regulator gene gntR was absent in the 
predator group examined, but three gntR genes could be identified in ASxL5. The 
availability of more diverse predatory bacterial genomes will enable the 
development of finer resolution analyses in the future that can take into account 
evidence of functional and environmental differences between group members. 
The most remarkable features of Venatorbacter cucullus gen. nov. sp. nov. as 
captured by TEM images, are its unique flexible morphologies that facilitate 
interactions with prey bacteria. The type of interaction observed is different from 





6.7) A proposed predatory life cycle of ASxL5 (Fig 6.6). 
 







Figure 6.7 TEM of ASx5L and different type interaction between predatory and 
prey bacterium has not been identified or reported previously (A, D ASx5L 
predator) (B,C and E ASx5L attacking a C.hyointestinalis (CH) cell) (F ASx5L cell 







There are few examples in the literature of similar apical structures to those we 
report here, but these include those of Terasakiispira papahanaumokuakeensis an 
Oceanospirillaceae bacterium, that shows occasional apical enlargement(Zepeda 
et al., 2015) and the Alphaproteobacteria, Terasakiella pusilla previously in the 
genus Oceanospirillum, that exhibits what are described as “polar membranes” 
(Terasaki, 1979). The presence of coccal forms in older cultures is a frequent 
observation particularly for bacteria with curved morphology, such as Vibrio, 
Campylobacter and Helicobacter (Baker and Park, 1975, Ng et al., 1985, 
Reshetnyak and Reshetnyak, 2017) and probably represents a degenerative state. 
Further work is required to elucidate the precise life cycle of Venatorbacter cucullus 
gen. nov. sp. nov. to determine how it traps and feeds on its prey, and whether 
its genome encodes bioactive compounds that can be exploited for medicinal or 
biotechnological purposes. 
Description of Venatorbacter gen. nov. Venatorbacter (Ven.a.tor, ba’c.ter, L. 
composed of venator from L. n. venator, ‘hunter’ and Gr. n. bacter, ‘a rod’. 
Venatorbacter, ‘a hunting rod’. Cells are aerobic, halotolerent, Gram-negative, 
motile rods. Catalase and oxidase activities are positive. 
Description of Venatorbacter cucullus gen. nov. sp. nov. Venatorbacter 
cucullus (cu'cull.us.; L. n. cucullus meaning cowl). 
In addition, the description features of the genus, cells are of 1.63 µm in length 
by 0.37 µm wide when grown on BA or BHI. Colonies on BHI agar are small 
reaching 2 mm in diameter after 72 h. They are beige, translucent, circular, convex 
and shiny. The type strain ASxL5 can use E. coli, Klebsiella spp. Campylobacter 
spp. and several other Gram-negative bacteria as prey. It was isolated in 
Nottinghamshire UK from bovine slurry and is deposited at National Collection of 
Type Cultures (UK): accession number NCTC 14397 and the Netherlands Culture 


































7.1 General discussion and Conclusion 
 
Campylobacter jejuni is the major cause of human bacterial gastroenteritis and is 
the most commonly reported foodborne bacterial disease in the EU and worldwide. 
Consumption of poultry products is thought to be the main source of infection but 
consumption of contaminated raw milk also plays a significant role in 
campylobacteriosis.  
Chapter 3 of this thesis updated research undertaken in 1980s into the survival of 
Campylobacter spp. in milk but here using UHT milk without microflora. However, 
the consumption of raw milk (Davys et al., 2020) and outbreaks associated with 
milk (Kenyon et al., 2020) have prompted international interest in campylobacters 
from milk and dairy sources (Hansson et al., 2019, Jaakkonen et al., 2020). This 
work also included a study of the survival of C. ureolyticus thought to be associated 
with milk-borne outbreaks. Investigation into phage survival in milk was also 
carried out as this was completely unknown. Evidence from this work showed that 
campylobacters survive very well in milk, particularly C. ureolyticus which showed 
evidence of increasing numbers. The phage study provided evidence that milk 
would potentially be an ideal medium for administering bacteriophage therapy to 
bovine subjects being both cheap and safe. 
 
Chapter 4 described the genomic characterisation of selected isolates of 
Arcobacter and Campylobacter from bovine slurry to use as candidate hosts in 
order to isolate bacteriophage from bovine samples. The DNA sequences were 
analysed and compared to isolates with known sequences in the NCBI database 
from isolates from various different sources. Genomic characterisation provides a 
strong base for the bacteriophage isolation experiments and considerably adds to 
our knowledge of the genomic characteristics of Arcobacter and Campylobacter 





seems to be distinctively cattle adapted being dissimilar to human and swine 
isolates in the database. The C. coli S9 strain fell within a genomic group 
representing non-poultry C. coli strains as expected.  The A. skirrowii isolated was 
most related to a strain in the database isolated from water and in contrast to the 
Campylobacter isolates showed little evidence of pathogenic traits. Prophage were 
particularly prevalent in this strain potentially making it potentially resistant to 
some bacteriophage. 
 
In Chapter 5 attempts were made to use the isolates described in Chapter 4 as 
hosts to isolate bacteriophage from bovine slurry. Despite rigorous attempts 
bacteriophage could not be directly isolated from the slurry. This was surprising 
due to the comparative ease in which bacteriophage can be isolated from pig or 
chicken sources. Small plaques thought to be phages were instead predatory 
bacteria described in chapter 6. A bacteriophage sequence was obtained during 
the sequencing of this bacteria which was probably a prophage released from the 
host due to the stress of predation. Clearly slurry is not an ideal environment for 
isolation of Campylobacter and Arcobacter bacteriophage. Whether they are 
present but in low and undetectable numbers or they are inactivated by inorganic 
or organic components of slurry or predated upon by the eukaryotic microflora 
(Pinheiro et al., 2007) is unknown. 
 
Chapter 6 describes the taxonomic and microscopic characterisation of the 
predatory bacterium isolated during attempts to isolate bacteriophage (Chapter 
5). The isolation of a completely new type of predatory bacteria was an important 
discovery. The proposed name for this predatory bacterium is Venatorbacter 
cucullus. The process of getting this new genus and species recognised has been 
initiated. This has been problematic as standard biochemical tests cannot be 
carried out on an organism that does not grow in broth medium. The way in which 





few examples. Why this morphologically unusual relative of marine bacteria is 
thriving in a slurry tank in central England is an intriguing mystery. Much further 
work needs to be done to understand this new bacterium which may have useful 
bioactive compounds that can be exploited for medicinal or biotechnological 
purposes. 
 
In conclusion although most human disease associated with Campylobacter is 
thought to originate from poultry, the study of bovine campylobacters and 
arcobacters have been somewhat neglected. It is clear from this work that we do 
not have the full picture regarding their taxonomy, pathogenicity, survival and 
genetic characteristics. It is also clear that the microflora of slurry is complex and 
contains species and genera that have not previously been isolated. 
The future work, will include plane to study this novel predatory bacteria in two 
line, the first is to complete the phenotypical studies that I established to find out 
more about properties of this properties bacteria including the prey rang, 
predating capacity, comparing with other predatory bacteria, etc. 
The second line is the genotypical studies to have more understanding about the 
genomic structure of this novel predatory bacterium, which may demonstrates the 
role of this bacteria in the environment or If there any possible biomedical 
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Appendix 1:  
Genes present in A. skirrowii A2S6 but absent in A. skirrowii CCUG 10374 studied 
Gene Product 
EI285_00040 DMT famliy transporter  
EI285_00045 Crp/Fnr famliy transcriptional regulator 
EI285_00305 hyothetical protein 
EI285_00310 nuclease 
EI285_01150 DUF4885 domain-containing protein 
EI285_01155 hyothetical protein 
EI285_01765 mechanosensitive ion channel 
EI285_01770 hyothetical protein 
EI285_01885 diguanylate cyclase 
EI285_02930 hyothetical protein 
EI285_02935 hyothetical protein 
EI285_02940 hyothetical protein 
EI285_02945 lipolytic protein 
tmK dTMP kinase 
EI285_02975 phosphoribosyltransferase 
EI285_03210 DNA methyltransferase 
EI285_03435 aldose 1-epimerase family protein 
EI285_03490 methylated-DNA--[protein]-cysteine S-methyltransferase            
EI285_03500 hyothetical protein 
EI285_03540 hyothetical protein 
EI285_03545 metal-dependent hydrolase 
EI285_03550 hyothetical protein 
EI285_03555 hyothetical protein 
EI285_03565 tetratricopeptide repeat protein 
EI285_03570 hyothetical protein 
EI285_03575 hyothetical protein 
EI285_03580 WYL domain-containing protein 
EI285_03585 hyothetical protein 
EI285_03590 DUF3482 domain-containing protein 
EI285_03595 hyothetical protein 
EI285_03600 hyothetical protein 
EI285_03605 IS3 family transposase 
EI285_03610 transposase 
EI285_03615 DNA polymerase IV 
EI285_03620 phage repressor protein 
EI285_03625 gamma-glutamylcyclotransferase 
EI285_03630 HU family DNA-binding protein 









Appendix 1 continued 
Gene Product 
EI285_03645 hyothetical protein 
EI285_03650 IS256 family transposase 
EI285_03690 hyothetical protein 
EI285_03695 ATP-binding protein  
EI285_03700 hyothetical protein 
EI285_03705 hyothetical protein 
EI285_03710 hyothetical protein 
EI285_03715 hyothetical protein 
EI285_03720 hyothetical protein 
EI285_03725 DUF2493 domain-containing protein 
EI285_03730 hyothetical protein 
EI285_03735 hyothetical protein 
EI285_03740  transcriptional regulator 
EI285_03745 hyothetical protein 
EI285_03750 hyothetical protein 
EI285_03755 hyothetical protein 
EI285_03760 Fic family protein 
EI285_03765 hyothetical protein 
EI285_03770 hyothetical protein 
EI285_03775 NAD-dependent deacetylase 
EI285_03780 DUF2779 domain-containing protein 
EI285_03785 hyothetical protein 
EI285_03790 hyothetical protein 
EI285_03795 ATP-binding protein  
EI285_03800 5'-nucleotidase 
EI285_03805 M28 family peptidase 
EI285_03810 hyothetical protein 
EI285_03815 hyothetical protein 
EI285_03820 DUF2779 domain-containing protein 
EI285_03825 hyothetical protein 
EI285_03830 hyothetical protein 
EI285_03835 ATP-binding protein  
EI285_03840 5'-nucleotidase 
EI285_03845 M28 family peptidase 
EI285_03850 hyothetical protein 
EI285_03855 hyothetical protein 
EI285_03865 hyothetical protein 
EI285_03870 restriction endonuclease subunit S 
EI285_03875 type I restriction - modification system subunit M 








Appendix 1 continued 
Gene Product 
EI285_03885 restriction endonuclease subunit S 
EI285_03890 hyothetical protein 
EI285_03895 hyothetical protein 
EI285_03900 hyothetical protein 
EI285_03905 hyothetical protein 
EI285_03910 winged helix-turn-helix transcriptional regulator 
EI285_03915 type I restriction - modification system subunit R 
EI285_03920 M48 family peptidase 
EI285_03925 IS630 family transposase 
EI285_03930 hyothetical protein 
EI285_03935 hyothetical protein 
EI285_03940 hyothetical protein 
EI285_03945 hyothetical protein 
cas9 type II CRISPR RNA-guided endonuclease Cas9 
cas1 type II CRISPR-associated endonuclease Cas1 
EI285_03985 transposase 
EI285_03990 IS3 family transposase 
cas2 type II CRISPR-associated endonuclease Cas2 
EI285_04060 DUF4885 domain-containing protein 
EI285_04065 DUF4885 domain-containing protein 
EI285_04070 hyothetical protein 
EI285_04075 hyothetical protein 
EI285_04080 hyothetical protein 
EI285_04200 hyothetical protein 
EI285_04775 hyothetical protein 
EI285_04780 DNA-dinding protein 
EI285_05230 hyothetical protein 
EI285_05255 GGDEF domain-containing protein 
pglF UDP-N-acetylglucosamine 4,6-dehydratase(configuration-retaining) 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 
EI285_05335 glycosyltransferase family 4 protein 
EI285_05340 type II toxin-antitoxin system prevent-host-death family antitoxin 
EI285_05345 NAD-dependent epimerase/dehydratase family protein 
EI285_05355 glycosyltransferase 
EI285_05360 oligosaccharide repeat unit polymerase 
EI285_05365 glycosyltransferase family 1 protein 
EI285_05370 glycosyltransferase 
EI285_05375 polysaccharide biosynthesis protein 
EI285_05380 glycosyltransferase 








Appendix 1 continued 
Gene Product 
EI285_05390 GDP-L-fucose synthase 
gmd GDP-mannose 4,6-dehydratase 
EI285_05400 GDP-mannose mannosyl hydrolase 
EI285_05405 mannose-1-phosphateguanylyltransferase/mannose-6-phosphate 
isomerase 
EI285_05410 MarR family EPS-associated transcriptional regulator 
EI285_06010 hyothetical protein 
EI285_06015 hyothetical protein 
EI285_06020 hyothetical protein 
EI285_06025 hyothetical protein 
EI285_06030 hyothetical protein 
EI285_06035 ATP-dependent Clp protease proteolytic subunit 
EI285_06040 hypothetical protein 
EI285_06045 WYL domain-containing protein 
EI285_06050 hyothetical protein 
EI285_06055 DUF4062 domain-containing protein 
EI285_06060 hyothetical protein 
EI285_06065 hyothetical protein 
EI285_06070 hyothetical protein 
EI285_06095 XRE family transcriptional regulator 
EI285_06100 type II toxin-antitoxin system HipA family toxin 
EI285_06530 sel1 repeat family protein 
EI285_07040 flavodoxin family protein 
EI285_07275 hypothetical protein 
EI285_07280 hypothetical protein 
EI285_07285 hypothetical protein 
EI285_07290 hypothetical protein 
EI285_07295 hypothetical protein 
EI285_07300 hypothetical protein 
EI285_07305 hypothetical protein 
EI285_07310 XRE family transcriptional regulator 
EI285_07315 hypothetical protein 
EI285_07320 site-specific integrase 
EI285_07325 hypothetical protein 
EI285_07330 hypothetical protein 
EI285_07335 hypothetical protein 
EI285_07350 type III restriction endonuclease subunit R 
EI285_07355 Abi family protein 
EI285_07360 DUF2130 domain-containing protein 
EI285_07365 site-specific DNA-methyltransferase 







Appendix 1 continued 
Gene Product 
EI285_07385 transposase 
EI285_07390 IS3 family transposase 
EI285_07395 DUF1016 domain-containing protein 
EI285_07400 hypothetical protein 
EI285_07405 site-specific integrase 
EI285_07410 hypothetical protein 
EI285_07415 linear amide C-N hydrolase 
EI285_07420 ShlB/FhaC/HecB family hemolysin secretion/activation protein 
EI285_07425 filamentous hemagglutinin N-terminal domain-containing protein 
EI285_07430 hypothetical protein 
EI285_07435 DNA-binding response regulator 
EI285_07440 methyl-accepting chemotaxis protein 
EI285_07450 response regulator 
EI285_07455 response regulator 
EI285_07465 YgiW/YdeI family stress tolerance OB fold  protein 
EI285_07470 hypothetical protein 
EI285_07475 response regulator 
EI285_07480 hypothetical protein 
EI285_07510 hypothetical protein 
EI285_07515 hypothetical protein 
EI285_07520 hypothetical protein 
EI285_07525 hypothetical protein 
EI285_07530 hypothetical protein 
EI285_07535 hypothetical protein 
EI285_07540 hypothetical protein 
EI285_07545 hypothetical protein 
EI285_07550 hypothetical protein 
EI285_07555 hypothetical protein 
EI285_07560 hypothetical protein 
EI285_07675 MBL fold metallo-hydrolase 
EI285_07680 AraC family transcriptional regulator 
EI285_08005 Flagellin 
EI285_08220 hypothetical protein 
EI285_08230 hypothetical protein 
EI285_08420 transposase 
EI285_08425 IS3 family transposase 
EI285_08840 linear amide C-N hydrolase 
EI285_08845 ShlB/FhaC/HecB family hemolysin secretion/activation protein 
EI285_08850 filamentous hemagglutinin N-terminal domain-containing protein 
EI285_08855 diguanylate cyclase 







Appendix 1 continued 
Gene Product 
EI285_08865 DNA-binding response regulator 
EI285_09065 Flagellin 
EI285_09070 Flagellin 
EI285_09075 DUF115 domain-containing protein 
EI285_09090 poly(glycerol-phosphate) alpha-glucosyltransferase 
EI285_09095 hypothetical protein 
EI285_09100 class I SAM-dependent methyltransferase 
EI285_09110 type II toxin-antitoxin system prevent-host-death family antitoxin 
EI285_09115 type II toxin-antitoxin system VapC family  toxin 
EI285_09120 glycosyltransferase 
EI285_09125 WxcM-like domain-containing protein 
EI285_09130 N-acetyltransferase 
EI285_09135 DegT/DnrJ/EryC1/StrS family aminotransferase 
EI285_09140 glycosyltransferase family 61 protein 
EI285_09145 hypothetical protein 
EI285_09150 hypothetical protein 
EI285_09155 MBL fold metallo-hydrolase 
EI285_09160 hypothetical protein 
EI285_09165 amino acid adenylation domain-containing protein 
EI285_09170 acyl carrier protein 
EI285_09175 ketoacyl-ACP synthase III 
EI285_09180 SDR family oxidoreductase 
EI285_09185 SDR family oxidoreductase 
EI285_09190 acyl carrier protein 
EI285_09195 hypothetical protein 
EI285_09200 ketoacyl-ACP synthase III 
EI285_09205 hypothetical protein 
EI285_09215 winged helix-turn-helix transcriptional regulator 
EI285_09240 sodium-dependent transporter 
EI285_09245 deoxyribonuclease IV 
EI285_09250 C4-dicarboxylic acid transporter DauA 
EI285_09260 ATP-binding protein 
EI285_09265 hypothetical protein 
EI285_09270 succinate--CoA ligase 
EI285_09275 UDP-N-acetylmuramate dehydrogenase 
EI285_09280 glycerol kinase 
EI285_09285 type I DNA topoisomerase 
EI285_09290 YfcE family phosphodiesterase 
Gene  
EI285_09295 biotin synthase 
EI285_09745 FAD-dependent thymidylate synthase 
EI285_09750 trimeric intracellular cation channel family  protein 
EI285_09755 hypothetical protein 
purN phosphoribosylglycinamide formyltransferase 





Appendix 2:  
Genes absent in A. skirrowii A2S6 but present in A. skirrowii CCUG 10374examined 
Gene Product 
ASKIR_0049 two-component system response regulator,putative CusR 
ASKIR_0050 two-component system sensor histidine kinase,putative CusS 
ASKIR_0051 putative copper resistance protein 
ASKIR_0052 outer membrane efflux protein, TolC family,putative CusC 
ASKIR_0053 putative copper/silver efflux system, membrane fusion protein CusB 
ASKIR_0054 CusA family copper/silver efflux pump 
ASKIR_0077 Fic family protein (DUF4172 domain) 
ASKIR_0078 DUF262 domain-containing protein 
ASKIR_0092 putative lipid asymmetry ABC transporter MlaABCDEF component MlaB 
mlaD lipid asymmetry ABC transporter MlaABCDEF, periplasmic component MlaD 
mlaF lipid asymmetry ABC transporter MlaABCDEF,  ATPase component MlaF 
mlaE lipid asymmetry ABC transporter MlaABCDEF, permease component MlaE 
ASKIR_0327 major facilitator superfamily transporter 
ASKIR_0328 SAM-dependent methyltransferase 
ASKIR_0329 TonB-dependent receptor 
ASKIR_0330 transcriptional regulator, AraC family 
ASKIR_0331 manganese efflux pump MntP 
ASKIR_0332 major facilitator superfamily transporter 
ASKIR_0333 major facilitator superfamily transporter 
ASKIR_0334 ABC transporter, ATP-binding/permease components 
ASKIR_0335 ABC transporter, ATP-binding/permease components 
ASKIR_0336 TonB-dependent siderophore receptor 
ASKIR_0337 transcriptional regulator, AraC family 
ASKIR_0338 transcriptional regulator, RcnR/FrmR family 
ASKIR_0339 divalent metal cation transporter 
ASKIR_0361 Sel1 domain-containing protein 
ASKIR_0393 SRPBCC domain-containing protein 
ASKIR_0394 transcriptional regulator, AraC family 
ASKIR_0395 acetyltransferase 
ASKIR_0396 SRPBCC domain-containing protein 
ASKIR_0397 chorismate mutase, type II 
ASKIR_0398 transglutaminase family protein 
ASKIR_0399 histidine phosphatase family protein 
ASKIR_0400 helix-hairpin-helix domain-containing protein 
ASKIR_0401 acetyltransferase 
ASKIR_0402 RhuM family protein 
ASKIR_0403 hypothetical protein 
ASKIR_0404 type IIG restriction/modification system 








Appendix 2 continued 
Gene Product 
ASKIR_0544 hypothetical protein 
ASKIR_0545 YchJ family protein (SEC-C domain) 
ASKIR_0555 phosphate ABC transporter, ATP-binding protein 
ASKIR_0556 phosphate ABC transporter, permease protein 
ASKIR_0557 phosphate ABC transporter, permease protein 
ASKIR_0558 phosphate ABC transporter, periplasmic phosphate-binding protein 
ybaK cysteinyl-tRNA(Pro) deacylase 
ASKIR_0594 putative membrane protein 
ASKIR_0602 putative ribonuclease, YlaK/PhoH family 
ASKIR_0625 acyltransferase 
tmk dTMP kinase 
ASKIR_0677 virulence protein RhuM family protein 
ASKIR_0678 toxin-antitoxin system, antitoxin component, HicB family 
ASKIR_0679 toxin-antitoxin system, toxin component, HicA  family 
ASKIR_0704 hypothetical protein 
ASKIR_0705 cold shock domain-containing protein 
ASKIR_0706 hypothetical protein 
ASKIR_0727 putative class D beta-lactamase 
argDII N-succinyldiaminopimelate-aminotransferase/acetylornithine transaminase 
ASKIR_0739 nitroimidazol reductase (NimA) family protein 
ASKIR_0740 benzoate:proton symporter BenE 
ada O6-methylguanine-DNA methyltransferase 
glyA2 serine hydroxymethyltransferase 
ASKIR_0743 hypothetical protein 
ASKIR_0744 hypothetical protein 
ASKIR_0745 hypothetical protein 
ASKIR_0754 hypothetical protein 
ASKIR_0755 hypothetical protein 
ASKIR_0757 hypothetical protein 
ASKIR_0758 hypothetical protein 
ASKIR_0759 hypothetical protein 
ASKIR_0760 hypothetical protein 
ASKIR_0761 hypothetical protein 
ASKIR_0762 hypothetical protein 
ASKIR_0763 hypothetical protein 
ASKIR_0764 hypothetical protein 
ASKIR_0765 type IIP restriction/modification system, restriction endonuclease, PstI family 
ASKIR_0766 type IIP restriction/modification system, DNA methyltransferase 
ASKIR_0767 resolvase 








Appendix 2 continued 
Gene Product 
ASKIR_0777 zeta toxin domain-containing protein 
ASKIR_0778 hypothetical protein 
ASKIR_0779 group II intron reverse transcriptase/maturase 
ASKIR_0780 transcriptional regulator, XRE family 
ASKIR_0781 hypothetical protein 
ASKIR_0782 putative membrane protein 
ASKIR_0784 putative membrane protein 
ASKIR_0785 hypothetical protein 
ASKIR_0786 hypothetical protein 
ASKIR_0787 putative membrane protein 
ASKIR_0788 transposase, IS256 family 
ASKIR_0789 putative membrane protein 
ASKIR_0790 hypothetical protein 
ASKIR_0792 putative membrane protein 
ASKIR_0793 putative membrane protein 
ASKIR_0794 hypothetical protein 
tssI1 type VI secretion system, syringe needle protein 
tssD type VI secretion system, inner tube protein 
ASKIR_0797 hypothetical protein 
ASKIR_0798 tetratricopeptide repeat protein 
ASKIR_0799 putative membrane protein 
tssA type VI secretion system, baseplate protein 
tssB type VI secretion system, tubular sheath protein 
tssC type VI secretion system, tubular sheath protein 
tssE type VI secretion system, baseplate protein 
tssF type VI secretion system, baseplate protein 
tssG type VI secretion system, baseplate protein 
tssH type VI secretion system, ClpV1 family ATPase TssH 
ASKIR_0807 type VI secretion system-associated FHA  domain-containing protein TagH 
tssJ type VI secretion system, membrane platform  protein 
tssK type VI secretion system, baseplate protein 
tssL type VI secretion system, membrane platform  protein 
tssM type VI secretion system, membrane platform  protein 
ASKIR_0812 serine/threonine-protein kinase 
tssI2 type VI secretion system, syringe needle protein 
ASKIR_0814 putative chitinase 
ASKIR_0815 hypothetical protein 
ASKIR_0816 hypothetical protein 
ASKIR_0818 putative chitinase 








Appendix 2 continued 
Gene Product 
ASKIR_0820 putative membrane protein 
ASKIR_0821 methyltransferase 
ASKIR_0822 site-specific tyrosine recombinase, phage  integrase family 
sbcD DNA repair exonuclease SbcCD, nuclease subunit 
sbcC DNA repair exonuclease SbcCD, ATPase subunit 
ASKIR_0825 hypothetical protein 
ASKIR_0826 ATP-binding protein (AAA domain) 
ASKIR_0827 hypothetical protein 
ASKIR_0828 DUF2779 domain-containing protein 
ASKIR_0829 helicase 
ASKIR_0830 putative membrane protein 
ASKIR_0831 hypothetical protein 
ASKIR_0832 hypothetical protein 
ASKIR_0835 hypothetical protein 
ASKIR_0836 putative membrane protein 
ASKIR_0837 putative membrane protein 
ASKIR_0838 hypothetical protein 
ASKIR_0839 putative DNA-binding protein 
ASKIR_0840 replication initiation protein 
ASKIR_0846 hypothetical protein 
ASKIR_0866 hypothetical protein 
ASKIR_0870 hypothetical protein 
ASKIR_0871 putative membrane protein 
ASKIR_0872 hypothetical protein 
cas6 CRISPR/Cas system-associated RAMP protein Cas6 
ASKIR_0874 hypothetical protein 
ASKIR_0875 CRISPR/Cas system-associated RAMP protein 
ASKIR_0876 hypothetical protein 
ASKIR_0877 CRISPR/Cas system-associated RAMP protein Cas7/Csm3, type III 
ASKIR_0878 CRISPR/Cas system-associated RAMP protein, type  III 
ASKIR_0879 CRISPR/Cas system-associated RAMP protein 
ASKIR_0880 CRISPR/Cas system-associated protein Csx1, type  III 
ASKIR_0881 Cas2 family CRISPR/Cas system-associated protein 
cas1 CRISPR/Cas system-associated endonuclease Cas1 
cas2 CRISPR/Cas system-associated endoribonuclease Cas2 
ASKIR_0884 hypothetical protein 
ASKIR_0885 porin family protein 
ASKIR_0886 hypothetical protein 
ASKIR_0887 putative membrane protein 








Appendix 2 continued 
Gene Product 
ASKIR_0889 paraslipin family protein, SPFH superfamily 
ASKIR_0890 putative membrane protein 
ASKIR_0952 hypothetical protein 
ASKIR_1111 putative membrane protein 
ASKIR_1112 hypothetical protein 
ASKIR_1127 UDP-glucose 4-epimerase 
ASKIR_1128 toxin-antitoxin system, toxin component, MazF/PemK family 
ASKIR_1129 hypothetical protein 
ASKIR_1130 sugar transferase 
ASKIR_1131 toxin-antitoxin system, transcriptional regulator HipB 
ASKIR_1132 toxin-antitoxin system, toxin component, HipA  family 
ASKIR_1134 glycosyltransferase, family 2 
ASKIR_1135 WbsX-like glycosyltransferase 
ASKIR_1136 polysaccharide biosynthesis acetyltransferase 
ASKIR_1137 hypothetical protein 
ASKIR_1138 polysaccharide biosynthesis protein 
ASKIR_1139 putative membrane protein 
ASKIR_1140 HAD superfamily hydrolase, probable phosphatase 
ASKIR_1141 hypothetical protein 
ASKIR_1142 ATP-binding protein (AAA domain) 
ASKIR_1143 acylneuraminate cytidylyltransferase family  protein 
ASKIR_1144 UDP-N-acetylglucosamine 4-epimerase 
ASKIR_1145 acylneuraminate cytidylyltransferase family  protein 
ASKIR_1146 hypothetical protein 
ASKIR_1147 putative KAP family NTPase 
ASKIR_1148 hypothetical protein 
ASKIR_1149 dTDP-4-amino-4,6-dideoxygalactose transaminase 
ASKIR_1150 WxcM-like sugar acyltransferase 
ASKIR_1151 WxcM-like domain-containing protein 
ASKIR_1215 polyferredoxin-like protein 
ASKIR_1216 TonB-dependent receptor 
ASKIR_1250 toxin-antitoxin system, toxin component, HicA  family 
ASKIR_1251 hypothetical protein 
ASKIR_1252 hypothetical protein 
ASKIR_1280 RecQ family ATP-dependent DNA helicase 
ASKIR_1281 site-specific tyrosine recombinase, phage integrase family (INT_Rci_Hp1_C 
domain) 
ASKIR_1282 hypothetical protein 
ASKIR_1283 HNH endonuclease 
ASKIR_1284 hypothetical protein 







Appendix 2 continued 
Gene Product 
ASKIR_1285 SprT-like domain-containing protein 
ASKIR_1286 hypothetical protein 
ASKIR_1287 hypothetical protein 
ASKIR_1288 hypothetical protein 
ASKIR_1289 hypothetical protein 
ASKIR_1290 hypothetical protein 
ASKIR_1291 hypothetical protein 
ASKIR_1292 type IIP restriction/modification system, cytosine-specific DNA 
methyltransferase 
ASKIR_1293 hypothetical protein 
ASKIR_1294 type IIP restriction/modification system, restriction endonuclease, Fnu4HI 
family 
ASKIR_1295 KAP family NTPase 
ASKIR_1296 hypothetical protein 
ASKIR_1297 putative membrane protein 
ASKIR_1298 hypothetical protein 
ASKIR_1299 ATP-binding protein (AAA domain) 
ASKIR_1300 hypothetical protein 
ASKIR_1301 DUF4297 domain-containing protein 
ASKIR_1302 transcriptional regulator, XRE family 
ASKIR_1303 hypothetical protein 
ASKIR_1304 hypothetical protein 
ASKIR_1305 putative DNA-binding protein 
ASKIR_1306 hypothetical protein 
ASKIR_1307 hypothetical protein 
ASKIR_1308 putative DNA-binding protein 
ASKIR_1309 single-stranded DNA-binding protein 
ASKIR_1310 putative membrane protein 
ASKIR_1311 putative membrane protein 
ASKIR_1312 P-type type IV conjugative transfer system ATPase TrbE/VirB4 
ASKIR_1313 hypothetical protein 
ASKIR_1314 P-type type IV conjugative transfer system protein TrbL/VirB6 
ASKIR_1315 hypothetical protein 
ASKIR_1316 hypothetical protein 
ASKIR_1317 P-type type IV conjugative transfer system protein TrbF/VirB8 
ASKIR_1318 P-type type IV conjugative transfer system  translocation pore protein 
TrbG/VirB9 
ASKIR_1319 P-type type IV conjugative transfer system translocation pore protein 
TrbI/VirB10 
ASKIR_1320 hypothetical protein 
ASKIR_1321 P-type type IV conjugative transfer system ATPase TrbB/VirB11 
ASKIR_1322 P-type type IV conjugative transfer system coupling protein TraG/VirD4 
ASKIR_1323 hypothetical protein 
ASKIR_1356 putative membrane protein 






Appendix 2 continued 
Gene Product 
ASKIR_1397 toxin-antitoxin system, toxin component, MazF/PemK family 
ASKIR_1401 toxin-antitoxin system, toxin component, YafQ family 
ASKIR_1402 toxin-antitoxin system, antitoxin component, RelB family 
ASKIR_1404 hypothetical protein 
ASKIR_1405 toxin-antitoxin system, toxin component,  RelE/ParE family 
ASKIR_1429 ATP-binding protein (AAA, DUF4143 domains) 
ASKIR_1517 hypothetical protein 
ASKIR_1518 putative membrane protein 
ASKIR_1519 putative membrane protein 
ASKIR_1520 hypothetical protein 
ASKIR_1521 putative membrane protein 
ASKIR_1522 hypothetical protein 
ASKIR_1523 putative membrane protein 
ASKIR_1524 hypothetical protein 
ASKIR_1525 putative membrane protein 
ASKIR_1526 hypothetical protein 
ASKIR_1527 hypothetical protein 
ASKIR_1528 putative membrane protein 
ASKIR_1529 hypothetical protein 
ASKIR_1530 hypothetical protein 
ASKIR_1531 putative membrane protein 
ASKIR_1532 hemagglutinin domain-containing protein 
ASKIR_1533 hemolysin secretion/activation protein, ShlB/FhaC/HecB family 
ASKIR_1540 ferritin-like protein 
ASKIR_1541 acyl-CoA dehydrogenase 
ASKIR_1542 phosphonate ABC transporter, periplasmic substrate-binding protein 
ASKIR_1604 hypothetical protein 
ASKIR_1757 MCP-domain signal transduction protein 
ASKIR_1758 PAS sensor-containing signal transduction  protein 
ASKIR_1759 MCP-domain signal transduction protein 
ASKIR_1760 PAS sensor-containing diguanylate cyclase/phosphodiesterase 
ASKIR_1761 putative periplasmic substrate-binding protein 
ASKIR_1808 TonB-dependent receptor 
ASKIR_1844 sulfite exporter TauE/SafE family protein 
maf1 motility accessory factor 
maf2 motility accessory factor 










Appendix 2 continued 
Gene Product 
ASKIR_1890 aminotransferase, DegT/DnrJ/EryC1/StrS family 
ASKIR_1891 WbqC family protein 
ASKIR_1892 methyltransferase 
ASKIR_1893 SAM-dependent methyltransferase 
fldA flavodoxin 
ASKIR_1895 leucine-rich repeat domain-containing protein 
ASKIR_1896 SAM-dependent methyltransferase 
ASKIR_1897 methyltransferase 
ASKIR_1898 UDP-glucose 6-dehydrogenase 
ASKIR_1899 glycosyltransferase, family 2 
ASKIR_1900 glycosyltransferase, family 2 
ASKIR_1901 dTDP-4-amino-4,6-dideoxygalactose transaminase 
ASKIR_1902 WxcM-like sugar acyltransferase 
ASKIR_1903 WxcM-like domain-containing protein 
ASKIR_1904 Phosphonate metabolism-associated iron-containing alcohol dehydrogenase 
ASKIR_1905 phosphonopyruvate decarboxylase 
ASKIR_1906 phosphoenolpyruvate mutase /cytidylyltransferase 
ASKIR_1907 putative polysaccharide biosynthesis protein 
ASKIR_1908 acyl-CoA synthetase (AMP-forming) / AMP-acid ligase II 
ASKIR_1909 short-chain dehydrogenase/reductase 
ASKIR_1910 hypothetical protein 
pseH UDP-4-amino-4,6-dideoxy-beta-L-AltNAc  o-acetyltransferase 
ASKIR_1912 deacetylase, PIG-L family 
ASKIR_1913 hypothetical protein 
pseI pseudaminic acid synthase 
pseG UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranosyl transferase 
pesF CMP-pseudaminic acid synthetase 
pesC UDP-2-acetamido-2, 6-dideoxy-beta-L-arabino-hex-4-ulose aminotransferase 
ASKIR_1936 type II cytosine-specific DNA methyltransferase 
ASKIR_1937 DUF1863 domain-containing protein 
ASKIR_1938 putative membrane protein 
ASKIR_1939 DUF1863 domain-containing protein 
ASKIR_1940 type IIP restriction/modification system,restriction endonuclease, HaeIII family 
ASKIR_1941 hypothetical protein 
ASKIR_1942 type IIP restriction/modification system,cytosine-specific DNA 
methyltransferase 
ASKIR_1943 putative histidine kinase 
ASKIR_1944 transposase endonuclease subunit TnsA 
ASKIR_1945 integrase (rve domain) 
ASKIR_1946 transposition-related ATP-binding protein TniB 







Appendix 2 continued 
Gene Product 
ASKIR_1948 ATP-binding protein (AAA domain) 
ASKIR_1949 peptidase, S8 family 
ASKIR_1950 type IIG restriction/modification system 
ASKIR_1951 site-specific tyrosine recombinase, phage  integrase family 
ASKIR_1952 DUF4145 domain-containing protein 
ASKIR_1953 hypothetical protein 
ASKIR_1981 membrane-anchored protein, YitT family (DUF161,DUF2179 domains) 
ASKIR_1997 Cupin domain-containing protein 
ASKIR_2003 hypothetical protein 
ASKIR_2028 phosphoethanolamine transferase 
ASKIR_2029 DUF1924 domain-containing protein 
ASKIR_2030 diheme cytochrome c 
ASKIR_2031 diheme cytochrome c (N-terminal cytochrome bdomain) 
ASKIR_2032 hypothetical protein 
ASKIR_2033 two-component system response regulator 
ASKIR_2034 two-component system sensor histidine kinase 
ASKIR_2035 sulfatase 
thy thymidylate synthase complementing protein 
ASKIR_2037 UPF0126 domain-containing membrane protein 
ASKIR_2038 hypothetical protein 
purN phosphoribosylglycinamide formyltransferase 1 


















Appendix 3:  
Nucleotide BLAST results from CRISPR spacers in Arcobacter skirrowii A2S6.CRISPAR 1 and 2 
 
CRISPR 1 






Ruminococcus torques ATCC 27756 
Scfld0215 





Clostridium oryzae strain DSM 28571 
CLORY_contig000030 










Aliiarcobacter faecis strain AF1078 
scaffold7.1 















Vibrio alginolyticus NBRC 15630 = ATCC 
17749 chromosome 1 










Halobacillus massiliensis strain Marseille-
P3554 










Paraliobacillus ryukyuensis strain Marseille-
P3391 





Ileibacterium valens strain NYU-BL-A3 
NODE_4_length_46638_cov_242.499_ID_7 















Clostridium botulinum B str. Eklund 17B 
(NRP) 





Carnobacterium jeotgali MS3 
BP18DRAFT_scf7180000000062_quiver.2_C 




















   
1870948 TTCTCTTTTTTTGCTGTTCGTTTTCT  











CRISPR DR Consensus 
sequence 




A. thereius LMG 24486  100 100 8 X 109 
A. pacificus LMG 26638  100 100 8 X 109 
2 TTCTCTTTTTTGGCTG
TTCGTTTTCT 
A. porcinus CCUG 56899  100 96.15 0.067 
A. cryaerophilus D2610  100 96.15 0.067 
A. skirrowii CCUG 10374 
c 







Genes present in C. coli S9 but absent in C. coli BFR-CA-9557 studied 
Gene Product 
FD987_00185 hypothetical protein 
FD987_00300 hypothetical protein 
FD987_00305 hypothetical protein 
FD987_00315 peptidase C39 
FD987_00320 MobC family plasmid mobilization relaxosome protein 
FD987_00325 mobilization protein 
FD987_00330 replication initiation protein 
FD987_00335 hypothetical protein 
FD987_00340 bacteriocin 
FD987_00350 hypothetical protein 
FD987_00355 S24 family peptidase 
FD987_00405 hypothetical protein 
FD987_00430 deoxyribonuclease 
FD987_00520 phage baseplate assembly protein V 
FD987_00525 hypothetical protein 
FD987_00625 hypothetical protein 
FD987_01865 OXA-61 family class D beta-lactamase OXA-489 
FD987_02470 hypothetical protein 
FD987_02475 hypothetical protein 
FD987_03865 hypothetical protein 
FD987_03870 hypothetical protein 
FD987_04185 hypothetical protein 
FD987_05345 restriction endonuclease 
FD987_05595 hypothetical protein 
FD987_05795 glycosyltransferase family 2 protein 
rfbH lipopolysaccharide biosynthesis protein RfbH 
FD987_05805 NAD-dependent epimerase/dehydratase family protein 
FD987_05810 thiamine pyrophosphate-binding protein 
rfbG CDP-glucose 4,6-dehydratase 
rfbF glucose-1-phosphate cytidylyltransferase 
FD987_05825 alpha-1,2-fucosyltransferase 
FD987_05830 hypothetical protein 










Appendix 4 continued 
Gene Product 
FD987_05840 NAD-dependent epimerase/dehydratase family protein 
gmd GDP-mannose 4,6-dehydratase 
FD987_05850 mannose-1-phosphate guanylyltransferase/mannose-6-
phosphate isomerase 
FD987_05855 glycosyltransferase family 2 protein 
waaF lipopolysaccharide heptosyltransferase II 
FD987_05865 glycosyltransferase family 25 protein 
FD987_06690 class I SAM-dependent methyltransferase 
FD987_06695 aminoglycoside N(3)-acetyltransferase 
FD987_06700 acyl carrier protein 
FD987_06705 hypothetical protein 
FD987_06750 GNAT family N-acetyltransferase 
FD987_06755 formyl transferase 
FD987_06770 3-oxoacyl-ACP synthase 
FD987_06910 DUF2920 family protein 
FD987_07265 haloacid dehalogenase 
FD987_07270 3-hydroxy-3-methylglutaryl-CoA lyase 
FD987_07275 3-deoxy-manno-octulosonate cytidylyltransferase 
FD987_07280 alpha-2,3-sialyltransferase 
FD987_07285 hypothetical protein 
FD987_07305 hypothetical protein 
FD987_07310 glycosyltransferase 
FD987_07325 polyhydroxyalkanoate biosynthesis repressor PhaR 
neuC UDP-N-acetylglucosamine 2-epimerase  (hydrolyzing) 
FD987_07335 acylneuraminate cytidylyltransferase family  protein 
FD987_07340 hypothetical protein 
glf UDP-galactopyranose mutase 
galE UDP-glucose 4-epimerase GalE 
FD987_07355 UDP-glucose/GDP-mannose dehydrogenase family 
protein 
FD987_07360 SDR family oxidoreductase 
FD987_07365 glycosyltransferase family 2 protein 
FD987_07760 GyrI-like domain-containing protein 
FD987_07915 RloC protein 
FD987_07920 restriction endonuclease subunit S 
FD987_08270 DUF262 domain-containing protein 
FD987_08275 hypothetical protein 










Appendix 5:  
Genes absent in C. coli S9 but present in C. coli BFR-CA-9557 
Gene Product 
AB430_00025 hypothetical protein 
AB430_00055 general secretion pathway protein GspF 
AB430_00060 general secretion pathway protein GspE 
AB430_00065 transformation system protein 
AB430_00070 transformation system protein 
AB430_00075 general secretion pathway protein GspD 
AB430_00080 transformation system protein 
AB430_00085 pyruvate-flavodoxin oxidoreductase 
AB430_00090 hydrolase 
AB430_00095 fibronectin-binding protein 
AB430_00470 hypothetical protein 
AB430_00475 hypothetical protein 
AB430_00480 hypothetical protein 
AB430_00545 chemotaxis protein 
AB430_00710 transposase 
AB430_00715 hypothetical protein 
AB430_00720 adenine specific DNA methyltransferase 
AB430_01465 hypothetical protein 
AB430_01470 restriction endonuclease 
AB430_02135 hypothetical protein 
AB430_02140 hypothetical protein 
AB430_02235 mcrBC 5-methylcytosine restriction system 
component 
AB430_02895 DNA methylase N-4 
AB430_02900 hypothetical protein 
AB430_02970 hypothetical protein 
AB430_03015 hypothetical protein 
AB430_03020 hypothetical protein 
AB430_03025 XRE family transcriptional regulator 
AB430_03630 membrane protein 
AB430_03635 hypothetical protein 
AB430_03640 membrane protein 
AB430_03645 ABC transporter ATP-binding protein 
AB430_05350 hypothetical protein 











Appendix 5 continued 
Gene Product 
AB430_05605 hypothetical protein 
AB430_06540 restriction endonuclease 
AB430_06790 hypothetical protein 
AB430_06990 hypothetical protein 
AB430_06995 asparagine synthase 
AB430_07000 glycerol-3-phosphate cytidylyltransferase 
AB430_07015 hypothetical protein 
AB430_07455 hypothetical protein 
AB430_07460 transcriptional regulator 
AB430_07465 hypothetical protein 
AB430_07515 hypothetical protein 
AB430_07520 sugar-phosphate nucleotidyltransferase 
AB430_07425 cytochrome C553 
AB430_07650 baseplate assembly protein 
AB430_07655 membrane protein 
AB430_07755 hypothetical protein 
AB430_08165 acetyltransferase 
AB430_08170 acyl carrier protein 
AB430_08175 SAM-dependent methyltransferase 
AB430_08255 PseD protein 
AB430_08270 transferase 
AB430_08275 3-hydroxyacyl-CoA dehydrogenase 
AB430_08280 hypothetical protein 
AB430_08285 N-acetyl sugar amidotransferase 
AB430_08290 methyltransferase 
AB430_08735 adenylylsulfate kinase 
AB430_08740 transporter 
AB430_08745 sulfate adenylyltransferase 
AB430_08750 sulfate adenylyltransferase subunit 2 
AB430_08755 3'-5'-bisphosphate nucleotidase 
AB430_08765 D-glycero-D-manno-heptose1-phosphate 
guanosyltransferase 
AB430_08770 phosphoheptose isomerase 
AB430_08775 dehydrogenase 
AB430_08780 GDP-mannose 4,6-dehydratase 
AB430_08785 pyridoxamine 5-phosphate oxidase 
AB430_08790 GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-
reductase 
AB430_08795 dTDP-4-dehydrorhamnose 3,5-epimerase 
AB430_08805 hypothetical protein 
AB430_08810 capsular biosynthesis protein 








A total of 182 genes were identified to present in C. hyointestinalis S12 and 
absent in C. hyointestinalis LMG 9260. Which encode 52 hypothetical proteins 
Gene Product 
FFA43_00110 UDP-N-acetylglucosamine 4,6-dehydratase 
FFA43_00115 LegC family aminotransferase 
FFA43_00120 acetyltransferase 
FFA43_00125 methionyl-tRNA formyltransferase 
FFA43_00130 acetyltransferase 
asnB asparagine synthase (glutamine-hydrolyzing) 
neuB N-acetylneuraminate synthase 
FFA43_00145 ORF6N domain-containing protein 
neuC UDP-N-acetylglucosamine 2-epimerase  (hydrolyzing) 
FFA43_00155 methionyl-tRNA formyltransferase 
FFA43_00160 MaoC family dehydratase 
FFA43_00165 GNAT family N-acetyltransferase 
neuC UDP-N-acetylglucosamine 2-epimerase  (hydrolyzing) 
FFA43_00195 PIG-L family deacetylase 
neuC UDP-N-acetylglucosamine 2-epimerase  (hydrolyzing) 
FFA43_00205 class I SAM-dependent methyltransferase 
FFA43_00210 N-acetyl sugar amidotransferase 
FFA43_00215 CBS domain-containing protein 
FFA43_00220 acylneuraminate cytidylyltransferase family protein 
FFA43_00225 hypothetical protein 
FFA43_00230 acylneuraminate cytidylyltransferase family protein 
FFA43_00235 glutamate-1-semialdehyde 2,1-aminomutase 
FFA43_00240 serine acetyltransferase 
FFA43_00245 flagellin modification protein PseA 
FFA43_00250 SDR family oxidoreductase 
FFA43_00255 ABC transporter ATP-binding protein 
FFA43_00260 hypothetical protein 
FFA43_00265 hypothetical protein 
FFA43_00270 hypothetical protein 
FFA43_00275 hypothetical protein 
FFA43_00280 class I SAM-dependent methyltransferase 
asnB asparagine synthase (glutamine-hydrolyzing) 
FFA43_00290 glycosyltransferase family 4 protein 
FFA43_00295 hypothetical protein 
FFA43_00300 peptidoglycan bridge formation glycyltransferase 
FemA/FemB family protein 
FFA43_00305 hypothetical protein 
FFA43_00310 glycosyltransferase family 4 protein 
FFA43_00315 hypothetical protein 
FFA43_00320 glycosyltransferase family 2 protein 






Appendix 6 continued 
Gene Product 
FFA43_00330 GtrA family protein 
asnB asparagine synthase (glutamine-hydrolyzing) 
FFA43_00340 zinc-binding dehydrogenase 
FFA43_00345 hypothetical protein 
FFA43_00350 glycosyltransferase family 4 protein 
FFA43_00355 UDP-N-acetylglucosamine 2-epimerase (non-
hydrolyzing) 
wecC UDP-N-acetyl-D-mannosamine dehydrogenase 
cdtB cytolethal distending toxin nuclease subunit Ch-CdtB 
cdtC cytolethal distending toxin subunit Ch-CdtC 
FFA43_00410 prepilin-type N-terminal cleavage/methylation domain-
containing protein 
FFA43_00600 formyl transferase 
FFA43_00910 molybdopterin molybdotransferase MoeA 
FFA43_00915 DUF2156 domain-containing protein 
FFA43_00920 GNAT family N-acetyltransferase 
FFA43_01215 hypothetical protein 
FFA43_01220 hypothetical protein 
FFA43_01225 hypothetical protein 
FFA43_01230 DDE-type integrase/transposase/recombinase 
FFA43_01235 bacteriocin 
FFA43_01240 hypothetical protein 
FFA43_01245 hypothetical protein 
FFA43_01250 host-nuclease inhibitor protein Gam 
FFA43_01255 hypothetical protein 
FFA43_01260 hypothetical protein 
FFA43_01265 DUF1018 domain-containing protein 
FFA43_01270 hypothetical protein 
FFA43_01275 hypothetical protein 
FFA43_01280 phage virion morphogenesis protein 
FFA43_01285 phage head morphogenesis protein 
FFA43_01290 DUF935 family protein 
FFA43_01295 hypothetical protein 
FFA43_01300 DUF1804 family protein 
FFA43_01305 DUF1320 domain-containing protein 
FFA43_01310 hypothetical protein 
FFA43_01315 hypothetical protein 
FFA43_01320 hypothetical protein 
FFA43_01325 hypothetical protein 
FFA43_01330 lysozyme 
FFA43_01335 hypothetical protein 







Appendix 6 continued 
Gene Product 
FFA43_01345 hypothetical protein 
FFA43_01350 phage baseplate assembly protein V 
FFA43_01355 baseplate assembly protein 
FFA43_01360 baseplate assembly protein 
FFA43_01365 phage tail protein I 
FFA43_01370 hypothetical protein 
FFA43_01375 hypothetical protein 
FFA43_01380 hypothetical protein 
FFA43_01385 DUF4376 domain-containing protein 
FFA43_01390 DUF1353 domain-containing protein 
FFA43_01395 phage tail protein 
FFA43_01400 phage tail protein 
FFA43_01405 phage tail assembly protein 
FFA43_01410 hypothetical protein 
FFA43_01415 phage tail tape measure protein 
FFA43_01420 phage tail protein 
FFA43_01425 phage tail protein 
FFA43_01430 phage tail protein 
FFA43_01435 hypothetical protein 
FFA43_01440 HNH endonuclease 
FFA43_01445 hypothetical protein 
FFA43_01925 c-type cytochrome 
FFA43_01940 glycosyltransferase family 4 protein 
FFA43_01945 glycosyltransferase family 2 protein 
FFA43_01950 polysaccharide deacetylase family protein 
FFA43_01955 glycosyltransferase 
FFA43_01960 glycosyltransferase family 1 protein 
FFA43_01965 glycosyltransferase 
FFA43_01970 polysaccharide deacetylase family protein 
FFA43_01975 O-antigen ligase family protein 
FFA43_01980 glycosyltransferase family 4 protein 
FFA43_01990 lysophospholipid acyltransferase family protein 
FFA43_02275 HAMP domain-containing histidine kinase 
FFA43_02280 response regulator transcription factor 
FFA43_02300 aryl-sulfate sulfotransferase 
FFA43_02660 prepilin-type N-terminal cleavage/methylation domain-
containing protein 
FFA43_03390 autotransporter outer membrane beta-barrel domain-
containing protein 
FFA43_04145 hypothetical protein 
FFA43_04420 AEC family transporter 







Appendix 6 continued 
Gene Product 
FFA43_04575 GGDEF domain-containing protein 
FFA43_04740 hypothetical protein 
FFA43_04745 hypothetical protein 
hypA hydrogenase maturation nickel metallochaperone HypA 
hypE hydrogenase expression/formation protein HypE 
hypD hydrogenase formation protein HypD 
hypB hydrogenase nickel incorporation protein HypB 
FFA43_05185 beta-ketoacyl-ACP synthase 
fabG 3-oxoacyl-ACP reductase FabG 
FFA43_05195 thioester dehydrase 
FFA43_05200 beta-ACP synthase 
FFA43_05205 hypothetical protein 
FFA43_05210 NAD(P)/FAD-dependent oxidoreductase 
FFA43_05215 4-phosphopantetheinyl transferase family protein 
FFA43_05220 hypothetical protein 
FFA43_05225 outer membrane lipoprotein carrier protein LolA 
FFA43_05230 acyl-CoA thioesterase 
FFA43_05575 Crp/Fnr family transcriptional regulator 
FFA43_05580 DUF2892 domain-containing protein 
FFA43_06080 helix-turn-helix domain-containing protein 
FFA43_06085 ATP-binding protein 
FFA43_06095 hypothetical protein 
FFA43_06170 hypothetical protein 
FFA43_06270 hypothetical protein 
FFA43_06425 hypothetical protein 
FFA43_06465 hypothetical protein 
FFA43_06470 hypothetical protein 
FFA43_06475 hypothetical protein 
FFA43_06480 hypothetical protein 
FFA43_06485 hypothetical protein 
FFA43_06490 conjugal transfer protein TraG 
FFA43_06495 transposase 
FFA43_06810 site-specific DNA-methyltransferase 
FFA43_06955 DASS family sodium-coupled anion symporter 
tcuB tricarballylate utilization 4Fe-4S protein TcuB 
tcuA FAD-dependent tricarballylate dehydrogenase TcuA 
FFA43_06970 hypothetical protein 
FFA43_06975 GntR family transcriptional regulator 
FFA43_06980 cupin domain-containing protein 








Appendix 6 continued 
Gene Product 
FFA43_07090 major outer membrane protein 
FFA43_07095 major outer membrane protein 
FFA43_07335 DUF302 domain-containing protein 
nhaA Na+/H+ antiporter NhaA 
FFA43_07505 MFS transporter 
FFA43_07510 sel1 repeat family protein 
FFA43_07555 3-oxoacyl-ACP synthase 
pseF pseudaminic acid cytidylyltransferase 
FFA43_07970 TIM barrel protein 
FFA43_07975 hypothetical protein 
FFA43_07980 ATP-grasp domain-containing protein 
FFA43_07985 class I SAM-dependent methyltransferase 
FFA43_07990 class I SAM-dependent methyltransferase 
FFA43_08145 GNAT family N-acetyltransferase 
FFA43_08155 hypothetical protein 
FFA43_08165 methyltransferase domain-containing protein 
FFA43_08235 sel1 repeat family protein 
FFA43_08315 type II toxin-antitoxin system PemK/MazF family  toxin 
FFA43_08320 hypothetical protein 
FFA43_08325 restriction endonuclease subunit S 
FFA43_08805 hypothetical protein 



















Appendix 7:  
Genes absent in C. hyointestinalis S12 but present in C. hyointestinalis LMG 
9260 examined 
Gene Product 
CHH_0008 IS605/IS607 family integrase/resolvase 
CHH_0009 IS605/IS607 family transposase 
CHH_0022 iron-containing alcohol dehydrogenase 
CHH_0023 putative serine acetyltransferase 
CHH_0024 methyltransferase 
CHH_0025 aminotransferase, DegT/DnrJ/EryC1/StrS family 
CHH_0026 PseG family hydrolase 
CHH_0027 cytidylyltransferase, putative 
CHH_0028 N-acetylneuraminate synthase 
CHH_0029 putative Zn-peptidase, M28 family (DUF2172 domain) 
CHH_0030 hypothetical protein 
CHH_0031 putative tungsten cofactor oxidoreducase radical SAM 
maturase 
CHH_0032 hypothetical protein 
CHH_0033 methyltransferase 
CHH_0034 hypothetical protein 
CHH_0035 polysaccharide biosynthesis protein, putative 
CHH_0036 aldolase/citrate lyase family protein 
CHH_0037 3-deoxy-D-manno-octulosonate cytidylyltransferase 
CHH_0038 methyltransferase FkbM family protein, putative 
CHH_0039 maltose O-acyltransferase (MAT)-like  acetyltransferase 
CHH_0040 nucleoside-diphosphate-sugar epimerase 
CHH_0041 maltose O-acyltransferase (MAT)-like  acetyltransferase 
CHH_0042 xenobiotic acyltransferase (XAT) family 
acetyltransferase 
CHH_0043 SAM-dependent methyltransferase 
CHH_0044 dehydrogenase, putative 
CHH_0045 nucleoside-diphosphate-sugar epimerase 
CHH_0046 cyclase family protein 
CHH_0047 putative phosphatase, HAD family protein 
CHH_0048 putative membrane protein 
CHH_0049 glucose-1-phosphate cytidylyltransferase, putative 
CHH_0050 CDP-glucose 4,6-dehydratase, putative 
CHH_0051 dTDP-4-dehydrorhamnose 3,5-epimerase 
CHH_0052 nucleoside-diphosphate-sugar epimerase 
CHH_0053 glycosyltransferase, family 2 
CHH_0054 SAM-dependent methyltransferase 
CHH_0055 aminotransferase, DegT/DnrJ/EryC1/StrS family 
CHH_0056 FemAB family protein 
CHH_0057 polysaccharide deacetylase 






Appendix 7 continued 
Gene Product 
CHH_0059 glycosyltransferase, family 1 
CHH_0060 hypothetical protein 
CHH_0061 hypothetical protein 
CHH_0062 hypothetical protein 
CHH_0063 sugar transferase 
CHH_0069 putative type II secretion system protein 
CHH_0072 [FeFe] hydrogenase H-cluster maturation GTPase HydF 
CHH_0073 [FeFe] hydrogenase H-cluster radical SAM maturase 
HydE 
CHH_0074 [FeFe] hydrogenase H-cluster radical SAM maturase 
HydE 
CHH_0075 hydrogenase, cytochrome b subunit 
CHH_0076 [FeFe] hydrogenase, small subunit 
CHH_0077 [FeFe] hydrogenase, large subunit 
CHH_0174 acetyltransferase 
CHH_0175 putative DUF2156 domain protein 
moeA2 molybdopterin molybdenumtransferase 
CHH_0177 putative selenium metabolism protein, YedE family 
CHH_0211 hypothetical protein 
CHH_0212 putative transcriptional regulator, XRE family  
(peptidase S24 LexA-like domain) 
CHH_0214 hypothetical protein 
CHH_0216 hypothetical protein 
CHH_0217 hypothetical protein 
CHH_0218 putative replication protein 
CHH_0219 hypothetical protein 
gmhB D,D-heptose 1,7-bisphosphate phosphatase 
waaD ADP-L-glycero-D-mannoheptose-6-epimerase 
waaE D,D-heptose 1-phosphate adenosyltransferase / 7-
phosphate kinase 
gmhA sedoheptulose 7-phosphate isomerase 
waaF heptosyltransferase II 
CHH_0352 glycosyltransferase, family 1 
CHH_0353 putative O-antigen ligase 
CHH_0354 glycosyltransferase, family 9 
CHH_0355 glycosyltransferase, family 1 
CHH_0356 glycosyltransferase, family 9 
CHH_0357 glycosyltransferase, family 1 
CHH_0358 glycosyltransferase, family 9 
CHH_0359 putative polysaccharide deacetylase 
waaQ heptosyltransferase III 
CHH_0361 glycosyltransferase, family 2 
waaM lipid A biosynthesis lauroyl acyltransferase 
waaC heptosyltransferase I 






Appendix 7 continued 
Gene Product 
CHH_0422 IS605/IS607 family integrase/resolvase 
CHH_0423 IS605/IS607 family transposase 
CHH_0506 putative type II secretion system protein 
CHH_0592 membrane-associated zinc metalloprotease,  S2P/M50 
family 
CHH_0736 putative copper homeostasis protein, NlpE family 
CHH_0810 hypothetical protein 
CHH_0811 putative AAA domain protein 
CHH_0823 toxin-antitoxin system, antitoxin component 
CHH_0824 toxin-antitoxin system, toxin component, YafQ  family 
CHH_0825 putative restriction endonuclease 
CHH_0826 hypothetical protein 
CHH_0828 putative membrane protein 
CHH_0829 hypothetical protein 
CHH_0830 putative membrane protein 
CHH_0831 zonula occludens toxin (Zot) family protein 
CHH_0832 type II and III secretion system protein 
CHH_0833 putative phage replication initiation protein 
CHH_0833 putative phage replication initiation protein 
CHH_0834 site-specific recombinase, phage integrase family 
CHH_0837 outer membrane beta-barrel domain protein 
CHH_0941 DASS family sodium/dicarboxylate symporter 
CHH_0942 MatE efflux family protein 
hypA hydrogenase nickel insertion protein HypA 
hypE hydrogenase expression/formation protein HypE 
hypD hydrogenase expression/formation protein HypD 
hypC hydrogenase assembly chaperone HypC 
CHH_0982 membrane protein, TerC family 
CHH_0983 TerZ/TerD family protein 
CHH_0984 TerZ/TerD family protein 
CHH_0985 transcriptional regulator, XRE family 
CHH_1055 type III restriction/modification system, mod  subunit 
CHH_1056 type III restriction/modification system, res subunit 
CHH_1107 tellurite-resistance/dicarboxylate transporter  (TDT) 
family protein 
CHH_1108 cytochrome b 
CHH_1109 dehydrogenase/reductase, iron-sulfur cluster subunit 
CHH_1110 transcriptional regulator, Crp family 
CHH_1111 putative oxidoreductase/sulfur reductase 
CHH_1112 putative DUF2892 domain protein 
CHH_1113 putative DUF2892 domain protein 







Appendix 7 continued 
Gene Product 
CHH_1228 hypothetical protein 
CHH_1231 putative membrane protein 
CHH_1232 hypothetical protein 
CHH_1233 hypothetical protein 
CHH_1234 hypothetical protein 
CHH_1274 putative membrane protein 
CHH_1275 hypothetical protein 
CHH_1276 hypothetical protein 
CHH_1296 YopX family protein 
CHH_1297 putative membrane-bound metal-dependent hydrolase 
(DUF457 domain) 
CHH_1298 hypothetical protein 
CHH_1299 putative membrane protein 
CHH_1303 transcriptional regulator, AraC family 
CHH_1307 IS605/IS607 family transposase 
CHH_1308 IS605/IS607 family integrase/resolvase 
fla1 flagellin 
CHH_1466 autotransporter domain protein 
CHH_1518 putative type II secretion system protein 
CHH_1539 IS605/IS607 family transposase 
CHH_1540 IS605/IS607 family integrase/resolvase 
pseF CMP-pseudaminic acid synthetase 
CHH_1589 ATP-grasp domain-containing protein 
CHH_1590 ATP-grasp domain-containing protein 
CHH_1591 adenylylsulfate kinase 
CHH_1592 phosphonopyruvate decarboxylase, putative 
CHH_1593 phosphoenolpyruvate phosphomutase, putative 
CHH_1594 radical SAM superfamily enzyme,MoaA/NifB/PqqE/SkfB 
family (SPASM domain) 
CHH_1595 putative CDP-alcohol phosphatidyltransferase 
pseG UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-
altropyranosyl transferase 
CHH_1597 WbqC family protein 
CHH_1598 SAM-dependent methyltransferase 
CHH_1599 aminotransferase, DegT/DnrJ/EryC1/StrS family 
CHH_1646 hypothetical protein 
hsdS type I restriction/modification system, S subunit 
CHH_1681 hypothetical protein 
CHH_1682 putative OmpA/MotB domain protein 
CHH_1683 putative membrane protein 
CHH_1764 hypothetical protein 
CHH_1768 hypothetical protein 







Appendix 7 continued 
Gene Product 
CHH_1770 relaxase 
CHH_1771 putative toxin-antitoxin system, toxin component, 
RelE/ParE family 
CHH_1772 putative toxin-antitoxin system, toxin  component, 
RelE/ParE family 
CHH_1773 hypothetical protein 
CHH_1774 hypothetical protein 
CHH_1775 site-specific recombinase, phage integrase family 


























Appendix 8:  
 
Nucleotide BLAST results from CRISPR direct repeats consensus sequence in 



















Campylobacter fetus subsp. 
testudinum 772 
100 100 2e-08 
Campylobacter fetus subsp. 
testudinum Sp3 
 
100 100 2e-08 
Campylobacter fetus subsp. 
testudinum pet-3 
 
100 100 2e-08 
 
 



































Appendix 9:  




















































Appendix 10:  
Nucleotide BLAST results from CRISPR Number 2 spacers in C. hyointestinalis 
S12 
CRISPAR 2 
















































































































































































































Nucleotide BLAST results from CRISPR Number 3 spacers in C. hyointestinalis 
S12 
CRISPAR 3 
Regions Direct Repeats 
 





























































































































































































































































































































































































































Nucleotide BLAST X results from CAS-Type IB genes sequences in C. 
hyointestinalis S12 
 
CAS-Type IB genes Best Match Description Cover % Identity % e-value 
 









99 99.09 0.0 
CRISPR-associated endonuclease 
Cas1 [Campylobacter fetus] 
 
99 98.48 0.0 
Cas2_0_I-II-III_2 CRISPR-associated endonuclease 
Cas2 [Campylobacter fetus] 
 
99 98.91 2e-51 
MULTISPECIES: CRISPR-
associated endonuclease Cas2 
[Campylobacter] 
 
99 100 2e-51 
CRISPR-associated endonuclease 
Cas2 [Campylobacter fetus] 
 
99 98.91 8e-51 














99 98.79 3e-118 
Cas3_0_I_4 CRISPR-associated helicase Cas3 
domain-containing protein 
[Campylobacter fetus subsp. 
fetus] 
99 99.31 0.0 
CRISPR-associated helicase Cas3 
domain-containing protein 
[Campylobacter fetus subsp. 
fetus] 
99 99.03 0.0 
CRISPR-associated helicase Cas3 
domain-containing protein 
[Campylobacter fetus subsp. 
fetus] 
99 99.03 0.0 
Cas5_1_IB_5 CRISPR-associated protein Cas5 
[Campylobacter hyointestinalis] 
99 100 3e-174 
CRISPR-associated protein Cas5 
[Campylobacter hyointestinalis] 
 
99 99.58 8e-174 
CRISPR-associated protein Cas5 
[Campylobacter fetus] 
 









Cas7_2_IB_6 type I-B CRISPR-associated protein Cas7/Csh2 
[Campylobacter hyointestinalis] 
 
99 100 0.0 
type I-B CRISPR-associated protein Cas7/Csh2 
[Campylobacter hyointestinalis] 
 
99 99.67 0.0 
type I-B CRISPR-associated protein Cas7/Csh2 
[Campylobacter hyointestinalis] 
 
99 99.02 0.0 
